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Summary
Over the last 20 years, the number of assisted reproduction procedures has 
drastically increased, and this trend is expected to continue as parenthood is 
postponed. In Europe, more than half a million in vitro fertilization (IVF) cycles 
are performed annually, resulting in 100,000 newborns. With the increased use 
of assisted reproduction, a concomitant increase in success rates would also be 
expected. However, the pregnancy rate per cycle has remained constant over 
the same 10-year range, despite important progress in the field. The majority 
of women using assisted reproduction are over 35 years old, and this needs to 
be taken into consideration since the rate of chromosomal abnormalities in the 
oocytes increases with age. As a consequence, advanced maternal age may 
result in an increase in the number of aneuploid embryos, which would be 
translated into high miscarriage rates and low live-birth rates. Since we are not 
able to modify the IVF population or to change embryo quality, our goal should 
be to focus on improving IVF techniques. Such improvement necessitates a 
better understanding of the etiology of embryo aneuploidies. Recent advances 
in imaging and molecular and genetic analyses are postulated as promising 
strategies to unveil the mechanisms involved in aneuploidy generation. Thus, 
our goal was to analyse, simultaneously in the same human embryo, 
morphology, kinetics, transcriptomics and genetics to find a correlation 
between these parameters in the origin of aneuploidies. 
Here we combine time-lapse, complete chromosomal assessment and single-cell 
real-time quantitative PCR to simultaneously obtain information from all cells 
that compose a human embryo until the approximately eight-cell stage. Our 
data indicate that the chromosomal status of aneuploid embryos correlates 
with significant differences in the kinetic pattern when compared with euploid 
embryos, especially in the duration of the first mitotic phase. We also 
demonstrate that embryo kinetics is affected by the existence of irregular 
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divisions during development, and this should be taken into consideration for 
future studies. Gene expression analyses reveal that embryonic genome 
activation starts as early as the zygote stage. Moreover, gene expression 
profiling suggests that a subset of genes is differentially expressed in aneuploid 
embryos during the first 30 hours of development. Thus, we propose that the 
chromosomal fate of an embryo is likely determined as early as the pronuclear 
stage and may be predicted by a 12-gene transcriptomic signature. Finally, the 
atlas generated from the data obtained in this study shows the high variability 
underlying human embryo development. While euploid embryos seem to follow 
a uniform development without high variability for morphokinetics, aneuploid 
embryos may follow different pathways, overlapping with and mimicking 
euploid embryos in some cases, making them hard to differentiate. 
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Resumen 
 
Introducción 
Durante los últimos veinte años, el número de procedimientos de reproducción 
asistida ha aumentado drásticamente e, igualmente, se espera que continúe 
aumentando debido al retraso existente en la maternidad. En Europa se 
realizan más de medio millón de ciclos de fecundación in vitro (FIV) cada año, 
dando lugar a aproximadamente 100.000 recién nacidos, lo cual equivale al 
1.5% de niños nacidos en Europa. 
Junto con la expansión en el campo de la reproducción asistida, el número de 
avances, tanto técnicos como científicos, también ha ido en aumento. Sin 
embargo, a pesar de los esfuerzos, las tasas de embarazo por ciclo han 
permanecido constantes durante los últimos diez años. Las características de la 
población que hace uso de estos tratamientos, cuya edad sobrepasa los 35 años 
en más del 70% de los casos, puede estar correlacionada con la existencia de 
este techo de cristal, ya que se ha descrito que la tasa de anomalías 
cromosómicas aumenta significativamente con la edad materna. Como 
consecuencia, los embriones fecundados in vitro a partir de ovocitos de 
mujeres de edad materna avanzada tienen una mayor probabilidad de ser 
cromosómicamente anormales, lo cual tiene como consecuencia un aumento en 
las tasas de aborto y una disminución en las de recién nacido vivo. 
Puesto que no existe la posibilidad de modificar las características de la 
población que requiere tratamientos de FIV, al menos desde un punto de vista 
clínico, ni tampoco la de modificar la calidad embrionaria a nivel genético, el 
objetivo actual debería estar dirigido a mejorar las técnicas empleadas durante 
los tratamientos de FIV para minimizar el posible efecto sobre la calidad 
embrionaria. Para el desarrollo de nuevas herramientas de cultivo y selección 
embrionaria es necesario un mejor conocimiento de la biología de los 
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embriones humanos. Sin embargo, debido al uso limitado de estos para fines 
científicos, el número de estudios en embriones completos y de buena calidad 
es muy limitado. Y esto, junto a la naturaleza multifactorial de las anomalías 
cromosómicas, ha hecho aún más complejo encontrar los mecanismos 
relacionados con las causas y consecuencias de la existencia de aneuploidías 
durante el desarrollo embrionario. 
Los avances tecnológicos más recientes en análisis de imagen, análisis 
molecular y genético se presentan como una prometedora estrategia para 
desvelar la maquinaria implicada en la generación de aneuploidías. Así, nuestra 
hipótesis es que tanto la morfología, la cinética, como la transcriptómica del 
embrión están relacionados con la existencia de aneuploidías, ya sea como 
causa o como efecto, y un estudio simultáneo de todos estos parámetros en un 
mismo embrión podría permitir entender mejor la biología del desarrollo 
preimplantacional humano. 
Objetivos 
El objetivo general de este estudio fue investigar en detalle el origen y las 
consecuencias de la aparición de aneuploidías durante el desarrollo 
preimplantacional del embrión humano. Para ello, se llevaron a cabo los 
siguientes objetivos específicos: 
O1. Realización de un análisis descriptivo del embrión humano a cuatros 
niveles diferentes: morfología, cinética, transcriptómica y tasa de 
aneuploidías. 
O2. Estudio de las posibles relaciones entre morfología, patrones cinéticos, 
expresión génica y existencia de aneuploidías. 
O3. Desarrollo de un modelo de predicción de aneuploidías basado en las 
diferencias más significativas encontradas entre embriones 
aneuploides y euploides.  
O4. Integración de los datos sobre morfocinética, transcriptómica y 
aneuploidías para crear un atlas único sobre el desarrollo 
preimplantacional humano.  
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Métodos 
Se descongelaron ciento diecisiete (117) cigotos humanos donados a 
investigación provenientes de 19 parejas con una edad media materna de 33.7 
± 4.3 años. De ellos, sobrevivieron Ochenta y cinco cigotos, los cuales fueron 
cultivados usando la tecnología de time-lapse, que permite crear una película 
del desarrollo embrionario a partir de fotografías tomadas cada 5 minutos. Los 
embriones fueron cultivados durante diferentes tiempos incluyendo el estadio 
pronuclear y las siete primeras divisiones mitóticas. Tras el cultivo, cada 
embrión se desagregó en células individuales, incluyendo los corpúsculos 
polares en aquellos en estadio de cigoto. La mitad de las células de cada 
embrión se amplificaron usando la técnica de WGA (Whole Genome 
Amplification), que permite la amplificación de ADN a nivel de célula única, 
para ser analizadas posteriormente mediante arrays de CGH (Comparative 
genomic hybridization) y determinar así su dotación cromosómica. Por otro 
lado, la otra mitad de las células de cada embrión se analizaron mediante PCR 
cuantitativa mediante un sistema de microfluidos que permitía el análisis a 
nivel de célula única. Así, se estudió la expresión de 86 genes relacionados con 
la existencia de aneuploidías en la bibliografía previa para determinar el perfil 
transcriptómico de los embriones. Finalmente, se correlacionaron los 
parámetros morfocinéticos, obtenidos en las películas de time-lapse, el estadio 
cromosómico y los niveles de expresión génicos para cada embrión. 
Conclusiones 
C1. Los parámetros morfológicos pueden tener un comportamiento dinámico 
durante el desarrollo embrionario. En concreto, los fragmentos celulares, 
los cuales aparecen mayoritariamente durante la primera división mitótica 
del embrión pueden dividirse, fusionarse a otros fragmentos o ser 
reabsorbidos por blastómeras. 
C2. Los parámetros cinéticos se ven alterados por la existencia de divisiones 
irregulares durante el desarrollo embrionario, por lo cual estos deben 
calcularse de manera independiente según el tipo de división para evitar 
conclusiones confusas. 
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C3. Más de la mitad de los embriones humanos en este estudio, provenientes 
de pacientes de técnicas de reproducción asistida fueron aneuploides. 
Además, según los resultados, la incidencia de aneuploidías está 
correlacionada con la existencia de multinucleación, aunque no con la 
existencia de fragmentación o vacuolas en el embrión.  
C4. Durante el desarrollo embrionario, encontramos grupos de genes con 
diferentes patrones de expresión según su origen de transcripción: 
materno, embrionario o ambos. Además, se observó que la activación 
embrionaria ocurre desde el estadio más temprano del embrión humano, 
el cigoto.  
C5. La cinética de los embriones aneuploides está alterada en comparación 
con los euploides. En concreto, el tiempo entre la desaparición pronuclear 
y el comienzo de la primera citocinesis fue más largo en los embriones 
aneuploides. Además, el tiempo entre los estadios de tres y cuatro células 
fue también más largo en los embriones aneuploides, aunque esta 
diferencia se debió a la mayor proporción de embriones aneuploides con 
divisiones irregulares, las cuales alteran el patrón cinético embrionario.  
C6. El perfil transcriptómico de los embriones aneuploides mostró diferencias 
estadísticamente significativas durante las primeras 30 horas de desarrollo 
frente al de los embriones euploides. Gracias a estas diferencias, se 
comprobó que la existencia de aneuploidías en los embriones en estadio 
de células se puede predecir haciendo uso de una firma transcriptómica 
basada en 12 genes. 
C7. El atlas del embrión humano generado con los datos de este estudio 
muestra una alta variabilidad durante el desarrollo preimplantacional 
embrionario. Mientras que los embriones euploides parecen seguir una 
única ruta para desarrollarse satisfactoriamente sin mucha variabilidad en 
su morfocinética, los embriones aneuploides siguen múltiples rutas, 
solapándose y camuflándose en ocasiones con el comportamiento de los 
embriones euploides, dificultando así su diferenciación mediante técnicas 
no-invasivas. 
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SNP Single nucleotide polymorphism  
SOX2 SRY-box 2  
SPS Serum Protein Substitute  
TE Trophectoderm  
TP53 Tumor protein p53  
TSC2 Tuberous sclerosis 2  
WGA Whole genome amplification  
WOI Window of implantation  
XPA DNA damage recognition and repair factor  
YBX2 Y-box-binding protein 2  
YY1 Yin Yang 1 transcription factor  
ZAR1 Zygote arrest 1  
ZSCAN4 Zinc finger and SCAN domain containing 4  
μL Microliter 
°C Degrees Celsius  
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1 | Introduction 
 
1.1 Assisted reproduction overview 
Over the last 20 years, the number of assisted reproduction procedures has 
drastically increased. This trend is expected to continue as parenthood is 
postponed. In Europe, more than half a million in vitro fertilization (IVF) cycles 
are performed annually, resulting in 100,000 newborns, or 1.5% of all babies 
born in Europe (Sullivan et al., 2013). The number of IVF cycles registered in 
Spain increased 1.7-fold over 10 years, from 63,215 in 2004 to 108,492 in 2013 
(Figure 1). Similarly, over the same time period, the annual number of cycles in 
the United States increased 1.5-fold, from 128,216 to 190,773 (Figure 1). 
 
 
Figure 1 | Number of assisted reproduction cycles registered in Spain and the United 
States from 2004 to 2013.  
Data were obtained from the annual reports created by the Spanish society of fertility 
(Sociedad Española de Fertilidad, SEF; www.registrosef.com) and the United States 
Centers for Disease Control and Prevention (CDC, www.cdc.gov/art/reports). 
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With the increased use of assisted reproduction, a concomitant increase in 
success rates would also be expected. However, the pregnancy rate per cycle 
has remained constant over the same 10-year range, despite important progress 
in the field (Figure 2).  
 
 
Figure 2 | Pregnancy rate per cycle started in Spain and the United States from 2004 
to 2013.  
Data were obtained from the annual reports created by the Spanish society of fertility 
(Sociedad Española de Fertilidad, SEF; www.registrosef.com) and the United States 
Centers for Disease Control and Prevention (CDC, www.cdc.gov/art/reports). The 
pregnancy rate per cycle from the United States was derived from fresh non-donor cycles 
since pregnancy rates from frozen and/or donor cycles were not available. The pregnancy 
rate from Spanish data was calculated including fresh and frozen cycles, as well as non-
donor and donor cycles. 
 
To understand the origin of the slow progress in IVF success rates, it is 
important to understand the type of populations that require these techniques. 
In 2013, the population undergoing IVF and intracytoplasmic insemination (ICSI) 
in Spain was mostly over 35 years old (72.3%), with a significant percentage of 
women over 40 years old (28.9%, Figure 3a). Furthermore, the age distribution 
for 2013 in the United States assisted reproduction technology (ART) population 
indicates 64.6% of patients were over 35 years old, and 23.1% over 40 years old 
(Figure 3b). Both countries’ populations showed a similar age distribution in the 
same year, with a slight increase in younger patients (<35 years) in the United 
States. This majority of women using ART at over 35 years old needs to be 
taken into consideration since it is well known that the rate of chromosomal 
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abnormalities increases with age (Hassold and Hunt, 2001). As a consequence, 
the advanced maternal age (AMA) may result in an increase in the number of 
aneuploid embryos (Demko et al., 2016), which would be translated into high 
miscarriage rates and low live-birth rates (Schoolcraft et al., 2009; Rubio et 
al., 2013a). 
 
 
 
Figure 3 | Age distribution in assisted reproduction cycles in Spain and the United 
States in 2013. 
(a) In the Spanish ART population, almost 29% of the patients are 40 years and older. Data 
obtained from the annual reports created by the Spanish society of fertility. *Based on 
67,754 cycles. (b) In the United States population using ART, 23.1% of the registered 
patients were over 40 years old. Data obtained from the annual reports generated by the 
Centers for Disease Control and Prevention. Based on 190,773 cycles. 
 
Once we characterize the population that needs IVF treatments, a better 
understanding of the human embryo is also crucial. We need to know how 
infertility affects embryo biology and how frequent embryos will fail in 
development with the possible causes: aneuploidies, abnormal pool of inherited 
transcripts, fail in embryonic genome activation (EGA) or others. 
Finally, since we are not able to modify the IVF population nor to possibly 
change the embryo quality, our goal should be mainly to focus on improving the 
IVF techniques by developing new physiological stimulation protocols, better 
culture systems and more effective selection methods. This knowledge and 
improvements, together with proper endometrial synchronization, would help 
to guarantee the success of ART as resulting in a healthy newborn. 
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1.2 The molecular inner life of the human embryo 
For a complete understanding of the influence of each in vitro procedure on 
embryo biology, it is important to understand the underlying biological 
processes. Notably, most knowledge related to the preimplantation embryo 
relies on in vitro models due to the difficulties in observing it in natural 
conditions. 
1.2.1 Meiosis and mitosis 
Meiosis in humans varies considerably between males and females (Figure 4). In 
females, meiosis begins somewhat synchronously in all oocytes during fetal 
development, but then arrests before birth. Resumption of meiosis occurs 
asynchronously after puberty, at the time of ovulation, but arrests again until 
fertilization (Vera et al., 2012). In contrast, male meiosis does not begin until 
puberty and occurs continuously throughout adulthood. Primary spermatocytes 
divide into two secondary spermatocytes through meiosis I, and each secondary 
spermatocyte divides into two spermatids, which will differentiate and 
maturate into sperm. The main difference between the male and female 
production of gametes is that oogenesis only leads to the production of one 
final ovum from each primary oocyte; in contrast, in males four sperm result 
from each primary spermatocyte (Figure 4). Three events can lead to 
aneuploidy during MI: failure to resolve chiasmata, resulting in a true non-
disjunction; no chiasma formation or early disappearance of one, resulting in an 
achiasmate non-disjunction; and, finally, a premature separation of sister 
chromatids (Hassold and Hunt, 2001). In meiosis II the only cause of aneuploidy 
is non-disjunction of sister chromatids (Hassold and Hunt, 2001).  
After fertilization, the zygote undergoes multiple rounds of mitosis to further 
develop. In human embryos, mitotic errors occur frequently; their origins have 
been attributed to the non-disjunction of some chromosomes or to a failure in 
separating during anaphase, creating one daughter cell with an extra 
chromosome and another with a missing chromosome (Mantikou et al., 2012; 
Carbone and Chavez, 2015). In general, mitotic errors will then produce mosaic 
embryos, with different chromosomally distinct cells, whereas meiosis errors 
will produce aneuploid embryos in which every blastomere will be affected 
INTRODUCTION 
 7 
with the same alteration, unless subsequent mitotic errors have modified the 
chromosome complement of some blastomeres, or some aneuploidy-correcting 
mechanism have taken place. The rates of aneuploidies from meiotic or mitotic 
origin in the bibliography are very varied, as they will be modified by the 
maternal age, sperm quality or culture conditions between others (Voullaire et 
al., 2000; Chavez et al., 2012; Capalbo et al., 2013a; Chow et al., 2014). 
 
Figure 4 | Gamete formation in males (spermatogenesis) and females (oogenesis). 
During spermatogenesis, the primordial germ cell will suffer a series of mitotic and 
meiotic divisions that will originate four spermatozoa from each primary spermatocyte. 
By contrary, during oogenesis, each primary oocyte will develop into a single oocyte, 
since the rest of the daughter cells will correspond to the polar bodies, that are not 
destined to further develop. n, number of chromosomes; c, number of chromatids. 
  
  8 
1.2.2 Embryo transcriptomics  
One unique process that takes place during embryonic development is the 
maternal-zygotic transition (MZT). During the last part of oogenesis, the oocyte 
accumulates a series of transcripts and proteins to support very early 
development, before the embryonic genome is activated. Although the average 
life span of a messenger ribonucleic acid (mRNA) is estimated at around 10 
hours (Schwanhausser et al., 2011), maternal transcripts can last longer thanks 
to a protection mechanism that stabilizes them, as it has been described in 
mouse (Yu et al., 2003).  
Studies of embryo transcriptomics have been limited, especially for good-
morphology embryos, as embryo availability is very limited. Nevertheless, 
several reports have contributed to a better understanding of the MZT and 
embryonic genome activation (Table 1). The major wave of embryonic 
transcription occurs at the six- to eight-cell stage, though there is minor 
transcription of certain genes beginning at the two-cell stage (Dobson et al., 
2004; Zhang et al., 2009; Galan et al., 2010; Vassena et al., 2011) (Table 1). A 
subset of genes is potentially activated as early as the zygote stage (Xue et al., 
2013). These observations suggest that, contrary to a longstanding hypothesis, 
there is not a punctual activation by the embryo genome, but it is rather a 
gradual process in which different genes start their transcription according to 
the moment in which they are required in development. This would not 
undermine the maternal transcripts, which may still play an important role in 
guaranteeing the necessary machinery for fertilization and to escort the 
zygote/embryo to start its development with a minimal support is provided, 
allowing the embryo to become molecularly independent in a gradual manner. 
An interesting study with human embryos showed that the embryonic genome 
activation and maternal transcript degradation are independent processes of 
cell division (Dobson et al., 2004). More specifically, arrested embryos showed 
similar transcriptomic status to embryos with similar developmental time, 
instead of embryos at a similar cell-stage (Dobson et al., 2004). This 
information provides a question mark for the reliability of performing 
comparative studies of embryos according to their number of cells. It remains 
  
Table 1 | Transcriptomic studies in human embryo development 
 
Technique Embryo stage N Main outcomes 
Dobson et al. 2004 Microarrays from 
whole embryos 
6 stages: GV, MI, MII, 2-c, 
4-c, 8-c 
22  Arrested embryos are not linked to EGA failure 
Zhang et al. 2009 Microarrays from 
pool of embryos 
6 stages: GV, MI, MII, 4-c, 
8-c, blastocyst 
12  Two EGA waves  
 Embryo development genes are very conserved 
Galan et al. 2010 Microarrays from 
single cells 
4 stages: 5-c, 6-c, 8-c, 
blastocysts (TE and ICM) 
49  Blastomere fate is not committed for ICM or TE at 
the cleavage stage. 
Vassena et al. 2011 Microarrays from 
whole embryos 
7 stages: oocyte, 2-c, 4-c, 
6-c, 8/10-c, morula, 
blastocyst 
19  Three EGA waves at 2-c, 4-c and 8/10-c  
 Activation of pluripotency genes 
Shaw et al. 2013 Microarrays from 
whole embryos 
3 stages: oocyte, 4-c, 
blastocyst 
9  High variability between embryos from same stage 
Xue et al. 2013 Single-cell  
RNAseq 
6 stages: oocyte, zygote, 
2-c, 4-c, 8-c, morula 
36  EGA starts already at zygote stage 
 Detection of monoallelic expression genes 
Yan et al. 2013 Single-cell  
RNAseq 
7 stages: oocyte, zygote, 
2-c, 4-c, 8-c, morula and 
blastocysts (ICM and TE) 
90  Patterns of alternative splicing during development 
 Description of novel long noncoding RNAs 
 EPI, PE, and TE lineage segregation 
GV, germinal vesicle; MI, metaphase I; MII, metaphase II; 2-c, two-cell; 4-c, four-cell; 5-c, five-cell; 6-c, six-cell; 8-c, eight-cell; TE, trophectoderm; ICM, inner cell mass; EGA, embryonic genome 
activation; EPI, epiblast; PE, primitive endoderm. 
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to be known if this feature would also be similar at different biological levels, 
such as cell fate decisions, cell communications or embryonic metabolic needs. 
1.2.3 Early embryo metabolism  
Once the oocyte has been fertilized and starts the process of transcription, the 
embryo also activates its own metabolism to provide energy for the cell, to 
maintain intracellular homeostasis and to provide all necessary metabolites for 
growth and development. Under in vitro conditions, the human embryo obtains 
ATP, the main energy source, by non-oxidative and also by oxidative 
metabolism. Thus, the importance of oxygen during in vitro embryo culture, 
whose consumption would increase with development.  
As the human embryo development is a series of subsequently cell divisions, 
deoxyribonucleic acid (DNA) synthesis and replication are crucial processes that 
require energy consumption. The pentose phosphate pathway generates ribose-
5-phosphates that are the nucleotides involved for all DNA-related processes. 
This pathway also generates nicotinamide adenine dinucleotide phosphate 
(NADPH), which is necessary in the majority of anabolic pathways, such as 
glycolysis. After EGA, the glucoses are a key component for embryo 
development, as they are essential for the synthesis of lipids, amino acids and 
nucleic acids. It has been suggested that the ratio between different amino 
acids is more relevant than the concentration, as they compete with each other 
for the different membrane transport systems (Baltz, 2012). 
For proper homeostasis and pH regulation in the cells, a correct balance of 
electrolytes is also crucial. Similarly, vitamins are necessary for some metabolic 
processes, such as methylation, by folic acid and vitamin B12; or for redox 
system, by vitamins C and E. Finally, the role of the growth factors in vitro is 
still unclear, although they seem to have a positive effect on the cell number 
and embryo quality. 
In summary, for in vitro embryo development, the composition of the embryo 
culture media is essential and needs to be very carefully designed, as this is the 
main source from which the embryo has to obtain all necessary molecules for 
growth.
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1.3 In vitro fertilization procedures 
The regular natural process of reproduction involves the ovulation of a single 
oocyte by the woman, which needs to be fertilized by a single sperm from the 
semen of the man. Both gametes, oocyte and sperm, are haploid, thus their 
union creates a diploid cell that will develop into a healthy newborn. When 
there is a problem of infertility, an IVF process is needed, preceded by a 
controlled ovarian stimulation (COS) and followed by a supervised embryo 
development to select the best embryo to be transferred at the right timing for 
a correct synchronization with the endometrium. Each step of the process is 
crucial for the final success of the procedure, and therefore the reproductive 
medicine community should work toward the improvement of all of them.  
1.3.1 Controlled ovarian stimulation  
The human ovulation system involves, in most cases, the availability of only one 
oocyte per cycle, meaning a unique possibility for pregnancy every 28 days. If 
we add to this an infertility situation, the chances of success diminish 
significantly. This observation resulted in COS being established as a procedure 
to bypass the low expectations of natural cycles once infertility is present, 
enabling production of a higher number of mature follicles per cycle and, 
therefore, a higher number of oocytes capable of being fertilized. 
Nevertheless, recent studies have shown that lower gonadotrophin doses 
increase embryo quality (Rubio et al., 2010) and that only when the stimulation 
is mild the aneuploidy rate is comparable to natural cycles, 40.6% and 34.8% 
aneuploid embryos, respectively (average female age: 25.4 ± 4 years) (Labarta 
et al., 2012). Indeed, in assessing the events occurring in the oocyte during 
gonadotrophin stimulation (Figure 5), the differences in aneuploidy rates 
between stimulation protocols may have a biological explanation. In natural 
cycles, during follicle recruitment, meiosis I is resumed with the extrusion of 
the first polar body and the selection of only one follicle; whereas in COS 
cycles, this resumption and maturation occurs in multiple follicles 
simultaneously. 
  
  
Figure 5 | Stages and events of human embryo development during in vitro fertilization procedures. 
From top to bottom, the different procedures that are performed during IVF,the equivalence of day of culture, the timing between stages according 
to the literature (Hyun et al., 2007; Wong et al., 2010; Strassburger et al., 2010; Meseguer et al., 2011; Escrich et al., 2012; Alvarez et al., 2013; 
Desai et al., 2014; Chawla et al., 2015), the developmental stages, the chromosomal content in the individual nucleus –with n being the number of 
chromosomes and c the number of chromatids per chromosome-, the transcripts maternal-zygotic transition, and the most relevant molecular events 
of embryo development. COS, controlled ovarian stimulation; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; 2n, two copies per 
chromosome; 1n, one copy per chromosome; 2c, two chromatids; 4c, four chromatids. * Average maximum time on arrest. ** Average recommended 
time in clinical routine. 
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1.3.2 In vitro fertilization process  
Once good-quality mature oocytes are obtained, we then need to focus on their 
proper fertilization, with two possible techniques to achieve this: conventional 
IVF or ICSI, which are chosen according to the seminal and clinical background 
of the patients.  
Conventional IVF is recommended for patients with good-quality sperm 
(Bhattacharya et al., 2001) and it involves the incubation of the oocyte, 
generally overnight, with sperm of good motility (ESHRE Guideline Group on 
Good practice in IVF, December, 2015). The sperm concentration is the main 
factor to control: if is too low it can decrease the chances of fertilization, and 
if is too high, it can cause polyspermia and polyploid embryos (Fukuda and 
Chang, 1978). The recommended sperm concentration for conventional IVF 
ranges from 0.1 to 0.5 million/mL of motile sperm (ESHRE Guideline Group on 
Good practice in IVF, December, 2015). 
In contrast, ICSI involves the manual injection of a single spermatozoon into a 
mature oocyte. Thus, it is specifically recommended for severe male infertility 
cases. The selection of a spermatozoon to inject is crucial for the later 
embryonic development since it has been correlated with aneuploidies in the 
sperm (Rodrigo et al., 2011). Selection of a motile and good morphology 
spermatozoon is critical to reduce the chances to introduce an abnormal 
chromosomal content (Collodel et al., 2007). The spermatozoon not only 
contributes to half of the embryonic chromosomal content, but also contributes 
one of the most essential cell organelles, the centrioles (Sathananthan et al., 
1991). The centrioles are tubulin structures that, together with the 
pericentriolar material, will create the centrosome, which has a crucial role in 
cell division by helping organize the mitotic spindle. Further, ICSI requires 
careful attention to the way in which the spermatozoon is injected into the 
embryo to avoid damage of internal structures of the embryo, such as the 
spindle. For that, it is recommended to place the polar body in the opposite 
site to the injection site, as it is an indicator of spindle position (ESHRE 
Guideline Group on Good practice in IVF, December, 2015). 
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Additionally and independently of the technique selected, the introduction of 
the sperm inside the oocyte will start the resumption of meiosis II, triggering 
the extrusion of the second polar body (Figure 5). Thus, the evaluation of 
correct fertilization includes the observation of the two pronuclei, one 
maternal and one paternal, and the first and second polar bodies. According to 
the number of polar bodies and pronuclei, abnormalities can be attributed to 
female meiosis errors or fertilization failures (Flaherty et al., 1998). This 
evaluation is recommended to be performed 16-18 hours (h) post insemination 
(ESHRE Guideline Group on Good practice in IVF, December, 2015). 
1.3.3 Embryo culture  
The preimplantation embryo development comprises multiple mitotic divisions 
starting from the zygote stage. The cell number then increases exponentially, 
since each daughter cell´s mitosis takes place in parallel, producing double the 
number of daughter cells. Thus, the normal mitosis rate of an embryo would be 
from 1 to 2 cells, from 2 to 4 cells, from 4 to 8 cells, from 8 to 16, etc. 
reaching in only five days of development around 250 cells (Niakan et al., 
2012). 
During this in vitro development we can differentiate at least three stages 
according to the cell-number and morphology (Figure 5): (1) The cleavage-
stage, when the embryo has between 2 to 8 individual cells and corresponding 
to the first 3 days of development. At this stage, each cell is called a 
blastomeres; (2) The morula, approximately 4 days after fertilization, when all 
cells of the embryo start to fuse their cytoplasm in a process called 
compaction, creating a syncytium; (3) The blastocyst stage, when, thanks to 
the Na+/K+ channels, the morula will start to accumulate fluid inside the 
embryo. This process is known as cavitation and creates a space inside the 
embryo called the blastocoel. The embryo, now known as a blastocyst, contains 
two different cell lineages: the trophectoderm, whose cells form a hollow 
sphere; and the inner cell mass, that will form a cluster inside the trophoblastic 
cells.  
During the first two stages of development, cleavage and morula, the embryo 
divides without a significant change in size; at blastocyst stage, due to 
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different collapsing movements, the embryo starts increasing its size. 
Eventually, the zona pellucida will develop a crack, in which the blastocyst will 
start hatching until, after multiple collapsing movements, the embryo leaves 
the zona pellucida. 
Sometimes an embryo does not follow the whole developmental process and 
arrests at a certain stage, eventually dying. This phenomenon of the embryo 
has been correlated with failures in embryo biology, such as transcriptomic 
alterations (Wong et al., 2010), but also with metabolic problems (Leese et al., 
2008) and an increased rate of chromosomal abnormalities (Munne et al., 
1995). 
The main goal of in vitro embryo culture is to replicate the natural conditions 
of the endometrial cavity in more optimal way. For this, the embryo culture 
must be done under very well monitored conditions (temperature, oxygen 
levels, humidity, etc.) by using incubators and heated surfaces, and by 
selecting the best culture media according to the stage and the nutritional 
requirements of the embryo, choosing between single embryo culture or co-
culture of multiple embryos of the same patient. Depending on these 
parameters, each IVF laboratory develops different protocols for embryo 
culture to achieve the best success rates, which also implies the existence of 
substantial differences between centers that create difficulties in comparisons 
between them. 
1.3.4 Implantation  
Finally, after a high-quality blastocyst is obtained, we would expect to have a 
correct implantation, but at this step, a new actor comes into scene, the 
endometrium. For implantation to occur, the endometrium needs to be 
receptive, and this is only possible during a limited period of time known as the 
window of implantation (WOI) that could be different among patients from day 
19 to 23 of their natural cycle or from progresterona+3 to progresterone+7 in 
hormonal replacement cycles (Diaz-Gimeno et al., 2011). This is different to 
what has been always established, being the reason for standard embryo 
transfer (ET) to fail, as different women would need a personalized embryo 
transfer (pET). 
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In clinical practice, it was common to transfer two embryos at the same time. 
This increases the pregnancy rates up to approximately 70% (Gardner et al., 
2000). However, although it increases slightly the pregnancy rates, it also 
increases the chances of a twin pregnancy (McLernon et al., 2010). To avoid 
this, SET has been proposed as an effective strategy to decrease the incidence 
of twins (McLernon et al., 2010; Gianaroli et al., 2012). However, to maintain 
similar pregnancy rates, especially for bad-prognosis patients, improvements on 
the embryo selection are needed. 
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1.4 How to select the best embryo 
The purpose of embryo selection is to reduce the number of transfer needed to 
achieve a pregnancy from a pool of embryos. Considering the best embryo—the 
one having the highest probabilities to implant and to develop into a healthy 
newborn—its selection should be based on all those embryonic parameters that 
have been demonstrated to be correlated with success rates in the clinical 
routine. Although this set of parameters is very wide, here we wish to discuss 
those that have gained greater popularity among the clinical community: 
morphology, kinetics and aneuploidies. We have also added transcriptomics 
since, although still experimental, it can provide some biological answers to 
support clinical observations. 
1.4.1 Morphology evaluation 
Morphology is the most traditional way to evaluate an embryo since there is no 
need for additional equipment beyond a heated surface and an inverted 
microscope. With the increase in IVF treatments and research, this type of 
evaluation has evolved toward selecting the most predictive parameters, such 
as fragmentation, cell number, symmetry, and multinucleation, and relying less 
on least predictive parameters like vacuole existence, cytoplasm anomalies and 
zona pellucida alterations (Alpha Scientists in Reproductive Medicine and ESHRE 
Special Interest Group of Embryology, 2011). 
1.4.1.1 Fragmentation  
Fragmentation is one of the main morphological parameters used in embryo 
assessment. Fragments appear when part of the blastomere’s cytoplasm 
protrudes. Embryos with a high degree of fragmentation have lower 
implantation rates (Alikani et al., 1999).  
Although the origin of the fragmentation remains unknown, it has been 
correlated to multiple inner events. One the most extended findings is that 
embryos with a higher percentage of fragments have a higher percentage of 
chromosomal abnormalities (Magli et al., 2001; Magli et al., 2007; Chavez et 
al., 2012). Indeed, one recent publication reported for the first time the 
existence of DNA in fragments of cleavage-stage embryos (Chavez et al., 2012). 
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Fragmentation has also been correlated with alterations in the expression of 
some genes, especially with increased expression of tumor protein p53 (TP53) 
transcription factor in DNA repair pathways and apoptosis (Wells et al., 2005). 
A relationship between embryo fragmentation and telomere shortening has also 
been found, which is related to TP53-mediated pathways and other precursors 
of aneuploidy abnormalities (Keefe et al., 2005; Treff et al., 2011). 
Furthermore, lower mitochondrial DNA copy number in embryos with a high 
fragmentation degree that could result in decreased ATP production, which is 
necessary for proper embryo development (Lin et al., 2004). Many other factors 
such as apoptosis (Jurisicova et al., 1996; Liu et al., 2000; Chi et al., 2011), 
cytoskeleton abnormalities (Neganova et al., 2000; Liu and Keefe, 2002; Alikani 
et al., 2005) and toxic substances (Keltz et al., 2006; Hutt et al., 2010) have 
been correlated with fragmentation. 
1.4.1.2 Cell number and symmetry  
The number of cells in the embryo is the main indicator of the number of cell 
divisions it has undergone. In conventional morphology evaluation, it is 
expected to observe one cell at day 1 (zygote stage), two to four cells at day 2, 
six to eight cells at day 3 and fourteen to sixteen cells before compaction at 
day 4 (Figure 5). When the number of cells at one stage is lower or higher than 
expected, it means that the embryo cleavage rate is either too slow or too fast, 
which has a negative impact on the implantation rate (Ziebe et al., 1997; Van 
Royen et al., 1999). A higher cell number may also be related with the previous 
existence of irregular divisions from one to more than two cells. Thus, there is 
a correlation between the cell number and the chromosomal constitution of the 
embryo (Magli et al., 2007). 
Similarly, the uneven size of blastomeres can originate from asynchronous 
divisions or from irregular divisions, as 1 to 3 divisions in which one blastomere 
is bigger or smaller than the others. Blastomere asymmetry is correlated with a 
higher percentage of aneuploidies (Hardarson et al., 2001; Munne, 2006) and 
with a decrease in the pregnancy rate (Racowsky et al., 2003). 
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1.4.1.3 Multinucleation 
In the cleavage-stage, an embryo is considered multinucleated when at least 
one of its blastomeres contains more than one nucleus. It is normally 
differentiated between binucleation, when two nuclei are present, and 
multinucleation when we can observe more than two nuclei, also called 
micronuclei.  
The origin of multinucleation has been related to nuclear membrane anomalies 
(Webster et al., 2009), DNA damage (Norppa and Falck, 2003) or to an 
asynchrony between karyokinesis and cytokinesis (Pickering et al., 1995). This 
is in concordance with the correlation found between multinucleation and a 
higher rate of aneuploidies (Pickering et al., 1995; Hardarson et al., 2001; 
Munne et al., 2006). Thus, transfer of multinucleated embryos is not 
recommended (Alpha Scientists in Reproductive Medicine and ESHRE Special 
Interest Group of Embryology, 2011), although some studies have reported 
healthy newborns from multinucleated embryos (Balakier and Cadesky, 1997; 
Jackson et al., 1998; Fauque et al., 2013).  
Finally, multinucleation has been also correlated with other morphological 
parameters, such as high degree of fragmentation (Van Royen et al., 2003; 
Chavez et al., 2012) or asymmetric divisions (Hnida et al., 2004). As a 
consequence, multinucleated embryos have been shown to reach less 
frequently the blastocyst stage, when it occurs at day 2/3 (Alikani et al., 2000), 
and have a lower implantation potential (Jackson et al., 1998; Van Royen et 
al., 2003; Chavez et al., 2012). 
1.4.1.4 Other morphological parameters 
There are also different parameters that, due to the low frequency in which 
they are found or to slight effect on embryo development, are considered to 
have secondary roles in the morphological evaluation. They include vacuole 
existence, cytoplasm anomalies or zona pellucida alterations, among others. If 
we focus on vacuoles, it seems crucial to differentiate the time of appearance, 
between oocyte, ICSI or embryo arrest, to estimate the consequences on 
success rates, being the latest the one with more detrimental effect (Ebner et 
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al., 2005). Nevertheless, vacuoles have been shown to not correlate with 
aneuploidies (Magli et al., 2001). 
1.4.2 Morphokinetics by time-lapse 
The incorporation of time-lapse culture systems for the evaluation of human 
embryo development has been an important achievement in the field during 
the last decade. Although these systems had been previously employed for 
embryo culture (Payne et al., 1997), new improvements such as a decrease in 
the light exposure or a decrease in the size of the microscopes allowed them to 
be incorporated into the clinical routine. The two studies that raised the 
popularity of this system were published by Wong and colleagues in 2010 and by 
Meseguer et al. in 2011. These studies agreed on the existence of certain 
kinetic parameters that enable prediction of the success of embryo 
development, either at the blastocyst stage (Wong et al., 2010) or at the 
implantation level (Meseguer et al., 2011). Since, the use of time-lapse 
technologies has gradually increased. 
1.4.2.1 The technology 
Time-lapse systems consist of the incorporation of a microscope inside a 
standard incubator, enabling observation of the embryo at any time without 
opening the incubator. Thus, this system avoids the disruption of culture 
conditions that occurs when taking the embryos out of the incubator for 
standard morphological assessment, such as temperature or pH variations that 
can negatively affect the embryo development. A camera takes pictures every 
5-20 minutes (min), depending on the commercial system, from right after 
fertilization to the latest stage before ET, on day 3, day 5 or day 6. To avoid 
light damage to the embryo, time-lapse systems use either dark-field 
illumination, as EevaTM (Auxogyn, CA, USA) or really short exposure times, as 
EmbryoscopeTM, the one with the lowest aperture (<0.032s) (Schatten, 2016). 
With dark-field technology, it is estimated that the embryos would be exposed 
during the whole recording process to the light equivalent to the one used in 
less than a minute under typical bright-field microscopes (Wong et al., 2010). 
Indeed, no differences were observed in embryo development, blastocyst rate 
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or gene expression between embryos observed by this technique compared with 
the standard assessment (Wong et al., 2010; Kirkegaard et al., 2012).  
In addition, time-lapse systems normally include software that allows image 
analysis algorithms and some additional features depending on the commercial 
system employed. For instance, EevaTM system (Auxogyn, CA, USA) includes an 
automatic cell identification that allows the software to calculate kinetic 
parameters by itself and to automatically score each embryo according to the 
predictive potential. Nevertheless, EmbryoscopeTM (Unisense Fertilitech, 
Denmark) offers the possibility to change the focus plane for each picture, 
which is especially useful for the evaluation of some spatial parameters like 
fragmentation. Other systems, like the BioStation IM-Q (Nikon, Japan), even 
allow the taking of fluorescence images, although this is more useful for 
research purposes. 
1.4.2.2 Morphology evaluation 
The significant improvement of time-lapse technology versus previous 
evaluation methods is that it provides a non-invasive alternative to the 
morphological assessment of embryos. The creation of whole-development 
movies for each embryo allows a more extensive morphological analysis of the 
embryo, enabling the observation of cellular events that would otherwise 
remain undetected by conventional methods, such as irregular divisions, also 
known as direct-cleavage divisions. Normal mitotic divisions are expected to 
give two daughter cells, nevertheless abnormal divisions to 3, 4 or even 5 cells 
have been reported in human embryo development (Schatten, 2016). The 
probability of identifying these types of divisions through classical evaluation is 
very low, since the division needs to take place in the moment that the embryo 
is being evaluated, to be detected. In some cases, the occurrence of irregular 
divisions may be hypothesized by the number of cells during conventional 
evaluation, but time-lapse allows the complete identification of them by just 
playing the final movie of the whole embryo development (Rubio et al., 2012; 
Athayde Wirka et al., 2014; Desai et al., 2014). This novel characterization in 
human embryo development has allowed correlating this feature with a 
decrease in blastocyst rate and implantation potential (Rubio et al., 2012; 
Athayde Wirka et al., 2014). Additionally, time-lapse has allowed the 
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identification of blastomere fusion, also known as reverse cleavage (Desai et 
al., 2014). This type of event typically occurs, although not necessarily, after 
an irregular division as an attempt to correct it. Both direct and reverse 
cleavage have been correlated with the existence of multinucleation (Desai et 
al., 2014). 
Finally, time-lapse allows analysis of a new dimension of fragmentation: 
fragment divisions and reabsorption. More specifically, fragments can be 
reabsorbed by the same or a different blastomere (Hardarson et al., 2002; 
Chavez et al., 2012), and this process may be the consequence of an embryonic 
response to aneuploidies (Chavez et al., 2012). 
1.4.2.3 Kinetic parameters 
In time-lapse, each time range between two different events that occur in 
routine of the human embryo can be considered as a kinetic parameter. Kaser 
and Racowsky (2014) performed in an extended review of time-lapse studies 
and compared the reported timings for each one (Figure 6). Depending on the 
interval selected, kinetic parameters allow the study of cell cycle duration, 
when measuring the time between one blastomere is generated and the same 
blastomere divides; cytokinesis duration, when measuring the time between 
the appearance of a cleavage furrow to complete daughter-cell separation 
(Hlinka et al., 2012); interphase duration, when measuring the time between 
the nucleus appears to the nucleus disappearance (Sundvall et al., 2013); or 
blastocyst-related events, such as the compaction duration, the time between 
the start of compaction until the time in which the embryo is totally compacted 
(Campbell et al., 2013). Additionally, kinetics allows determining the synchrony 
between daughter cells by calculating the difference between both cell cycles 
(Wong et al., 2010; Meseguer et al., 2011). 
Note that most of the time-lapse studies calculate the kinetic parameters using 
ICSI time as the reference (Kaser and Racowsky, 2014), and this has two 
disadvantages: first, there is no option to use frozen zygotes, although this is 
not a common practice as it is more frequent to freeze oocytes; and second, 
late parameters calculated from the ICSI time will be affected by earlier 
parameters, producing a bias in the analysis. 
  
                 
Figure 6 | Summary of reported timing for time-lapse parameters between fertilization and hatching blastocyst. 
Parameters that were not significantly different between implanted and non-implanted embryos are represented in black. When significant 
differences were reported, the implanted embryo timing is in orange, and the non-implanted in red. Values are expressed in hours, as mean for 
normally distributed populations, and median for non-normally distributed. PNa, pronuclei appareance. (Adapted from Kaser and Racowsky, 2014). 
  24 
1.4.2.4 Prediction models  
Concomitant with the increased use of time-lapse, an increase in the prediction 
models for different success rates have occurred. New knowledge about 
embryonic cell cycles and development has resulted in new models showing 
higher accuracy than the traditional scoring using exclusively morphology 
parameters (Yang et al., 2014; Aparicio-Ruiz et al., 2016). 
 Predicting blastocyst formation 
One of the first attempts that was made by time-lapse was to create a model 
for blastocyst formation prediction based on kinetic parameters until day 3 with 
high sensitivity and specificity (Wong et al., 2010). This type of model would 
allow transferring those embryos with the highest probability to develop into a 
blastocyst already on day 3. Some other studies went one step further to create 
a model that not only predicts the blastocyst formation, but also the good-
quality one with 80% success (Kirkegaard et al., 2013; Cetinkaya et al., 2015). 
Finally, in general, shorter kinetic parameters are linked to better blastocyst 
quality (Cruz et al., 2012). Interestingly, the kinetic dynamics of embryos with 
the highest probability to reach a blastocyst have less dispersion, compared to 
those embryos with lower chances to successfully develop (Milewski et al., 
2015). 
 Predicting clinical success rates 
Apart from obtaining high-quality blastocysts, it is important to understand 
their implantation potential, since aneuploid embryos can similarly develop 
into beautiful blastocysts (Alfarawati et al., 2011). The first study reporting a 
model for implantation was exclusively based on early kinetic parameters, 
which is relevant for prediction in case of day-3 ET (Meseguer et al., 2011). 
From these results, multiple studies tried later to test this model for their 
embryos or tried to develop their own algorithm for implantation prediction 
(Figure 6). The majority found significant differences between the kinetics of 
implanted embryos versus non-implanted (Meseguer et al., 2011; Azzarello et 
al., 2012; Dal Canto et al., 2012; Rubio et al., 2012; Chen et al., 2013; 
Campbell et al., 2013), and most of those were concordant in that non-
implanted embryos had longer parameters than one that implanted (Meseguer 
et al., 2011; Dal Canto et al., 2012; Campbell et al., 2013; Chen et al., 2013). 
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One study found a shorter kinetic parameter, the time between the two- and 
the three-cell stage, for the non-implanted embryos (Rubio et al., 2012), 
contrary to previous reports (Meseguer et al., 2011) in which embryos with 
direct cleavage were excluded. Only one study was focused on live-birth rate, 
finding that embryos resulting in live birth showed shorter time to pronuclear 
disappearing (PNd) than the no birth group (Azzarello et al., 2012). 
 Predicting ploidy status 
Several studies have combined chromosomal analysis technologies to generate a 
ploidy prediction model based on embryo kinetics (Table 2). Most of the studies 
found significant variations between the kinetics of euploid embryos versus 
aneuploid embryos, although no parameter resulted in a reliable predictor 
(Chavez et al., 2012; Campbell et al., 2013; Basile et al., 2014; Chawla et al., 
2015; Nogales et al., 2017). 
The first study comparing kinetics for ploidy groups was performed at the four-
cell stage with the main goal of doing the prediction as soon as possible in 
development (Chavez et al., 2012). Aneuploid embryos had a higher variability 
in the duration of cell cycles and also presented a higher incidence of 
fragments. Campbell et al. published the first model for embryo aneuploidy 
prediction at the blastocyst stage, based on the time between insemination to 
initiation of blastulation and the time from insemination to full blastulation 
(Campbell et al., 2013). Embryos were categorized according to the kinetics in 
a low-, medium-, or high-risk category. The chances of an aneuploid embryo in 
the low-risk group (0.37) were still too high to consider this method as an 
alternative to preimplantation genetic screening (PGS). Only the high-risk group 
of the model could be considered reliable, with a 0.97 probability of being 
aneuploid, although the proportion of embryos fitting in this category was as 
low as 12.4%. A similar later study performed by a different group did not find 
the same results as Campbell et al. (Kramer et al., 2014) and attributed the 
discordances to differences between clinic procedures and even to a variability 
among patients. The only parameter that was found as statistically significant 
between euploid and aneuploid embryos was the duration of compaction, with 
an area under the curve (AUC) of 0.674, although they concluded that this 
parameter was still poorly predictable for ploidy detection.  
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The published ploidy model based on kinetics with a higher number of embryos 
(n=504) found that prediction was possible by using the time between the two- 
and the five-cell stage and the time between the two- and the five-cell stage 
(Basile et al., 2014). It is important to note that the selected parameters for 
the model are multicollinear, and variability in the first one would produce 
variability in the second one. These results were confirmed by a second study in 
460 embryos, but in this case, they performed one different model for each 
parameter with similar accuracy (Chawla et al., 2015). Additionally, a recent 
report showed that the kinetics is altered differently depending on the type of 
chromosomal abnormality (Nogales et al., 2017). 
In summary, we can conclude that with the current data, morphokinetic 
classification by time-lapse technique is not accurate enough to predict ploidy, 
although it would be optimal to use when PGS is not possible, for instance due 
to legal reasons, or in combination with PGS to increase the success rates. In 
relation to this last option, one prospective study comparing the selection of 
embryos for transfer based only in PGS versus time-lapse plus PGS showed that 
time-lapse significantly increased the chances of getting a euploid embryo to 
implant and to obtain a clinical and ongoing pregnancy (Yang et al., 2014).  
1.4.3 Preimplantation Genetic Screening 
The chromosomal component in an embryo is a key factor to determine its 
developmental fate. It is well known that aneuploid embryos that can reach the 
blastocyst stage, implant, and even produce a pregnancy ending in a 
miscarriage or in an affected newborn (Rubio et al., 2005; Alfarawati et al., 
2011; Campos-Galindo et al., 2015). Thus, PGS was introduced in clinical 
routine practice, based on the assumption that the high aneuploidy rate 
frequently found in cleavage-stage embryos was responsible for the low 
pregnancy rate after ART. 
  
Table 2 | Ploidy prediction models based on kinetic parameters reported in the literature. 
 
N 
Average 
maternal age 
Stage of ploidy 
assessment Model parameters Accuracy 
Chavez et al. 2012 45 33.5 4-cell  Duration 1st cytokinesis 
 Time from 2- to 3-cell stage 
 Time from 3- to 4-cell stage 
100% sensitivity 
66% specificity 
Campbell et al. 2013 97 38.6 Blastocyst  Time from insemination to initiation of blastulation 
 Time from insemination to full blastulation 
AUC 0.720 
Kramer et al. 2014 145 37.3 Blastocyst  Duration of compaction AUC 0.674 
Basile et al. 2014 504 36.1 Day 3  Time from 2- to 5-cell stage 
 Time from 3- to 5-cell stage 
AUC 0.634 
Chawla et al. 2015 460 32.9 Day 3  Model (A): Time from 2- to 5-cell stage 
 Model (B): Time from 3- to 5 cell stage 
(A): AUC 0.632 
(B): AUC 0.631 
Nogales et al. 2017 485 35.5 Day 3  Time from 2- to 5-cell stage 
 Time from insemination to 3-cell stage 
NA 
AUC, area under the curve; NA, not available. 
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1.4.3.1 Clinical approach 
 Indications for PGS 
The chromosomal analysis of preimplantation embryos is highly relevant for 
patients with certain indications that have been previously correlated with high 
aneuploid rates, such as low implantation rates and/or high miscarriage rates. 
Advanced maternal age is the most common indication for PGS since maternal 
age is highly correlated with the prevalence of aneuploidy (Hassold, 1982). A 
recent study reported that the rate of mis-segregation for the most clinically 
relevant aneuploidies (chromosomes 13, 16, 18, 21, 22) increased from 20% to 
60% in women between the ages of 35 and 43 years (Kuliev et al., 2011). 
Nevertheless, the use of PGS in patients with AMA have shown contrary results 
between studies detecting no improvement in the clinical success rates 
(Mastenbroek et al., 2011) versus studies showing an increase in live-birth rates 
or a decrease in miscarriage rates when using PGS (Rubio et al., 2013b; Rubio 
et al., 2017).  
In addition to AMA, patients with recurrent miscarriages—two or more 
consecutive miscarriages—are also recommended to undergo PGS, as some 
studies have reported an increase of aneuploid products of conceptions in this 
type of patient (Nybo Andersen et al., 2000; Marquard et al., 2010). Similarly, 
when there is a repetitive implantation failure, although the cause is still 
poorly defined, some authors argue that these couples produce more aneuploid 
embryos (Pagidas et al., 2008) and exhibit a trend to higher live-birth rates 
with PGS (Rubio et al., 2013a). 
Another clinical indication for PGS would be male factor, as an increased 
incidence of chromosome abnormalities in the sperm of these patients has been 
reported (Rubio et al., 2001) producing low implantation and high miscarriage 
rates (Egozcue et al., 2000; Bernardini et al., 2004). Furthermore, couples with 
a previous trisomic pregnancy are also encouraged to follow PGS due to an 
increased risk versus a control group (Al-Asmar et al., 2012). 
Finally, PGS has also been applied for good-prognosis patients with the goal of 
reaching a healthy newborn in a shorter period of time or to promote single-
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embryo transfer (SET), which has been shown to have higher pregnancy rates 
when combined with PGS (Yang et al., 2012) 
 Sample collection 
PGS requires a sample of the embryo, which would be representative of the 
whole for its diagnosis. According to the developmental stages to analyze, 
different types of biopsies have been used. First, polar body biopsy would be 
performed the day of fertilization, allowing the detection of genetic diseases or 
chromosome abnormalities related to the oocyte. Nevertheless, this type of 
biopsy would not give information about the father/sperm or about embryonic 
de-novo alterations, which is an important drawback for chromosomal 
screening (Salvaggio et al., 2014).  
As an alternative, cleavage-stage embryos can be biopsied at day 3 by taking 
one or two blastomeres for analysis. Normally, only embryos with good 
morphology are recommended to be biopsied (Harton et al., 2011). Day-3 
biopsy allows detection of both maternal and paternal contributions, as well as 
de novo mitotic alterations. Furthermore, this type of biopsy permits 
transferring the embryo in a fresh cycle after getting the results.  
Finally, blastocyst biopsy is performed on day 5 or 6 of development by taking a 
group of cells (4-10 cells) from the trophectoderm. In comparison with day-3 
biopsy, this option also allows detection of mitotic errors in development that 
take place between day 3 and day 5. On the other hand, unless the diagnosis 
can be obtained within 24 hours, the blastocyst needs to be cryopreserved. 
Additionally, it is important to note that, in case of mosaicism, trophectoderm 
biopsy could allow the detection since several cells are obtained for the 
analysis. The development of new vitrification protocols with very high survival 
rates together with recent reports showing high concordance between the 
chromosomal component of the inner cell mass and the trophectoderm have 
made day-5/6 biopsy the most common practice for PGS (Johnson et al., 2010a; 
Capalbo et al., 2013b). 
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1.4.3.2 Technology in the laboratory 
Several methods currently allow for the study of aneuploidies in human 
embryos, including fluorescence in situ hybridization (FISH), single nucleotide 
polymorphism (SNP) arrays, comparative genomic hybridization arrays (aCGH) 
and, the most recent, next-generation sequencing (NGS). The evolution of the 
techniques for aneuploidy screening has allowed having more information about 
the genetics status and faster results that allow transferring the euploid 
embryos during the same cycle. 
 Fluorescence in situ hybridization 
FISH assay was the most widely applied methodology for aneuploidy screening 
for many years. It uses fluorescent nucleic acid probes complementary to DNA 
to visualize regions of interest (Rubio et al., 2013a). However, FISH cannot be 
performed for all chromosomes simultaneously (Abdelhadi et al., 2003) and is 
therefore exclusively used for those chromosomes in which aneuploidies are 
commonly implicated in spontaneous miscarriages or compatible with affected 
live births (Stephenson et al., 2002) such as chromosomes 3, 15, 16, 17, 18, 21, 
22, X and Y. FISH assays required the studied cell to be fixed by using Carnoy 
solution, and the quality of the fixation may vary with cell integrity, operator 
experience or room humidity, making the later hybridization quality also a 
variable factor to be considered. For this reason, the biopsy of 2 cells from the 
same embryo is a common procedure when aneuploidy screening is performed 
by FISH. Thus, the main disadvantages for FISH have been the high percentage 
of embryos with no results and the high false-positive rate (Uher et al., 2009), 
although one study reported an increase in the accuracy of the technique by 
the reanalysis of doubtful signals (Mir et al., 2010). 
 Array comparative genomic hybridization 
Fortunately, new technologies were developed, like array-based platforms, 
which facilitated the transition from the study of a limited number of 
chromosomes by FISH, to the analysis of all 23 chromosome pairs 
simultaneously in a single cell (Rodrigo et al., 2014). Array-based technologies 
give the opportunity to have the result in less than 24 hours and with less than 
3% of non-informative rate (Gutierrez-Mateo et al., 2011). One of the most 
used platforms is aCGH, which requires the placement of the sample, 
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blastomere or trophectoderm biopsy, in a sterile polymerase chain reaction 
(PCR) tube in which whole genome amplification will be performed. 
Amplification quality needs to be ensured (e.g., by gel electrophoresis), and 
then samples and control DNA are labeled with fluorophores (Rubio et al., 
2013b). Labeling mixes are combined and hybridized on the arrays. Each probe 
in the array is specific to a different chromosomal region and occupies a 
discrete spot on the slide. Chromosomal loss or gain is revealed by the color 
adopted by each spot after hybridization, this is because this technique 
involves the competitive hybridization of differentially labeled test and 
reference euploid DNA samples. Fluorescence intensity is detected with the use 
of a laser scanner, and specific software is used for data processing. Therefore, 
embryo transfer and vitrification of surplus euploid embryos can be scheduled 
on day 5 when day-3 biopsies are performed, or on day 6 for trophectoderm 
biopsies (Rubio et al., 2013b). 
 Next-generation sequencing 
Finally, NGS has been developed as an effective technique for the analysis of 
copy number variation in single cells (Zhang et al., 2013). The decrease of the 
cost of sequencing has made NGS one of the most promising platforms for the 
study of not only aneuploidies, but also mitochondrial DNA or gene disorders in 
a simultaneous analysis (Yan et al., 2015). Most NGS protocols share the first 
steps with aCGH, starting with a whole genome amplification from a single cell. 
This is followed by a barcoding procedure, in which the different samples are 
labeled with unique sequences, in the way that they can be mixed later and 
sequenced at a time as they can be individually identified. This pooling step is 
the one that has contributed to significantly reducing the cost of the technique 
and its transfer into the clinical routine. The deepness of the sequencing is also 
an important aspect to consider, especially for the simultaneous study of 
aneuploidies and gene disorders, which would need high coverage on those 
regions of interest. An alternative is the parallel study of the mitochondrial 
DNA, which has been related to embryo quality (Diez-Juan et al., 2015). In 
addition, sequencing has been shown to detect lower mosaicism degrees in 
trophectoderm biopsies than previous technologies (Ruttanajit et al., 2016; 
Vera-Rodriguez et al., 2016). Nevertheless, it would be important to consider 
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the relevance of mosaicism in the trophectoderm, as there are no studies 
related to the effect of different percentages of aneuploid cells in the 
blastocyst.  
 Non-invasive PGS 
The coming technologies for aneuploidy screening should be focused on non-
invasive techniques; currently, all clinical methods require the biopsy of a 
blastomere, when the embryo is on day 3 of development, or trophectoderm, if 
the embryo is on day 5 or 6. The first studies performing non-invasive PGS by 
the exclusive use of spent culture medium (Xu et al., 2016; Shamonki et al., 
2016) show concordant results with traditional PGS. Nevertheless, these studies 
have important issues to resolve, such a high non-informative rate, false 
negative and false positive results, or a methodological design that includes 
assisted hatching and therefore arises doubts about whether embryos without 
the zona pellucida altered would produce the same results. Thus, although this 
technology is not ready for clinical routine, new improvements in the method, 
as a more efficient removal of granulosa cells to avoid contamination with DNA 
of maternal origin, would allow the non-invasive technologies to be translated 
into the clinic for aneuploidy screening. 
1.4.3.3 Aneuploidy rates in the human embryo 
Aneuploidies are not a common feature in embryonic development for all 
mammals. For instance, aneuploidy rates in mouse embryos are really low, 
around 1% (Bond and Chandley, 1983). Nevertheless, the frequency of 
aneuploidies in humans is much higher than in any other species (Hassold and 
Hunt, 2001) resulting in low pregnancy rates.  
Although aneuploidy existence in the human embryo has been tightly linked to 
infertility, high rates are still reported in embryos from fertile couples (Wells et 
al., 2015). Furthermore, the chromosome segregation error rate increases 
drastically with the maternal age (Franasiak et al., 2014) with percentages 
between 30% and 60% of aneuploidies in oocytes (Obradors et al., 2011; 
Fragouli et al., 2011). If we consider also the mitotic errors that occur in later 
embryonic development, aneuploidy rates reach percentages as high as 70% 
(Vanneste et al., 2009; Mertzanidou et al., 2013). 
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In general, a wide range of abnormalities has been reported, in some instances 
even from similar populations. This variability derives from different factors, 
such as culture conditions, the quality of the biopsied embryos (Harton et al., 
2011), the quality of the biopsied cells, or the methods of assessment. In 
addition, another important factor to consider is mosaicism. Mitotic errors 
during embryo development can result in chromosomally distinct cell 
populations producing mosaic embryos. Mosaicism at day 3 or day 5 can 
produce misdiagnoses, since the PGS analysis performed of a embryonic 
sample, one blastomere or several trophectoderm cells, does not necessarily 
represent the embryo as a whole. 
1.4.4 Embryonic transcriptomics 
The transcriptomics of the embryo reflect what is happening at a biological 
level, since the response of a cell to any new situation often implies new gene 
transcription. Due to technical limitations, previous transcriptomic studies of 
human embryo development analyzed only a select group of genes (Taylor et 
al., 2001; Tachataki et al., 2003) and/or large pools of embryos (Zhang et al., 
2009), which can be confounded by potential embryo heterogeneity. As real-
time quantitative PCR (RT-qPCR) techniques have evolved and become more 
sensitive, gene expression analysis of individual human embryos followed (Wong 
et al., 2010; Shaw et al., 2013). More recently, single-cell RT-qPCR analysis has 
become a reality (Wong et al., 2010; Yan et al., 2013; Xue et al., 2013) 
allowing analysis at a minimum level. 
Embryo transcriptomics have been previously correlated with morphology. One 
study in 42 embryos analyzed 9 different genes versus different morphological 
parameters (Wells et al., 2005). They found that expression of certain genes 
was correlated mainly with multinucleation and fragmentation(Wells et al., 
2005), suggesting an apoptotic activation of the fragmented embryos by a 
chromosomal abnormality that may be correlated with multinucleation. 
Additional studies have supported that fragmented embryos have an altered 
transcriptomic profile linked to telomere maintenance genes (Keefe et al., 
2005; Treff et al., 2011) 
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To date, only a couple of studies have correlated gene expression patterns with 
aneuploidy in human embryos, one of which observed differential expression of 
certain epigenetic mediators in euploid versus aneuploid embryos (Chavez et 
al., 2014) and the other examining DNA repair genes in embryos with single 
over complex aneuploidies (Bazrgar et al., 2014). However, the latter study did 
not include euploid embryos, only evaluated 6 chromosomes via FISH, and 
analyzed 15-20 pooled day-4 embryos rather than individual embryos or single 
cells. 
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1.5 Hypothesis 
Aneuploidies are a frequent alteration during the in vitro development of the 
human embryo, contributing to the low clinical success rates that are found in 
assisted reproductive technology. A better understanding of embryo biology 
remains necessary for the improvement of selection tools that could allow 
transfer of the embryo with the best chance to develop into a healthy newborn. 
However, due to the restricted availability of human embryos for research 
purposes, few studies have been able to combine different analyses within the 
same embryo. This, in combination with the multifactorial nature of 
aneuploidies, has made difficult the understanding of its causes and 
consequences. 
Here, we propose that morphology, kinetics and gene expression alterations are 
correlated with the presence of aneuploidy in the human embryo. This 
knowledge could be used for explaining the etiology of chromosomal alterations 
in the human embryo and aiding in the improvement of IVF techniques, embryo 
selection methods and clinical success rates. 
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2 | Objectives 
 
The aim of this work was to better understand the causes and consequences of 
aneuploidy generation during human embryo development. To this end, the 
following specific objectives were addressed: 
O1. The descriptive analysis of the human embryo at four different levels: 
morphology, kinetics, transcriptomics and aneuploidy incidence. 
O1. The study of the relationship between morphology, kinetic behavior, 
gene expression and aneuploidy existence. 
O2. The development of a ploidy predictive model based on the most 
significant differences between aneuploid and euploid embryos. 
O3. The integration of morphokinetics, transcriptomics and aneuploidy 
data to create an atlas of the preimplantation human embryo. 
 
  
  
 
METHODS
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3 | Methods 
 
3.1 Experimental design 
One hundred-seventeen (117) human zygotes originating from 19 couples with 
an average maternal age of 33.7 ± 4.3 years were thawed for this study. Eighty-
five embryos survived and were cultured under time-lapse imaging (Figure 7), 
for a survival rate of 72.6%, which is a normal value for cryopreserved human 
embryos at the pronuclear stage (Reed et al., 2010; Pavone et al., 2011). 
Embryo retrieval was performed at continuous times throughout embryonic 
development at the pronuclear stage and during mitotic divisions 1 to 7; the 
number of the cells varied depending on the division types: 1 to 2, 1 to 3, or 1 
to 4 cells. After embryo culture, embryos were disassembled into single 
blastomeres, including polar bodies from zygotes. Half of the cells of each 
embryo underwent whole genome amplification (WGA) and were analyzed by 
aCGH to determine their chromosomal status at a single-cell level. The other 
half were analyzed by RT-qPCR for 86 genes to evaluate the specific 
transcriptome signature in each cell. Kinetic parameters, chromosomal status 
and expression levels were compared and analyzed for individual embryos. 
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Figure 7 | Experimental design of the study.  
One hundred-seventeen human embryos at the zygote stage were thawed; eighty-five of 
them survived and were cultured in nine different experiments. Embryo culture was 
performed in alphanumeric-labelled Petri dishes to allow embryo tracking during time-
lapse imaging. Embryos were removed at different times until approximately the eight-
cell stage. The number of cells varied depending on the type of divisions: one to two, one 
to three or one to four. Embryos were disaggregated into individual cells. Half of the cells 
from each embryo were analyzed using aCGH to determine the ploidy status, and the 
other half were analyzed using RT–qPCR to study gene expression. Time-lapse movies 
were generated for each embryo and kinetic parameters were analyzed. 
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3.2 Embryo manipulation 
3.2.2 Embryo source 
Human embryos from successful IVF cycles, subsequently donated for research, 
were obtained with written informed consent from the Stanford University 
RENEW Biobank. This cohort of embryos was cryopreserved at the pronuclear 
stage before the assessment of quality. Embryos in the RENEW Biobank are 
received from several IVF clinics across the United States. De-identification was 
performed according to the Stanford University Institutional Review Board-
approved protocol #10466 entitled ‘The RENEW Biobank’ and molecular analysis 
of the embryos were in compliance with institutional regulations. No protected 
health information was associated with individual embryos. 
3.2.2 Embryo thawing and culture 
Human embryos at the two-pronucleus stage stored by slow-freezing were 
thawed by a two-step process using Quinn’s Advantage Thaw Kit 
(CooperSurgical, CT, USA) as recommended by the manufacturer. In brief, 
cryocontainers were removed from the liquid nitrogen and placed in a 37 
degrees Celsius (°C) water bath after being held in the air for approximately 30 
seconds (s). Once thawed, liquid contents were transferred to an empty petri 
dish under a microscope to locate the embryos. The embryos were quickly 
picked and transferred to a 0.5 molar (M) sucrose solution for 10 min and then 
placed in a 0.2 M sucrose solution for 10 min more. Then, embryo survival was 
evaluated by visual observation; zygotes that did not survive were disregarded 
for further procedures. Dead zygotes were identified by a dark cytoplasm 
appearance. Only intact zygotes were washed in Quinn’s Advantage® Cleavage 
Medium (QACM; CooperSurgical) supplemented with 10% Quinn’s Advantage® 
Serum Protein Substitute (SPS; CooperSurgical) and cultured in 100-microliter 
(μL) drops of shared medium under mineral oil (Sigma, MO, USA). Embryos were 
cultured in custom polystyrene petri dishes (Auxogyn, CA, USA) with 12 
individual microwells in the center (Figure 8). Small markers (letters and 
numbers) were located at the edges to help with embryo identification. The 
dishes were prepared at least 5 h in advance and placed in the incubator to 
pre-equilibrate. The embryos were cultured at 37°C with 6% CO2, 5% O2 and 89% 
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N2, standard human embryo culture conditions in accordance with current 
clinical IVF practice. 
 
Figure 8 | Culture plate and individual labelled wells. 
Custom petri dish with three top wells for embryo washes and one centered well for 
embryo culture. In the center, 12 microwells labelled with numbers and letters for 
individual embryo identification. Culture media was shared for all embryos. 
 
3.2.3 Embryo disassembly and collection 
The embryos were collected at different times and stages. For this purpose, the 
dish was removed from the incubator for not more than 5 minutes to avoid 
affecting either the culture of the remaining embryos or the time-lapse imaging 
intervals. Embryos were individually transferred to 50-μL drops of Quinn's 
Advantage Medium with HEPES (QAM; CopperSurgical) plus 10% human albumin 
(HA; CooperSurgical), at 37°C under mineral oil. Each procedure was performed 
with one single embryo at a time to maintain embryo identification and 
tracking. The zona pellucida was removed from each embryo by transferring 
the embryos to 200-μL drops of Acidified Tyrode's Solution (Millipore, MA, USA) 
briefly and then washing in QAM plus 10% HA at 37°C under mineral oil. To 
weaken the cellular junctions between blastomeres, embryos were incubated in 
60-μL drops of Quinn’s Advantage Ca++/Mg++-Free Medium with HEPES 
(CooperSurgical) plus 10% HA for 10 minutes at 37°C under mineral oil. Embryos 
were disaggregated using gentle mechanical pipetting in the same medium 
(Figure 9). Once disaggregated, counting and identification of blastomeres and 
polar bodies was performed. Not all blastomeres from each embryo could be 
harvested. Annotations referring the cell appearance such as visible nuclei, 
membrane integrity and cytoplasmic anomalies, were recorded during the 
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tubing. Each sample was washed three times in 5-μL drops of phosphate-
buffered saline (PBS) 1% polyvinylpyrrolidone (PVP) buffer and transferred to a 
sterile 0.2 milliliter (mL) PCR tube. All tubes were stored at -80°C until 
subsequent analysis. 
 
 
 
Figure 9 | Representative images of embryo disassembly at different stages. 
Embryos were removed and disaggregated at different times during development. An 
embryo at the one-cell stage (a) was detached from its zona pellucida and separated into 
zygote (b) and polar bodies (c). Note that the differentiation between first and second 
polar bodies was not possible. Another embryo at the two-cell stage (d) had its zona 
pellucida removed (e) and was disassembled into individual blastomeres (g). An embryo 
at the eight-cell stage (g) was released from the zona pellucida (h) and disaggregated 
into individual cells (i). Note that in fragmented embryos, fragments were separated 
from blastomeres by mechanical pipetting since they may potentially interfere in the 
results. Scale bar, 100 μm 
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3.3 Time-lapse imaging 
3.3.1 Image taking 
Embryos were monitored continuously using a microscope system (Auxogyn) 
(Figure 10) inside a standard tri-gas incubator (Sanyo, Japan). The system 
consisted of an inverted digital microscope with light-emitting diode 
illumination, X10 Olympus objective, automatic focus knob and 5 megapixel 
CMOS camera. Three types of images were collected during culture: darkfield 
and brightfield images were taken automatically every 5 min and at 1 s and 500 
milliseconds (ms) of exposure time, respectively. In addition, brightfield images 
were also taken at 10 equidistant planes at several points throughout culture to 
capture images of the whole embryo. The time between multiplane captures 
varied depending on when the embryo was collected and one last capture was 
taken just before taking each embryo out of the incubator. 
 
 
Figure 10 | Time-lapse imaging technology. 
Time-lapse microscope took three types of pictures: darkfield images every 5 minutes, 
useful for a clear detection of cell membranes and embryo divisions; brightfield images 
every 5 minutes for the evaluation of cytoplasm related events, such as pronuclear 
disappearance, vacuole existence or blastomere multinucleation; and multiplane 
captures at 10 equidistant distance for a three-dimensional perception of the embryo, 
useful to measure spatial parameters such as percentage of fragmentation. 
 
3.3.2 Image processing 
After each experiment, all images were processed using ImageJ software 
(Schneider et al., 2012). Brightfield and darkfield images were cropped to get 
individual images from each embryo. Contrast and color balance were modified 
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to allow an easier identification of cytoplasmic events. All images from one 
single embryo were compiled into time-lapse movies. Identification labels and 
timestamps were included to facilitate the measurement of the imaging 
parameters. In addition, multiplane images of every embryo were assembled in 
a multi-stack file using ImageJ. For this, images from one embryo were grouped 
into consecutive stacks of 10 pictures. Each stack was equivalent to a different 
time point, and each picture of a stack corresponded to a different plane of the 
embryo, from the bottom to the top. 
 
3.3.3 Parameter evaluation 
Developmental kinetics of each embryo were translated from frames to hours 
on the basis that an image frame was captured every 5 min. All timing intervals 
between the one- and nine-cell stages were measured for each embryo unless 
removed for molecular or chromosomal analysis before reaching this stage of 
development (Figure 11 and Supplementary Movie 1). These intervals 
corresponded to the kinetic parameters to study. In addition, the existence of 
irregular divisions was also annotated, as the exact time in which the division 
took place and the type: direct division from 1 to 3 cells or 1 to 4 cells. 
Morphological parameters were also annotated, such as fragmentation, 
multinucleation or vacuole existence. We recorded the fragmentation 
percentage in each embryo according to the total cytoplasmic volume that the 
fragments were representing. In case of fragmentation existence, we also 
annotated when they appeared for the first time (one-cell stage, 1st division, 
two-cell stage or later). We also noted multinucleation when more than one 
nucleus was visible in a blastomere. We added all additional comments that 
could be useful for later embryo evaluation, such as vacuole existence, 
cytoplasm polarization, division attempts or uneven blastomere size. 
Multiplane captures were used to confirm brightfield and darkfield imaging 
observations and to assist in the measurement of certain parameters such as 
PNd or percentage of fragmentation, which may be difficult to determine using 
just one single plane. Embryo development evaluation was completed before 
ploidy and gene expression analyses to ensure blinded parameter 
measurements. 
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Figure 11 | Kinetic parameters. 
The standard kinetic parameters that were evaluated in the embryos included times 
between divisions. Due to the importance of the first mitosis the time from pronuclear 
disappearance to the start of the first cytokinesis and the duration of the first cytokinesis 
was also measured. The number of parameters analyzed depended on the final stage in 
which the embryo was retrieved. The nine-cell stage was included for those embryos in 
which divisions were faster than normal due to irregular divisions.  
 
3.3.4 Embryo classification 
Because an important part of our study was to analyze gene expression, a 
reliable manner to classify embryos was necessary to make proper comparisons 
between embryos. In the clinical routine, embryos are classified according to 
the number of cells, but since irregular divisions during development produce a 
greater number of faster-dividing cells, the number of blastomeres was 
disregarded as a method to stage embryos. As an example, an embryo with four 
blastomeres could result from three consecutive regular divisions, but it could 
also be produced during one direct cleavage from 1 to 4 cells. In both cases, 
the embryos would be at the four-cell stage and it would be inappropriate to 
make transcriptomic comparisons between them. Thus, the time from PNd was 
chosen as the best reference for the starting point to define embryo stage for 
all studies; PNd is the first event observed post-thaw and before mitotic 
divisions. 
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3.4 Detection of chromosomal abnormalities in single cells 
Aneuploidy screening for the detection of chromosomal abnormalities for all 24 
chromosomes was accomplished by aCGH. The completed protocol was 
performed in less than 24 h with five different steps: whole genome 
amplification, labelling, combination, hybridization and scanning (Figure 12). 
Arrays CGH was the chosen method not only for being the most popular 
technique inside PGS clinical programs, but because its efficiency and accuracy 
for the analysis of not only blastomeres, but also polar bodies, had been widely 
supported(Geraedts et al., 2011; Gutierrez-Mateo et al., 2011; Christopikou et 
al., 2013; Rubio et al., 2013b; Rodrigo et al., 2014). 
 
3.4.1 Whole genome amplification 
Single-cell DNA extraction and WGA was accomplished using the Sureplex Kit 
(Illumina, Cambridge, UK) in a three-step protocol: cell lysis, pre-amplification 
and amplification process. For cell lysis, 3 μL of Cell Extraction Buffer, 4.8 μL 
Extraction Enzyme Dilution Buffer and 0.2 μL of Cell Extraction Enzyme were 
added to each individual sample. A positive control (1 μL of genomic control 
DNA) and a negative control (2 μL of PBS 1% PVP buffer) were included. This 
first step was accomplished by incubated the samples 10 min at 75°C following 
by 4 min at 95°C. For pre-amplification step, 4.8 μL of SurePlex Pre-amp Buffer 
and 0.2 μL of SurePlex Pre-amp Enzyme were added to each lysed sample, 
following by an incubation process at 95°C for 2 min, followed by 12 cycles of 
95°C for 15 s, 15°C for 50 s, 25°C for 40 s, 35°C for 30 s, 65°C for 40 s, and 
75°C for 40 s. Final amplified DNA was obtained by adding 34.2 μL of Nuclease-
free Water, 25 μL of SurePlex Amplification Buffer and 0.8 μL of SurePlex 
Amplification Enzyme to each pre-amplified sample. Samples were incubated at 
95°C for 2 min, followed by 15 cycles of 95°C for 15 s, 65°C for 1 min, and 
75°C for 1 min. To determine the success of the whole genome amplification 
process, all amplified samples and controls were tested using the FlashGelTM 
system (catalog # 57067; Lonza Ltd., Switzerland) by loading 1 μL of each DNA 
together with 4 μL of loading mix (3 μL water : 1 μL loading buffer) in each well 
of the cassette (Figure 12). 
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3.4.2 Labelling 
WGA products and reference DNA (normal male and female controls) were 
labelled with either Cy3 or Cy5 fluorophores using random primers according to 
manufacturer´s protocol (Illumina). An automatic template was created to 
distribute all samples into two groups: half were labelled by Cy3, and half by 
Cy5 (Figure 12). Male and female DNA references were also included, and 
distributed into different slides, top and bottom subarrays, and Cy3/Cy5 
fluorophores, for an accurate paralleling process. For labelling, 5 μL of Primer 
Solution and 8 μL of DNA (either sample or reference) were first combined and 
then incubated at 94°C for 5 min and -20°C for 5 min. Afterwards, 12 μL of 
labelling mix (5 μL Reaction Buffer, 5 μL dCTP mix, 1 μL Cy3/Cy5, and 1 μL 
Klenow) were added to each sample following the template. Finally, samples 
were incubated for 2 h at 37°C. 
 
3.4.3 Combination, precipitation, and hybridization 
Labelled control and samples DNAs were combined by mixing one Cy3 labelled 
sample together with one Cy5 labelled sample, and by adding 25 μL of COT 
Human DNA (Figure 12). The resultant mix was reduced by centrifugal 
evaporation at 75°C for 1 h. The pellet was resuspended with 21 μL 
Hybridization Buffer (15% dextran sulphate) and incubated for 10 min at 75°C. 
Subsequently, 18 μL from each well were loaded in each subarray hybridization 
area (24sure, Illumina) and covered with a coverslip (Figure 12). All slides were 
placed inside a hybridization chamber containing a tissue saturated in 6 mL 2X 
SSC/50% formamide. Finally, hybridization chambers were incubated for 6-12 h 
in a 37°C water bath. 
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Figure 12 | Comparative genomic hybridization arrays illustrative protocol. 
For the detection of chromosomal abnormalities single cells were amplified and labelled 
with either Cy3 (red) or Cy5 (blue) fluorophores. Reference and sample labelled DNAs 
were combined and co-hybridized on 24sure arrays for a minimum of 4 h. After washing, 
slides were scanned and the data analyzed using the BlueFuse Multi software (Illumina). 
  54 
3.4.4 Post-hybridization washes and scan 
Before scanning, coverslips were removed carefully by immersion of the slides 
in a coplin jar containing 2X SSC/0.05% Tween20. Then slides were washed in 
the same solution and with agitation for 10 min. Afterwards, slides were quickly 
transferred to a 1X SSC solution for 10 min, then a 0.1X SSC solution at 60°C for 
5 min, and finally a 0.1X SSC solution for 1 min. After washes, slides were dried 
by centrifugation at 170 x g for 3 min. The scanning process was performed 
using Innoscan 710 (Innopsys, Carbonne, France) (Figure 12).  
 
3.4.5 Array CGH results interpretation 
All aCGH data were analyzed using the BlueFuse Multi software (Illumina). The 
software produces two profiles from each sample: one versus a female 
reference and another versus a male reference (Figure 12). Both profiles were 
evaluated to have an unequivocal evaluation of the sex chromosomes (X and Y). 
The X separation (log2 value) was a key parameter to know the quality of the 
experiment. Other quality parameters were the percentage of included clones 
and the confidence values for individual chromosomes results. Results obtained 
from questionable samples, such as fragmented polar bodies or those with 
inconsistent profiles, were disregarded (Figure 13). 
 
 
 
Figure 13 | Ploidy exclusion criteria. 
Ploidy results were discarded in cases of a zygote with polar body fragmentation (a) since 
DNA from fragmented polar bodies may be degraded and show an aCGH profile with 
amplification failure (b) rather than the typical aCGH profile (c). Scale bar, 100 μm 
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3.5 High-throughput single-cell gene expression analysis 
3.5.1 Gene selection and primer design 
A total of 86 genes were selected on the basis of their previously reported 
importance in the literature (Liu et al., 2000; Jurisicova et al., 2003; Wells et 
al., 2005; Ma et al., 2006; Bultman et al., 2006; Jaroudi and SenGupta, 2007; 
Wan et al., 2008; Jaroudi et al., 2009; Wong et al., 2010; Kiessling et al., 2010; 
Galan et al., 2010; Tashiro et al., 2010; Mantikou et al., 2012; Choi et al., 
2012; Shaw et al., 2012; Galan et al., 2013; Baran et al., 2013). The biological 
processes in which the genes were involved included, but were not limited to, 
cell cycle regulation, apoptosis, telomere maintenance and DNA methylation 
(Table 3). Primers were designed to span exons and detect all gene isoforms 
whenever possible (Supplementary Table 1). Primers were first tested in single 
blastomere and redesigned when nonspecific amplification was observed. 
 
3.5.2 Complementary DNA synthesis 
The procedure for gene expression analysis was adapted from the Advanced 
Development Protocol for Single-Cell Gene Expression Using EvaGreen DNA 
Binding Dye (Fluidigm, CA, USA). cDNA was prepared by adding to each 
individual sample: 9 μL RT-STA Solution [5 μL Cells Direct 2X Reaction Mix 
(Invitrogen, CA, USA); 0.2 μL SuperScript III RT Platinum Taq Mix (Invitrogen); 
2.5 μL 4X Primer Mix (200 nM); and 1.3 μL DNA Suspension Buffer (Teknova, CA, 
USA)]. Reverse transcription and pre-amplification was accomplished by 
incubating the samples at 50°C for 15 min and 95°C for 2 min, followed by 18 
cycles of 95°C for 15 s and 60°C for 4 min. Exonuclease I treatment method 
was used to remove unincorporated primers by adding 3.6 of Exo I Reaction 
Solution (2.52 μL purified water, 0.36 μL Exonuclease I Reaction Buffer, 0.72 μL 
Exonuclease I at 20U/μL) to each sample, and incubating at 37°C for 30 min 
followed by 15 min at 80°C. The final volume was diluted two-fold before RT-
qPCR. 
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Table 3 | Main functions for the studied genes. 
    
Gene 
Name Function 
Gene 
Name Function 
 
ACTB  Cytoskeleton organization GATA4 Transcription regulation 
AHR Apoptosis INCENP Centromere 
AKT1 Apoptosis KHDC3L Genomic imprinting 
ALKBH2 DNA repair MAD2L1 Spindle checkpoint 
APC Apoptosis MBD4 Methylation 
ATM Cell cycle checkpoint  MCL1 Apoptosis 
AURKA Spindle stabilization MLH1 DNA repair 
AURKB Chromosome segregation MRE11A DNA repair 
BAD Apoptosis MSH2 DNA repair 
BCL2 Apoptosis MSH3 DNA repair 
BRCA1 Genomic stability MSH6 DNA repair 
BRCA2 DNA repair NLRP5  Oocyte biology 
BUB1 Cell cycle checkpoint  NPM2 Histone chaperone 
BUB3 Cell cycle checkpoint  OOEP RNA binding 
CASP2 Apoptosis PADI6 Cytoskeleton organization 
CCNA1 Cell cycle regulation PCNT Centrosome organization 
CCND1 Cell cycle regulation PDCD5 Apoptosis 
CCNE1 Cell cycle regulation PER1 Cyrcadian regulation 
CCT3 Protein folding PLK1 Cell cycle checkpoint  
CDH1 Apoptosis POT1 Telomeres maintenance 
CDK1 Cell cycle regulation POU5F1  Pluripotency 
CDK2 Cell cycle regulation PRMT1 Histone methylation 
CDK7 Cell cycle regulation PTTG1 Chromatid separation 
CETN2 Centrosome organization RAD51 DNA recombination 
CFL1 Cytoskeleton organization RAD52 DNA recombination 
CHEK1 DNA damage checkpoint RB1 Cell cycle regulation 
CHEK2 Cell cycle checkpoint  RCC2 Cell cycle regulation 
CLOCK Cyrcadian regulation RPL10L Ribosome 
CRY1 Cyrcadian regulation RPLP0 Ribosome 
CTCF DNA methylation RPS24 Ribosome 
CTNNB1 Adherens junctions SMARCA4  Transcription regulation 
DDX20 RNA secondary structure SOX2 Pluripotency 
DDX4 RNA secondary structure TERF1 Telomere regulation 
DIAPH1 Actin polymerization TERF2 Telomere regulation 
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DNMT1 Methylation TERT Telomere maintenance 
DNMT3A Methylation TP53 Cellular stress 
DNMT3B Methylation TSC2 Cell cycle arrest 
DPPA3 Maternal factor TUBG1 Centrosome organization 
E2F1 Cell cycle regulation XPA DNA excision repair 
ECT2 Cytokinesis YBX2 mRNA stabilization 
FASLG Apoptosis YY1 Transcription regulation 
GADD45A DNA repair ZAR1 Embryogenesis 
GAPDH Metabolism ZSCAN4 Telomere maintenance 
  
 
3.5.3 Real-time quantitative PCR 
For RT-qPCR, 2 μL of STA and Exo I-treated sample was mixed with Sample Mix 
solution [2.5 μL 2X Taqman Gene Expression Master Mix (Applied Biosystems, 
CA, USA); 1.25 μL 20X DNA Binding Dye Sample Loading Reagent (Fluidigm); 
1.25 μL 20X EvaGreen DNA binding dye (Biotium, CA, USA)]. Gene assay mix 
solutions were prepared by adding 1.25 μL of 40 μM primer pairs with 2.5 μL 2X 
Assay Loading Reagent (Fluidigm) and 1.25 μL DNA Suspension Buffer. Both 
sample and assay mixes were loaded into 96.96 Dynamic Arrays for RT-qPCR on 
a BioMark System (Fluidigm). The same technical replicates were included on 
each dynamic array to check for variability between arrays and ensure reliable 
data. Data Collection and Real-Time PCR Analysis software (Fluidigm) were 
used to calculate threshold cycle (Ct) values from the melt curve of each gene 
assay. 
 
3.5.4 Raw data processing 
Raw data were normalized to avoid variability between chips and allow 
comparison between blastomeres from different developmental stages. As gene 
activation during embryo development may not be simultaneous in embryos of 
similar stage or between blastomeres within the same embryo, normalization 
using housekeeping genes was not performed. Instead, a quantile normalization 
method was applied using limma package (Smyth, 2005) for R (R Core Team, 
2013). This method was chosen to highlight expression differences rather than 
absolute expression values. Other normalization methods do not distinguish 
between genes with different dynamic range. We call dynamic range as the 
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distance between the minimal and the maximal expression values of a gene. If 
we do not attend to the dynamic range, we consider similar ΔCt to have the 
same biological relevance between two difference genes (Figure 14a). 
 
 
Figure 14 | Normalization process for gene expression data. 
Similar differences in expression values from two samples between genes can be 
translated in a different biological meaning when they have different expression ranges 
(a). With quantile normalization we can compare genes and samples between them since 
all genes acquire the same distribution (b). To evaluate the accuracy of data 
normalization, boxplots from each sample were generated. Each boxplot shows the 
median (black line), 25th percentile value (lower hinge), 75th percentile value (highest 
hinge), and the maximum and minimum values (whiskers) excluding outliers (circles). A 
common positive control was added to all chips to have a reference after normalization. 
Due to experimental variability, we observed different values in the raw data from 
positive control between chip data (c); quantile normalization allowed to equalize them 
(d). Sample raw data also showed high variability between experiments (e), but thanks to 
normalization they could all be compared by the acquisition of similar distributions (f). 
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Nevertheless, quantile normalization makes data have equal distributions, 
meaning equal dynamic ranges, and allows comparison of Ct values between 
genes (Figure 14b). This is also important since we compare samples different 
developmental stages. To detect experimental variability, the same positive 
control was run in all four chips (Figure 14c) and compared after normalization 
to confirm the efficacy (Figure 14d). Afterwards and before secondary analysis, 
all raw data (Figure 14e) were also normalized (Figure 14f). 
An assumed baseline Ct value of 28 or below was included on the basis of 
previous findings (Guo et al., 2010) and all Ct values higher than this value were 
called as no expression. Similarly, all samples with questionable results such as 
a disproportionately high number of failed gene assays or unusual melt curves 
were discarded (Figure 15). Absolute expression levels were obtained by 
subtracting Ct values from the Ct baseline value of 28.  
Finally, for group comparisons, relative expression was calculated by dividing 
each expression value between the average expression value of the reference 
group (Ex. non-vacuolated embryos, when comparing expression between 
embryos with and without vacuoles) to obtain a final fold-change value, which 
may be more informative in those cases. 
 
Figure 15 | Gene expression exclusion criteria. 
Since the integrity of the cell membrane could alter gene expression results, only 
blastomeres with an intact membrane were included (a); blastomeres with a 
compromised membrane (b) were disregarded in the analysis. This is on the basis of RT-
qPCR curves from blastomeres with an intact membrane (c, red lines) and a compromised 
membrane (c, blue lines). 
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3.6 Statistical analysis of gene expression data 
Data analyses including outliers, descriptive parameters and statistical tests 
were performed using IBM® SPSS® Statistics Version 21. For descriptive 
variables, Saphiro-Willg test was first performed to check for normal 
distribution. If they were normally distributed, t-test (for two groups) or one-
way analysis of variance (ANOVA; for more than two groups) was performed to 
compare mean values. When not normally distributed, the medians were 
compared by the non-parametric Mann-Whitney U-test (for two groups) or by 
Kruskal Wallis test (for more than two groups). For categorical variables chi-
square test was performed, except for variables with small sample size (one of 
the alternatives has a number smaller than 5) in which Fisher´s exact test was 
performed.  
 
For gene regressions models, gene expression values were adapted to a 
quadratic curve (ax2+bx+c) and the accuracy of the model was tested by 
ANOVA. For gene expression comparisons between groups of fragmentation, 
vacuoles, kinetics or ploidy, we first perform a t-test between the average 
collection times. In case of significant differences between groups (P<0.05) the 
comparison was discarded to avoid biased results.  
 
Babelomics was the selected platform for the analysis of the gene expression 
data (Medina et al., 2010). The functional analysis tool, FatiGO, was used to 
detect over-represented functional annotations in a cluster of genes and the 
class comparison tool assisted in the detection of genes differentially expressed 
between groups. Comparative expression between aneuploid and euploid 
embryos from the same time point was performed in the class comparison tool 
using the limma test in Babelomics (Medina et al., 2010) and Benjamini and 
Hochberg test was selected to estimate the false discovery rate. 
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3.7 Ploidy predictor model 
The prediction model was built using the k-nearest neighbors algorithm (k-NN) 
in the Babelomics platform (Medina et al., 2010), which consists of a function 
for the measurement of distances between samples on the basis of gene 
expression profiles. To avoid bias during model generation, sample-split was 
performed. Two-thirds of the samples were randomly selected and grouped as a 
training set and the other one-third of the samples became the validation set, 
which was used to test the model once generated. Each sample from the 
training group was assigned a class: euploid or aneuploid. For a test sample, 
the model was assigned a class attending to the most represented among the 
closest k samples. Several models were generated on the basis of the number of 
neighbors that were evaluated for the prediction. To select the most accurate 
model, a k-fold cross-validation was performed. In this method, the data set 
was automatically split into k partitions and k-1 was used for model training 
and error estimation, respectively. This process was complete when all samples 
were tested and repeated several times to improve prediction accuracy.  
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4 | Results and discussion 
 
4.1 Early human embryo developmental morphology 
4.1.1 Fragmentation 
A recent publication described for the first time the existence of chromosome 
content in embryo fragments (Chavez et al., 2012). Therefore, we wanted to 
focus on fragmentation as the main morphological parameter to study for a 
possible relationship with aneuploidy generation. We evaluated the percentage 
and timing of fragmentation. The percentage of fragmentation was defined as 
the volume of an embryo that is occupied by fragments. Multicapture imaging 
was essential to obtain a three-dimensional picture of each embryo and an 
accurate measurement of the fragmentation degree (Figure 16). 
The majority of embryos exhibited less than 25% fragmentation (n = 62), and no 
embryo showed fragmentation greater than 60% of the cytoplasmic volume 
(Figure 17a). Regarding the stage of the first appearance of fragmentation, we 
differentiated between three time points: before the first division, meaning the 
one-cell or zygote stage (Supplementary Movie 2), during the first division 
(Supplementary Movie 3), or after the first division (Supplementary Movie 4). In 
the 64 embryos displaying fragmentation to any degree, most (68.8%) were 
initially fragmented during the first division, highlighting the importance of the 
first mitosis. Of the remainder, 21.9% fragmented before, and 9.4% after the 
completion of this division (Figure 17b). Additionally, in 3 embryos we could 
observe several events of fragment dynamics, such as fragment division, fusion 
of fragments, and fragments resorption by a blastomere (Supplementary Movie 
5). These phenomena have been previously reported in the literature (Chavez 
et al., 2012). 
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Figure 16 | Embryo fragmentation degree range. 
Three human embryos showing different degrees of fragmentation at the four-cell stage. 
Some embryos did not show any fragmentation (a), but some other embryos showed 
fragmentation from intermediate (b) to very high degrees (c). 
 
 
 
 
Figure 17 | Cellular fragmentation dynamics in embryos. 
(a) The distribution of embryos according to the percentage of fragmentation at 
collection. Fragmentation was quantified at intervals of 5% and was confirmed via three-
dimensional multi-plane imaging. (b) A pie graph showing that almost all fragmentation 
appears before (n = 14) or during the first division (n = 44) with a much smaller 
percentage appearing later (n = 6). Note that each embryo was annotated by the stage in 
which fragmentation appeared for the first time. 
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4.1.2 Other morphological parameters 
In addition to fragmentation, we annotated any other morphological 
characteristic that may be relevant to aneuploidy, such as multinucleation. In 
total, 14% of the cultured embryos (n = 12) showed more than one nucleus at 
some cleavage stage, or more than two pronuclei at zygote stage. Most of the 
embryos (n = 9) were multinucleated at the two-cell stage (Figure 18a), but two 
of them had more than one nucleus in at least one blastomere at the four-cell 
stage. Another embryo also showed multinucleation at the one-cell stage after 
a failed division attempt (Supplementary Movie 6). This embryo had originally 
two pronuclei, which disappeared to start cytokinesis, but since the division did 
not end successfully, the embryo did not divide and the nuclei appeared again, 
but this time there were five nuclei, instead of two. 
In the literature, multinucleation rates range from around 30% (Van Royen et 
al., 2003; Ergin et al., 2014; Desai et al., 2014) to more than 40% (Aguilar et 
al., 2016; Balakier et al., 2016)of embryos. Those rates, which are much higher 
than our findings, include embryo culture until blastocyst stage; we cultured 
until eight-cell stage only, removing embryos at different times. As most of the 
multinucleation takes place during the two-cell stage (Van Royen et al., 2003; 
Ergin et al., 2014; Aguilar et al., 2016), if we consider only embryos from this 
stage (n = 47), the adapted multinucleation rate is 25.5%, which is closer to the 
one described in the literature. 
We also annotated other events such as cytoplasm polarization (Figure 18b), 
different pronucleus sizes, cytoplasm anomalies, or vacuoles existence. We 
found two interesting dynamics in embryos with vacuoles. First, most of the 
embryos with vacuoles showed a decrease in the vacuole number right after the 
first mitosis (Figure 18c). Second, we observed the fusion between small 
vacuoles to give rise to a larger one (Figure 18d and Supplementary Movie 7). 
Vacuole dynamics have been only reported in one previous study, in which the 
authors observed the vacuoles throughout embryo development. They described 
a vacuole frequency between 5 and 12% of the embryos, depending if the 
embryos were fertilized by IVF or ICSI, respectively, and around 28% of the 
vacuoles generated by ICSI disappeared by day 2. These data would explain why 
we saw a decrease in the number of vacuoles right after the first mitosis. 
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Figure 18 | Altered morphology in human embryos. 
(a) Embryo at the two-cell stage showing multinucleation. Red arrows point at three 
nuclei in the bottom blastomere. 
(b) Embryo at the two-cell stage showing cytoplasm polarization. Red arrow indicates the 
line between the two density areas from the cytoplasm in the bottom blastomere. 
(c) Human zygote with a high number of vacuoles (left frame); most of them disappear 
right after the first mitotic division (right frame). 
(d) Human zygote with several vacuoles of medium size (left frame) that fused to 
produce a larger vacuole (right frame). See also Supplementary Movie 7. 
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4.2 Kinetic behaviour of the early human embryo 
4.2.1 Description of kinetic parameters 
We began by examining previously reported parameters including the duration 
of the first cytokinesis (time between the appearance of a cleavage furrow and 
completion of daughter cell separation), the time between the two- to three-
cell stages, and time between the three- to four-cell stages (Wong et al., 2010; 
Meseguer et al., 2011) (Table 4). The median duration of the first cytokinesis 
was 20 min (range 15 min to 2.9 h), the time from two- to three-cell stages was 
11.4 h (range 0-16.8 h) and the median time between the three- and four-cell 
stages was 1.3 h (range 0-22.1 h). Note that some parameters range from 0 
hours, which is the result of the existence of an irregular division: if a zygote 
divides directly to three cells instead of two, the time between the two- and 
three-cell stages would be zero, and similar with the time between the three- 
and the four-cell stages when the zygote divides directly to four cells. 
Wong et al. studied embryo morphokinetics of 242 frozen zygotes and defined 
these three parameters predictive of blastocyst formation with the average 
values of 14.3 ± 6.0 min for the duration of the first cytokinesis, 11.1 ± 2.2 h 
for the time between the two- and the three-cell stages, and 1.0 h ± 1.6 for the 
time between the three- and the four-cell stages (Wong et al., 2010). Similarly, 
Meseguer et al. analyzed 2,120 fresh embryos and established the mean value 
for the parameters of those that implanted, with a time between the two- and 
three-cell stages (called as ‘CC2’) of 11.8 ± 1.2 h and a time between the 
three- and the four-cell stages (called as ‘S2-’) of 0.78 ± 0.73 h (Meseguer et 
al., 2011). Although our morphokinetic data are in concordance with these two 
previous publications, small differences are expected due to different embryo 
populations, as it would be for the one with embryos that exclusively succeed 
in blastocyst formation or implantation; or due to different embryo origins, as 
for embryos from fresh cycles, instead of frozen. 
Besides evaluating previously identified imaging parameters, we also measured 
the time between PNd and the start of the first cytokinesis, a recently 
described parameter that has been linked to human embryo viability (Athayde 
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Wirka et al., 2014; Desai et al., 2014), but not to chromosomal status. As 
shown in Table 1, the median for the time between PNd and the start of the 
first cytokinesis was 2.7 h (range 15 min-22.2 h) suggesting that the wide range 
of this parameter might reflect underlying differences in embryo 
developmental potential. 
Table 4 | Kinetic parameters in all cultured embryos. 
 N Median IQR 
PNd to first cytokinesis (h) 48 2.71 (2.33;3.15) 
First cytokinesis (min) 67 20.0 (15.0;30.0) 
Two to three cells (h) 47 11.42 (0.92;14.5) 
Three to four cells (h) 39 1.25 (0.58;4.42) 
Four to five cells (h) 21 8.08 (0.71;12.25) 
Five to six cells (h) 17 2.25 (0.46;7.29) 
Six to seven cells (h) 16 1.54 (0.79;6.44) 
Seven to eight cells (h) 14 0.79 (0.50;2.17) 
Eight to nine cells (h) 3 1.58 (0.50;NA) 
IQR, interquartile range (Q1;Q3);Q1, 25th percentile; Q3, 75th percentile; PNd, pronuclear disappearance; NA, not 
applicable 
 
4.2.2 Irregular divisions and effect on kinetics 
In addition to normal cell cycle divisions, we were able to detect irregular 
division events in certain embryos, including divisions from 1 to 3 cells or from 
1 to 4 cells instead of the regular division from 1 to 2 cells. Irregular divisions, 
also called “direct cleavage”, have been described in the literature with a 
frequency ranges from 14% to 26% (Rubio et al., 2012; Campbell et al., 2013; 
Desai et al., 2014). In our study, these atypical events occurred in 23.6% (n = 
20) of embryos with the majority dividing from 1 to 3 blastomeres (n = 17; 
Supplementary Movie 8) and a much smaller subset dividing from 1 to 4 cells (n = 
3; Supplementary Movie 9). Notably, 85% (n = 17) of all irregular divisions 
occurred during the first mitosis, as previously reported (Campbell et al., 
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2013), whereas only 15% (n = 3) occurred in either the second or third mitosis 
(Supplementary Movie 10), stressing the relevance of the first mitotic division. 
It is important to note that one irregular division altered all subsequent kinetic 
parameters (Figure 19). Thus, we considered that kinetic parameters should be 
always calculated for regular and irregular division separately to avoid drawing 
misleading conclusions, as has already been established in the literature 
(Herrero et al., 2013). In addition, this would be related with the use of 
developmental time instead of the cell stage to classify or compare embryos in 
a study, as two embryos with the same number of cells can proceed from very 
different origins, especially when irregular divisions are part of the process. 
As expected, the time between two- and three-cell stages was shorter in 
embryos with irregular divisions, and together with the time between the four- 
and five-cells stage were the most statistically differential parameters versus 
embryos with regular divisions (Table 5). Also, it is important to notice that the 
time between the PNd and the first cytokinesis, and the duration of the first 
cytokinesis, were not statistically different between groups, since irregular 
divisions only affect kinetics after they have occurred. 
The origin of direct cleavage during embryo development remains unknown. 
Different hypotheses have been postulated. The most accepted ones support 
that irregular divisions are originated from multipolar spindles that can be 
created during polyspermia (Kola et al., 1987) or by anomalies in the inherited 
centrosome from the sperm (Sathananthan et al., 1996). In our study, all 
embryos showed two polar bodies and two pronuclei, which are indicative of a 
proper fertilization, discarding polyspermia. Nevertheless, a previous study in 
rhesus monkey has shown that embryos from sperm that has been previously 
exposed to oxidative stress show higher proportions of irregular divisions 
(Burruel et al., 2014). Surprisingly, DNA oxidation has been correlated with 
lower sperm motility in infertile males (Meseguer et al., 2008), which would 
explain the high proportions of irregular divisions in embryos from IVF couples. 
Interestingly, a recent study has demonstrated that irregular divisions may 
create the segregation of the parental genomes in chimeric and/or mixoploid 
lineages inside the embryo (Destouni et al., 2016). 
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Figure 19 | Time ranges between the different cell stages according to the existence 
or non-existence of irregular divisions during embryo development. 
Irregular divisions altered all subsequent kinetics parameters. When the irregular division 
takes place during the first mitosis (lower part of the image), the time between the 2- 
and the three-cell stages is nonexistent compared to the regular first division (top part of 
the image). Similarly, the time between the three- and the four-cell stages is be much 
longer when the irregular division occurs, the time between the four- and the five-cell 
stages is shorter, and the majority of the next parameters are altered. Also the number 
of the total cells of the embryo is greater at the same time point when an irregular 
division takes place. Cells resulting from the same division have been labeled as (a), (b), 
and (c), if necessary. cc, cell cycle. 
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Table 5 | Kinetic parameters in embryos with regular and irregular divisions. 
 
Regular divisions Irregular divisions 
N Median  IQR N Median  IQR 
PNd to 1st cytokinesis (h) 32 2.58 (2.25;3.06) 16 2.88 (2.46;3.17) 
First cytokinesis (min) 47 0.25 (0.17;0.50) 20 0.42 (0.25;0.63) 
Two to three cells (h) 27 12.17 a (11.58;12.92) 20 0.88 a (0.27;2.46) 
Three to four cells (h) 27 1.00 b (0.42;1.67) 12 7.58 b (1.17;11.92) 
Four to five cells (h) 10 12.25 c (9.19;14.65) 11 0.75 c (0.00;8.08) 
Five to six cells (h) 10 2.08 (0.52;4.85) 7 2.75 (0.42;13.42) 
Six to seven cells (h) 9 1.25 d (0.54;2.04) 7 4.25 d (1.25;12.25) 
Seven to eight cells (h) 9 0.93 (0.50;2.42) 5 0.67 (0.33;3.54) 
Eight to nine cells (h) 0 NA NA 3 1.58 NA 
IQR, interquartile range (Q1;Q3); NA, not applicable; PNd, pronuclear disappearance. 
a,c P<0.001 b,d P<0.05 (Mann-Whitney U-test). 
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4.3 Aneuploidy incidence in the human embryo 
We further performed the chromosomal analysis of all embryos. Informative 
results for chromosome content were obtained for 89 cells, specifically 71 
blastomeres and 18 polar bodies, from a total of 57 embryos (Supplementary 
Table 2). The percentage of informative data (67%) was lower in comparison 
with the published clinical rate (97%) (Rodrigo et al., 2014), which may be 
caused by the freeze/thaw cycle of the embryos by slow freezing, which has 
been shown to be less efficient than vitrification (Fasano et al., 2014); or by a 
possible lower quality of some of the embryos dedicated to the study, as in the 
clinical routine only embryos with good development and morphology are 
selected for biopsy. 
The aneuploidy rate was 50.9% (n = 29; Figure 20), with no statistically 
significant differences according to the maternal age between euploid (33.4 ± 
3.1 years) and aneuploid embryos (32.6 ± 3.4 years). This is in agreement with 
previous reports using different array-based approaches (Vanneste et al., 2009; 
Johnson et al., 2010b; Ata et al., 2012; Chavez et al., 2012) and further 
supports the notion that there is still an important incidence of aneuploidy at 
the cleavage-stage even with low maternal age (Munne et al., 2004; Munne et 
al., 2006).  
Embryos were classified into different categories according to the aCGH results 
(Figure 20). Aneuploid embryos were differentiated according to the number of 
affected chromosomes between single aneuploid, when one chromosome was 
affected (n = 9; Figure 21a), complex aneuploid, when between 2 and 10 
chromosomes were affected (n = 11), or chaotic if more than 10 chromosomes 
were aneuploid (n = 9; Figure 20). We wanted to differentiate the chaotic 
profiles since this type of pattern remains to be more deeply analyzed, as it has 
been hypothesized that lysed cells and damaged DNA may lead to this result. 
Rebiopsy of these embryos may show different chromosomal composition, 
pointing to possible initial artefactual results (Rubio et al., unpublished data). 
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Figure 20 | Distribution of chromosome abnormalities according to aCHG results. 
Informative embryos were differentiated between euploid and aneuploid. ‘Single’ 
aneuploid embryos were considered when only one chromosome was affected, ‘Complex’ 
when 2-10 chromosomes were affected, and ‘Chaotic’ when more than 10 chromosomes 
were altered. In aneuploid embryos with 2 or more cells analyzed –including polar bodies- 
the origin was determined as meiotic, when all blastomeres shared the same alteration 
and/or the polar bodies were aneuploid; mitotic, when at least two blastomeres were 
aneuploid for different chromosomes and the polar bodies were euploid, if available; or 
both, when the altered chromosome(s) in blastomeres and polar bodies were different. 
Finally, in the aneuploid embryos from mitotic origin, they were classified according to 
the existence of only aneuploid blastomeres, or a mix of euploid and aneuploid 
blastomeres. aCGH, array-comparative genomic hybridization; chr, chromosome. 
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On the other hand, other authors support that chaotic aCGH patterns are 
caused by mosaic embryos (Le Caignec et al., 2006), which will also support the 
finding of a different result by the second biopsy. Independent of the origin of 
this pattern, DNA damage or mosaicism, their frequency ranges between 15% 
and 20% of the analyzed embryos at cleavage stage (Le Caignec et al., 2006; 
Rodrigo et al., 2014), which is concordant with the percentage in our study 
(12.3%, 7/57), and high enough to be considered for future studies. 
In some cases, when more than one sample from the same embryo was 
analyzed, it was also possible to infer the origin of the aneuploidy(s) (n = 14; 
Figure 20). Embryos with all blastomeres showing identical aneuploidies and/or 
with aneuploid polar bodies had most likely inherited meiotic errors. 
Unfortunately, we did not have information to differentiate between the first 
and the second polar body, as both of them were already extruded before 
freezing at pronuclear stage. In contrast, those embryos with different 
chromosomal constitution between blastomeres and euploid polar bodies had 
incurred mitotic errors. And embryos with aneuploid polar bodies and 
aneuploidy blastomeres, but for different chromosomes, were likely originated 
by meiotic and mitotic errors. According to these criteria, we proposed that 
50% (7/14) of those aneuploid embryos originated from mitotic errors, 43% 
(6/14) from meiotic errors, and 7% from both (Figure 20). From the 7 embryos 
with mitotic errors, 6 displayed mosaicism among blastomeres –the other one 
only had information from one blastomere and one polar body-: in 3 of them, 
all blastomeres were chromosomally abnormal, but with different abnormalities 
and complementary abnormalities in some cases (Figure 21b); and three 
embryos exhibited a mixture of euploid and aneuploid blastomeres (Figure 21c; 
Figure 20). The rate of mosaic embryos in our embryo population was 10.5% 
(6/57), and the rate of “risky” mosaic embryos was 5.3% (3/57); considering 
“risky” embryos those with at least one euploid blastomere, with the 
probability of misdiagnosing in case of genetic analysis of a single blastomere. 
These rates are in concordance with the ones described in the literature, which 
have shown that day-3 aCGH diagnoses has a false positive rate of 2-3% 
(Gutierrez-Mateo et al., 2011; Mir et al., 2013). We have to consider that the 
false positive rate only includes those embryos that were originally diagnosed 
as aneuploid and were not fully aneuploid after all blastomeres were analyzed, 
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whereas our rate (5.3%) would also include the opposite situation, embryos 
diagnosed as euploid using a single blastomere, that would be mosaic if we 
could analyze all cells. 
Finally, when we differentiated the aneuploidy rate at one-cell embryos versus 
cleavage-stage embryos, we obtained 37.5% versus 53% of aneuploid embryos, 
respectively. The percentage of aneuploidies at zygote stage would correspond 
to the meiotic error rate, whereas the increase in the aneuploidy rate 
throughout development would be caused by the appearance of aneuploidies 
due to errors in the subsequent mitotic cell divisions. This number similar to 
the one calculated in Figure 20, from embryos with 2 or more samples analyzed, 
so we could range meiotic error rate between 37.5% and 43% in this study. A 
previous publication in a similar population showed a meiotic error rate of 20% 
(Chavez et al., 2012), although this value was inferred exclusively from 
cleavage-stage embryos. Since the aneuploidy rate at the zygote stage 
calculated in this study was also based on polar body results, we should 
consider these issues as a possible source for the discrepancy. 
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Figure 21 | Representative aCGH results. 
(a) Two blastomeres from the same four-cell embryo showing chromosome 17 trisomy. (b) 
Two blastomeres from a chromosomally mosaic four-cell embryo with complementary 
aneuploidies for chromosomes 2, 7, 16, 19 and the sex chromosomes (Y0 and XXY). (c) 
Four blastomeres from a mosaic eight-cell embryo with two euploid blastomeres (46, XY), 
one blastomere with a trisomy for chromosome 18, and one blastomere with multiple 
aneuploidies (trisomies for chromosomes 10 and 21, and Y0). All profiles were compared 
with the male control DNA reference. 
 
 
RESULTS AND DISCUSSION 
 79 
      
Figure 21 (continued) 
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4.4 Gene expression throughout embryo development 
Besides assessing the chromosomal status and imaging behavior of each 
embryo, we also collected single-cell expression data from genes with relevant 
function during the first stages of human embryo development. Single-cell gene 
expression results were obtained for 119 blastomeres from 78 embryos. A total 
of 86 genes were selected on the basis of their previously reported importance 
to aneuploidies generation (Liu et al., 2000; Jurisicova et al., 2003; Wells et 
al., 2005; Ma et al., 2006; Bultman et al., 2006; Jaroudi and SenGupta, 2007; 
Wan et al., 2008; Jaroudi et al., 2009; Wong et al., 2010; Kiessling et al., 2010; 
Galan et al., 2010; Tashiro et al., 2010; Mantikou et al., 2012; Choi et al., 
2012; Shaw et al., 2012; Galan et al., 2013; Baran et al., 2013). The biological 
processes in which the genes were involved included, but were not limited to, 
cell cycle regulation, apoptosis, telomere maintenance and DNA methylation 
(Table 3). Individual gene expression patterns were analyzed in each 
blastomere of a given embryo to determine developmental progression of 
expression levels during preimplantation development. To compare expression 
between embryos at different stages, we established a common start and end 
time point for all embryos. As mentioned above, PNd was designated as zero in 
the time scale and 56 h after was set as the final time point; no gene 
expression data were obtained beyond this.  
4.4.1 Identification of gamete versus embryonic genome activated 
transcripts 
Since the human embryo remains largely transcriptionally silent for the first 
few days of development, with only a small subset of genes activated before 
the six- to eight-cell stage (Dobson et al., 2004; Zhang et al., 2009; Vassena et 
al., 2011; Xue et al., 2013), normal development relies on mRNA inherited from 
the gametes for survival. It is estimated that approximately 70% of retained 
RNAs derive from the oocyte, and approximately 30% are inherited paternally 
(Zhang et al., 2009). We aimed to definitively determine which transcripts from 
our study were from gametic origin or resulting from EGA. To accomplish this, 
we calculated the expression value at time zero for each gene using quadratic 
regression (Supplementary Table 3). Values higher than 2 indicated that the 
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transcript was present in the zygote and thus provided by the gametes. When 
the expression values were above 2 for the final time point (Supplementary 
Table 3), the transcript was considered activated by the EGA.  
Y-box-binding protein 2 (YBX2) expression was selected as a double check for 
this procedure. YBX2 has been described to be essential for the storage of the 
maternal mRNA in mouse embryos (Yu et al., 2003). Our data showed high 
levels of YBX2 transcripts at a pronuclear stage, but a gradual decrease along 
development, becoming at very low levels 56 hours from PNd (Figure 22). 
Relying on this, we stated that most maternal transcripts should be already 
degraded by that time and genes with transcripts have should have been 
activated by the embryonic genome.  
 
 
Figure 22 | Expression (log2) of YBX2 in blastomeres during embryo development.  
Blastomeres coming from the same embryo are represented as independent events. 
Pronuclear disappearance was set as time zero. Zygotes analyzed before the PNd were 
placed in the time scale as -10 h. 
 
 
From this analysis, we identified 40 genes that appeared to encode transcripts 
inherited from the gametes (Figure 23). In this group, aurora kinase A (AURKA), 
BUB3 mitotic checkpoint protein (BUB3), cadherin 1 (CDH1), cyclin-dependent 
kinase 7 (CDK7), developmental pluripotency associated 3 (DPPA3), the oocyte 
expressed protein (OOEP), and peptidyl arginine deiminase type VI (PADI6) were 
the inherited transcripts with the highest levels of expression at the zygote 
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stage (Supplementary Figure 1). In contrast, a total of 44 genes were activated 
by the embryonic genome, 10 of which were undetectable in the zygote and, 
thus, not likely required during the earliest stages of embryo development 
(Figure 23). More specifically, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), Cyclin A1 (CCNA1), DPPA3, and Yin Yang 1 transcription factor (YY1) 
were the most significant in this group and showed expression log2 values 
above 10 during the oocyte-to-embryo transition (Supplementary Figure 1). 
 
 
Figure 23 | Identification of gametic versus embryonic transcripts. 
Gametic transcripts (n = 40) were highly expressed at time zero, whereas EGA genes (n = 
44) were highly expressed at the final time point. The majority of these genes (n = 34) 
were originally inherited from the gametes and subsequently activated by EGA. See also 
Supplementary Figure 1. 
 
Here, we demonstrate new potential maternally or paternally-derived gene 
products, including CDH1, which has been described as only expressed at the 
cleavage and blastocyst stage (Galan et al., 2010). Other genes, such as OOEP 
and PADI6, identified as gametic in origin here, have been previously reported 
to represent maternal effect genes in murine embryos (Tashiro et al., 2010; Li 
et al., 2010), but our data suggest that they have a conserved function in early 
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human development. Note that, although we describe that many similarities 
exist between mouse and human embryos, with numerous studies in the 
former, important differences between the two species have been recently 
reported (Niakan et al., 2012; Niakan and Eggan, 2013; Madissoon et al., 2014). 
Therefore we should never rely on results from mouse without the 
corresponding replication study in human. 
4.4.2 Gene expression patterns throughout development  
To create a “best fit” model that allowed identification of statistically 
different gene profiles in embryos, a quadratic regression was performed for 
each gene as described in Methods. Using this regression, we observed 
statistically significant differences in 55 out of 86 genes analyzed (P<0.05, 
ANOVA test; Supplementary Figure 1 and Supplementary Table 3).  
We then grouped genes into different clusters according to their expression 
dynamics. For the interpretation of the clusters, we considered that the gene 
expression values for each time point were the result of inherited molecules 
from the gametes and/or newly synthesized molecules generated by the 
embryonic genome. Thus, inherited transcripts would be highly expressed at 
the pronuclear stage and decrease in expression as development proceeds 
unless they are activated by the embryonic genome. On the other hand, 
embryo transcribed genes would increase with development and would exhibit 
none or relatively minor transcriptional inheritance from the gametes. 
Cluster 1 (n = 29) comprised genes inherited from the gametes and showed no 
evidence of transcriptional activation by the embryo since expression levels 
decreased throughout development (Figure 24).  
On further analysis of the cluster 1 genes, we determined that the most 
significant annotations obtained (P≤0.001, Fisher´s exact test) were related to 
cell cycle regulation, DNA metabolism and chromosome organization (Table 6). 
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Figure 24 | Gene expression patterns in cluster 1 genes. 
Significant quadratic regressions were classified into four different clusters according to 
the expression trend versus time. The majority of genes included in cluster 1 (n = 29) 
were expressed in the zygote stage but decreased in expression by at least twofold 
between the start and the final time. The most significant regressions were selected by 
ANOVA test with P<1x10-6 and fold change>10. Each expression data point corresponds to 
the mean value obtained from three technical replicates. A baseline of Ct = 28 was used 
to obtained the shown expression values. For the rest of gene charts from this cluster see 
Supplementary Figure 1. 
 
 
Our findings are in accordance with previous reports (Wong et al., 2010), 
wherein PDCD5, the cell death-related gene that inhibits the degradation of 
DNA damage response proteins, was present in the zygote and decreased in 
expression until day 3. AURKA, which is involved in chromosome stabilization of 
the spindle, has been shown to be highly expressed at early stages and scarcely 
detected at the eight-cell stage (Kiessling et al., 2010). 
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Table 6 | Most represented gene ontology terms for cluster 1. 
GO:Term Term name C G 
Adjusted 
P value 
GO:0007049 Cell cycle  15 937 1.09E-10 
GO:0006259 DNA metabolic process  12 635 6.03E-09 
GO:0022402 Cell cycle process  11 638 1.00E-07 
GO:0009892 Negative regulation of metabolic process  11 707 2.20E-07 
GO:0009890 Negative regulation of biosynthetic process  10 561 3.68E-07 
GO:0051276 Chromosome organization  10 627 8.79E-07 
GO:0009893 Positive regulation of metabolic process  11 858 9.03E-07 
GO:0051726 Regulation of cell cycle  8 313 9.03E-07 
GO:0000278 Mitotic cell cycle  9 469 9.03E-07 
GO:0000279 M phase  8 386 3.88E-06 
GO:0009790 Embryonic development  9 608 6.72E-06 
GO:0033044 Regulation of chromosome organization  4 28 1.18E-05 
GO:0001701 In utero embryonic development  6 183 1.67E-05 
GO:0043009 Chordate embryonic development  7 344 2.63E-05 
GO:0051053 Negative regulation of DNA metabolic process  4 37 2.63E-05 
GO:0009792 
Embryonic development ending in birth or egg 
hatching  7 348 2.64E-05 
GO:0010628 Positive regulation of gene expression  8 578 4.53E-05 
GO:0034984 Cellular response to DNA damage stimulus  7 382 4.53E-05 
GO:0050790 Regulation of catalytic activity  9 851 6.49E-05 
GO:0006974 Response to DNA damage stimulus  7 422 7.55E-05 
GO:0006366 Transcription from RNA polymerase II promoter  9 882 7.90E-05 
GO:0000087 M phase of mitotic cell cycle  6 269 8.95E-05 
GO:0016481 Negative regulation of transcription  7 450 1.00E-04 
GO:0016568 Chromatin modification  6 282 1.07E-04 
GO:0006461 Protein complex assembly  8 682 1.12E-04 
GO:0031328 
Positive regulation of cellular biosynthetic 
process  8 700 1.25E-04 
GO:0006275 Regulation of DNA replication  4 65 1.25E-04 
GO:0010629 Negative regulation of gene expression  7 491 1.46E-04 
GO:0000075 Cell cycle checkpoint  4 77 2.16E-04 
GO:0008156 Negative regulation of DNA replication  3 26 4.36E-04 
GO:0051259 Protein oligomerization  5 217 4.91E-04 
GO:0051716 Cellular response to stimulus  8 865 4.99E-04 
GO:0033554 Cellular response to stress  7 623 5.80E-04 
GO:0032259 Methylation  4 106 6.07E-04 
GO:0006260 DNA replication  5 232 6.07E-04 
GO:0006306 DNA methylation  3 33 7.06E-04 
GO:0051096 Positive regulation of helicase activity  2 3 8.39E-04 
GO:0032206 Positive regulation of telomere maintenance  2 3 8.39E-04 
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GO:0030521 Androgen receptor signaling pathway  3 37 8.96E-04 
GO:0007067 Mitosis  5 260 8.96E-04 
GO:0051128 Regulation of cellular component organization  6 458 9.51E-04 
GO:0043086 Negative regulation of catalytic activity  5 266 9.51E-04 
GO, gene ontology; C, number of genes annotated by the given term in the test set; G, number of genes annotated 
by the given term in the reference set. 
Only GO terms with P≤0.001 (Two-tailed Fisher´s exact test) are shown. 
 
Cluster 2 (n = 4) comprised genes that showed relatively constant expression 
and likely represent the bulk of transcripts inherited from the gametes since 
they were detected at the pronuclear stage, but were also present at similar 
levels at later stages (Figure 25). By avoiding mRNA degradation, or if degraded, 
compensated for by new synthesis from the embryonic genome, these genes are 
able to maintain stable levels throughout development. The genes whose 
regressions were constant and statistically significant (P<0.05, ANOVA test) in 
this cluster were v-akt murine thymoma viral oncogene homolog 1 (AKT1), 
breast cancer 1 (BRCA1), GAPDH, and NLR family, pyrin domain containing 5 
(NLRP5) (Figure 25).  
RESULTS AND DISCUSSION 
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Figure 25 | Gene expression patterns for cluster 2 genes. 
Significant quadratic regressions were classified into four different clusters according to 
the expression trend versus time. Cluster 2 (n = 4) comprised genes that showed 
relatively constant expression as defined by an increase or decrease in expression of less 
than 1 point. All regressions for this cluster were significant (P<0.05, ANOVA test). Each 
expression data point corresponds to the mean value obtained from three technical 
replicates. A baseline of Ct = 28 was used to obtained the shown expression values. 
 
 
As a group, these genes have known functions in monosaccharide metabolism 
and lipid biosynthesis as well as food and stress response or RNA stability (Table 
7). Notably, we detected high variability in BRCA1 expression between cells 
from the same embryo, which could explain the discordance with previous 
findings since these studies detected differences between stages by using the 
average expression of all equivalent samples (Wells et al., 2005; Giscard 
d'Estaing et al., 2005). 
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Table 7 | Most represented gene ontology terms for cluster 2. 
GO:Term Term name C G 
Adjusted 
P value 
GO:0006006 Glucose metabolic process  3 163 6.65E-04 
GO:0010907 
Positive regulation of glucose metabolic 
process  2 12 6.65E-04 
GO:0019318 Hexose metabolic process  3 201 6.65E-04 
GO:0032094 Response to food  2 15 6.65E-04 
GO:0032369 Negative regulation of lipid transport  2 13 6.65E-04 
GO:0032770 Positive regulation of monooxygenase activity  2 17 6.65E-04 
GO:0034405 Response to fluid shear stress  2 8 6.65E-04 
GO:0045598 Regulation of fat cell differentiation  2 13 6.65E-04 
GO:0048009 
Insulin-like growth factor receptor signaling 
pathway  2 16 6.65E-04 
GO:0050995 Negative regulation of lipid catabolic process  2 17 6.65E-04 
GO:0050999 Regulation of nitric-oxide synthase activity  2 13 6.65E-04 
GO:0051000 
Positive regulation of nitric-oxide synthase 
activity  2 7 6.65E-04 
GO:0043487 Regulation of RNA stability  2 14 6.65E-04 
GO:0005996 Monosaccharide metabolic process  3 236 7.07E-04 
GO:0008633 Activation of pro-apoptotic gene products  2 19 7.08E-04 
GO:0043029 T cell homeostasis  2 20 7.30E-04 
GO:0015909 Long-chain fatty acid transport  2 22 8.21E-04 
GO:0043491 Protein kinase B signaling cascade  2 23 8.43E-04 
GO:0046889 
Positive regulation of lipid biosynthetic 
process  2 25 9.34E-04 
GO:0002260 Lymphocyte homeostasis  2 28 1.00E-03 
GO:0045862 Positive regulation of proteolysis  2 28 1.00E-03 
GO:0051353 Positive regulation of oxidoreductase activity  2 28 1.00E-03 
GO, gene ontology; C, number of genes annotated by the given term in the test set; G, number of genes annotated 
by the given term in the reference set. 
Only GO terms with P≤0.001 (Two-tailed Fisher´s exact test) are shown. 
 
Cluster 3 (n = 10) included genes that were activated during embryo 
development, but were not originally expressed in the zygote (Figure 26). Genes 
with an expression lower than 2 at time zero and at least a two-fold difference 
at the final time point were selected for this cluster.  
RESULTS AND DISCUSSION 
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Figure 26 | Gene expression patterns for cluster 3 genes. 
Significant quadratic regressions were classified into four different clusters according to 
the expression trend versus time. Cluster 3 (n = 10) comprised genes with an expression 
value lower than 2 at time zero and at least a two-fold difference at the final time point. 
The most significant regressions from the cluster were selected with P<1x10-6 (ANOVA 
test) and fold change>10. Each expression data point corresponds to the mean value 
obtained from three technical replicates. A baseline of Ct = 28 was used to obtained the 
shown expression values. For the rest of genes from this cluster see Supplementary Fig. 1. 
 
 
Gene ontology (GO) analysis showed that these genes were associated with 
regulation of the cell cycle, particularly interphase, but were also involved in 
other biological process such as the stress response (P≤0.001, Fisher´s exact 
test; Table 8). The most relevant genes in this cluster were Fas ligand (FASLG), 
growth arrest and DNA-damage-inducible alpha (GADD45A), SRY-box 2 (SOX2), 
and zinc finger and SCAN domain containing 4 (ZSCAN4; fold change>10 and 
P<1x10-6, ANOVA test; Figure 26). FASLG is a death receptor ligand whose 
expression has been shown to correlate with cellular fragmentation in human 
embryos at the two- and four-cell stage (Kawamura et al., 2001). We observed 
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a gradual increase in FASLG expression with development starting with basal 
levels at the pronuclear stage to suggest that embryos do not undergo apoptosis 
until later in development as previously described(Hardy, 1999). In addition, 
ZSCAN4, which is involved in telomere maintenance, exhibited the greatest 
increase in expression of all the genes in this cluster (fold change = 211), with 
considerably lower levels observed before PNd. This was also in accordance 
with previous studies showing ZSCAN4 expression in eight-cell embryos and no 
expression in zygotes (Shaw et al., 2012). 
Table 8 | Most represented gene ontology terms for cluster 3. 
GO:Term Term name C G Adjusted P value 
GO:0022402 Cell cycle process  6 643 9.19E-05 
GO:0051325 Interphase  4 115 9.19E-05 
GO:0051329 Interphase of mitotic cell cycle  4 109 9.19E-05 
GO:0007049 Cell cycle  6 948 4.28E-04 
GO:0009411 Response to UV  3 55 7.31E-04 
GO:0033554 Cellular response to stress  5 625 9.57E-04 
GO:0033273 Response to vitamin  3 69 9.57E-04 
GO:0046661 Male sex differentiation  3 71 9.57E-04 
GO, gene ontology; C, number of genes annotated by the given term in the test set; G, number of genes annotated 
by the given term in the reference set. 
Only GO terms with P≤0.001 (Two-tailed Fisher´s exact test) are shown. 
 
Cluster 4 (n = 12) genes also increased in expression on embryonic genome 
activated (EGA), but unlike cluster 3, were also detected at the pronuclear 
stage to suggest both a gametic and embryo source of transcripts. CCNA1, 
myeloid cell leukemia 1 (MCL1), and zygote arrest 1 (ZAR1) showed the most 
significant difference for this group (fold change>10 and P<1x10-6, ANOVA test; 
Figure 27). We detected low expression of CCNA1 at the pronuclear stage with 
significantly increased expression on EGA as previously described (Kiessling et 
al., 2010) and increasingly high levels of ZAR1 beginning at the pronuclear 
stage. While CCNA1 binds particular cell cycle regulators, ZAR1 is thought to 
function as a maternal effect gene in mouse and human embryos (Wu et al., 
2003). However, GO analysis did not show any statistically significant 
annotations for this cluster. 
RESULTS AND DISCUSSION 
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Figure 27 | Gene expression patterns for cluster 4 genes. 
Significant quadratic regressions were classified into four different clusters according to 
the expression trend versus time. Cluster 4 (n = 12) comprised genes with expression 
higher than 2 at time zero and two-fold or more at the last time point. The most 
significant regressions were selected with P<1x10-6 (ANOVA test) and fold change>10. 
Each expression data point corresponds to the mean value obtained from three technical 
replicates. A baseline of Ct = 28 was used to obtained the shown expression values. For 
the rest of gene charts from this cluster see Supplementary Figure 1. 
 
Although some of the genes in our study have been previously described in 
relation to human embryo viability, most of these studies examined expression 
patterns in whole embryos (Kawamura et al., 2001; Dobson et al., 2004; 
Giscard d'Estaing et al., 2005; Wells et al., 2005; Vassena et al., 2011; Shaw et 
al., 2012; Shaw et al., 2013), in pools of whole embryos (Jurisicova et al., 
2003; Jaroudi et al., 2009; Zhang et al., 2009; Kiessling et al., 2010; Bazrgar et 
al., 2014), and/or only at a single stage of preimplantation development 
(Giscard d'Estaing et al., 2005; Kiessling et al., 2010; Bazrgar et al., 2014). In 
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contrast, we evaluated gene expression at the single-cell level throughout 
multiple stages of early embryogenesis and showed that considerable variability 
is observed among samples, which complicate the identification of potential 
differences in embryos from the same stage. Note that we analyzed gene 
expression profiling in cryopreserved embryos and that some transcripts may be 
affected by the freezing-thawing procedures despite similar developmental 
timing and genome activation as fresh embryos (Shaw et al., 2012). However, 
we addressed this limitation by calculating expression levels in each 
blastomere, a method preferable to normalization to a housekeeping gene(s) 
due to individual gene variation as previously described (Warren et al., 2006). 
4.4.3 Activation times for EGA transcripts 
For genes that showed clear activation in EGA (clusters 3 and 4), we sought to 
determine the exact time in which activation occurs (Figure 28). The minimum 
of each quadratic function was calculated for this purpose, and 8 of the 22 
genes exhibited an increase in expression starting from PNd. Interestingly, most 
of the cluster 3 genes were activated earlier in development than cluster 4 
genes. This can be explained by the finding that they were not originally 
expressed in the gametes and thus needed to be activated by the EGA at the 
earliest stage. In contrast, we observed that the majority of the cluster 4 genes 
did not need such early activation by the embryo, as there was already an 
initial pool of transcripts inherited by the zygote. Further, genes with the 
observed stable expression pattern (cluster 2) could be the result of a balance 
between mRNA degradation and new mRNA synthesis. Therefore, although 
these genes could be transcriptionally activated as well, the activation time 
could not be established for this cluster. 
The major wave of human embryonic genome activation occurs at the six- to 
eight-cell stage; however, other studies suggest that there is minor 
transcription of certain genes beginning at the two-cell stage (Dobson et al., 
2004; Zhang et al., 2009; Galan et al., 2010; Vassena et al., 2011). In 
accordance with more recent findings (Xue et al., 2013), here we show the 
potential activation of a subset of genes as early as the zygote stage. More 
importantly, we also determined that this unique group of genes is associated 
with cell cycle regulation and shows nearly non-existent expression before 
RESULTS AND DISCUSSION 
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embryonic activation, to confirm that they were unlikely inherited from the 
gametes. Further studies should probe the role of these early-activated genes 
and their function in proper human preimplantation development. 
 
 
Figure 28 | Activation times of embryonic genes. 
EGA timing is shown in hours (h) after PNd. Two groups were identified according to the 
basal levels at the pronuclear stage: “Activated EGA genes” (n = 10) that were originally 
absent at the zygote stage and corresponded to cluster 3 genes, and “Upregulated genes” 
(n = 12) that were already present at the pronuclear stage were designated for cluster 4 
genes. A schematic representation of embryo development with normal mitotic divisions 
was included as a guide. 
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4.5 Correlation between morphology and kinetics 
The correlation between the different morphology parameters and the kinetic 
behavior of the embryos was studied to elucidate a possible relationship 
between them. All possible combinations were analyzed among every kinetic 
parameter or the irregular division existence versus fragmentation degree, 
multinucleation or vacuole existence. 
4.5.1 Morphology versus kinetic parameters 
Fragmentation was the first morphological parameter studied to detect a 
possible effect on kinetics. We differentiated between low degree of 
fragmentation, which represented less than 25% of the cytoplasmic volume, and 
high degree, which represented 25% or higher. The only kinetic parameter that 
was statistically significant among fragmentation groups was the time between 
the PNd and the first cytokinesis (P<0.05, Mann-Whitney U-test), which was 
longer in those embryos with higher fragmentation degree (3.0 h vs. 2.6 h) 
(Table 9). This finding should be taken into consideration with the data 
reported in section 1.1, in which we showed how most of the embryos in this 
study become fragmented during the first division (Figure 17b). Therefore, we 
could deduce that the fragment extrusion slows down the embryo development 
at the moment in which they originate. 
According to multinucleation, we observed important differences in most of the 
kinetic parameters analyzed (Table 9). The time between two and three cells 
was the first parameter that was highly different between groups (presence and 
absence of multinucleation), being shorter in the multinucleated embryos (1.6 
h vs. 11.7 h), although it was not statistically significant. The next two 
parameters, time between three and four cells and time between four and five 
cells, were both statistically significant between multinucleated and non-
multinucleated embryos (P<0.05, Mann-Whitney U-test). The first one was 
longer in multinucleated embryos (10.9 h vs. 1.0 h) and the second one was 
shorter (0.8 h vs. 11.3 h). These results support previous published data 
showing that morphokinetic parameters are affected by multinucleation (Ergin 
et al., 2014; Balakier et al., 2016). 
  
 
Table 9 | Kinetic parameters under the effect of different morphological events. 
  High fragmentation  Multinucleation  Vacuoles 
 
  N Median IQR  N Median IQR  N Median IQR 
 
PNd to 1st cytokinesis (h) 
No 45 2.6a (2.1;3.0)  54 2.6 (2.3;3.1)  57 2.6 (2.2;3.1)  
Yes 21 3.0a (2.6;4.6)  12 3.0 (2.5;4.3)  9 3 (2.7;3.8)  
First cytokinesis (min) 
No 46 15.0 (10.0;35.0)  55 15.0 (10.0;35.0)  57 20.0 (15.0;32.5)  
Yes 21 20.0 (15.0;30.0)  12 25.0 (16.2;30.0)  10 20.0 (10.0;31.2)  
Two to three cells (h) 
No 33 11.6 (0.9;12.5)  36 11.7 (1.7;12.6)  41 11.6 (1.3;12.7)  
Yes 14 8.8 (1.4;12.9)  11 1.6 (0.0;12.3)  6 2.1 (0.4;12.2)  
Three to four cells (h) 
No 28 1.1 (0.4;4.0)  30 1.0b (0.4;2.5)  36 1.2 (0.5;7.3)  
Yes 11 1.3 (0.8;8.3)  9 10.9b (1.0;12.3)  3 2.4 (0.8;NA)  
Four to five cells (h) 
No 15 2.7 (0.5;12.3)  14 11.3c (4.5;13.6)  18 5.0 (0.6;12.1)  
Yes 6 9.3 (5.1;15.7)  7 0.8c (0.5;4.8)  3 13.3 (8.1;NA)  
Five to six cells (h) 
No 12 2.3 (0.2;10.2)  13 1.3 (0.3;5.6)  14 2.5 (0.6;8.4)  
Yes 5 2.3 (0.6;5.8)  4 8.1 (2.4;14.4)  3 0.5 (0.1;NA)  
Six to seven cells (h) 
No 11 1.3 (0.6;4.3)  12 1.8 (0.6;6.4)  13 1.3 (0.8;3.6)  
Yes 5 1.8 (1.0;8.0)  4 1.5 (1.0;9.6)  3 7.2 (0.4;NA)  
Seven to eight cells (h) 
No 10 0.8 (0.4;1.4)  10 0.8 (0.5;2.2)  12 0.7 (0.5;1.1)  
Yes 4 1.7 (0.5;4.3)  4 0.6 (0.3;4.9)  2 2.4 (1.9;NA)  
Eight to nine cells (h) 
No 3 1.6 (0.5;NA)  1 0.5 (0.5;0.5)  3 1.6 (0.5;NA)  
Yes 0 NA (NA;NA)  2 2.5 (1.6;NA)  0 NA (NA;NA)  
IQR, interquartile range (Q1; Q3); NA, not applicable; PNd, pronuclear disappearance. 
Kinetic parameters medians were calculated according to if high fragmentation, multinucleation, or vacuoles were existent or absent (Yes/No). Fragmentation was considered high when equal or 
higher than 25%. a,b, c P<0.05 (Mann-Whitney U-test). 
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We did not observe any statistically significant differences between the kinetic 
parameters of embryos with or without vacuoles (Table 9). This could be due to 
the lower number of embryos that were detected with vacuoles in this study. 
Nevertheless, some parameters did exhibit a trend toward difference between 
groups, such as the time between two and three cells or the time between four 
and five cells, being the first one longer in embryos without vacuoles, and the 
second one shorter in embryos without vacuoles.  
Finally, we should highlight that the number of embryos decreased gradually 
with development as we were taking out some of them for analysis, and this 
affected the statistical power for the analysis of later kinetic parameters 
4.5.2 Morphology versus irregular divisions  
As an important event in the kinetic behavior of the human embryo, we also 
analyzed the existence of irregular divisions in relation to some morphological 
parameters (Table 10). In the correlation study with the fragmentation degree, 
35.4% of the embryos with regular divisions and 25.0% of the embryos with 
irregular divisions showed a high percentage of fragmentation, without 
statistical differences between groups. Nevertheless, 40.0% of the embryos 
with irregular divisions had multinucleation at some stage; this value was 
statistically significant compared with the percentage in embryos with regular 
divisions (8.3%; P<0.05, Fisher’s exact test). This correlation between irregular 
divisions and multinucleation supports the previous results in section 5.1, in 
which we observed that multinucleated embryos showed significant differences 
in the duration of most of the morphokinetic parameters versus those embryos 
without multinucleation (Table 9). This finding would support again the 
importance of analyzing kinetics in embryos with regular and irregular division 
separately. Finally, we did not observe any statistically significant correlation 
between the existence of vacuoles and irregular divisions and, as we mentioned 
before, this could be due to the low sample size in this group (n = 10). 
  
RESULTS AND DISCUSSION 
 97 
 Table 10 | Contingency table to analyze the relationship between division type and 
morphological events. 
 
 
 
 
Total 
 
Fragmentation  Multinucleation 
 
Vacuoles  
Low High No Yes No Yes  
 
Embryos with 
regular 
divisions (%) 
48 
(100) 
 
31  
(64.6) 
17 
(35.4) 
 
44a 
(91.7) 
4b 
(8.3) 
 
42 
(87.5) 
6 
(12.5) 
 
 
Embryos with 
irregular 
divisions (%) 
20 
(100) 
 
15  
(75.0) 
5 
(25.0) 
 
12a 
(60.0) 
8b 
(40.0) 
 
6 
(80.0) 
4 
(20.0) 
 
 
High fragmentation was considered when ≥25%. Pearson Chi-square test was performed in the fragmentation 
comparison, and Fisher’s exact test was performed to determine differences in multinucleation and vacuoles 
comparison since in both there was one cell with less than 5 cases.
 a,b P<0.05 (Fisher’s exact test). 
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4.6 Correlation between morphology and aneuploidy 
We determined if there was a correlation between the presence of aneuploidy 
and the incidence of cellular fragmentation on the basis of previous 
observations up to the four-cell stage (Chavez et al., 2012), in which DNA 
fragments were observed by 4',6-diamino-2-fenilindol (DAPI) staining in 
fragments from embryos at cleavage stage. We examined whether there was an 
association between aneuploidy and fragmentation degree considering embryos 
with low (<25%) versus high (≥25%) fragmentation. While 46.3% of the embryos 
with low fragmentation were aneuploid (19/41), the incidence of aneuploidy in 
highly fragmented embryos was 62.5% (10/16). Although we observed a general 
association trend between higher fragmentation degree and aneuploidy 
incidence, this was not statistically significant.  
We aimed to find the relationship between aneuploidy and multinucleation at 
any stage of the embryo development, as previous work has been contradictory 
about this correlation (Hardarson et al., 2001; Ambroggio et al., 2011; Balakier 
et al., 2016). In the embryos that did not show multinucleation, 42.6% were 
aneuploid (20/47); in embryos with multinucleation the percentage of 
aneuploid embryos was 90% (9/10). This difference is statistically significant 
(P<0.05, Fisher´s exact test), supporting previous studies (Ambroggio et al., 
2011). Surprisingly, one embryo showing multinucleation in one of the 
blastomeres at the two-cell stage was euploid. We did not find any differences 
in the number of chromosomes affected between multinucleated and not 
multinucleated embryos, which supports previous reports (Balakier et al., 
2016). 
Finally, we also assessed a possible correlation between the existence of 
vacuoles and aneuploidy, since vacuoles could affect spindle dynamics. No 
statistically significant differences were found between embryos with vacuoles 
versus those without, regarding aneuploidy or the number of chromosomes 
affected in case of aneuploidy. This supports a previous study that showed no 
spindle displacement in oocytes and embryos with big vacuoles (Wallbutton and 
Kasraie, 2010). 
RESULTS AND DISCUSSION 
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4.7 Correlation between morphology and gene expression  
Changes in gene expression can be correlated with changes in the morphology 
of the embryos. To study this, we analyzed the expression of all genes in the 
different morphological groups for the most frequent parameters: 
fragmentation, multinucleation and vacuole existence. To avoid bias during 
analysis due to expression differences in embryos collected at different 
developmental times, we used a discrete time variable. To ensure an adequate 
number of embryos in each group for drawing relevant conclusions, two 
different groups were created using a cutoff of 30 h after PNd, with both 
groups having the same time range: from 0 to 30 h after PNd and from 30 to 60 
h after PNd. 
4.7.1 Gene expression in fragmented embryos 
As we had information about fragmentation degree from all embryos with gene 
expression data, the sample size for the analysis was 78 embryos, with 119 
analyzed blastomeres in total. We differentiated two degrees of fragmentation: 
low when fragmentation was below 25%, and high if fragmentation was 25% or 
higher. We used Babelomics to compare gene expression levels between the 
groups and estimate the false discovery rate. In the embryos collected before 
30 h after PNd (n = 65), none of the 86 analyzed genes showed statistically 
significant differences between low-fragmented and high-fragmented embryos. 
Nevertheless, we found significant expression differences in embryos that were 
collected after 30 h post PNd. First, we compared the average collection time 
between groups. In total, 29 out 86 genes were differentially expressed 
between embryos with low and high fragmentation (P<0.05, limma test; Figure 
29a). The two most differentially downregulated genes in high-fragmented 
embryos after 30 h post PNd were GADD45A and ZSCAN4 (Figure 29b) GADD45A 
is related to DNA damage arrest, the low mRNA levels in high fragmented 
embryos could be related to the origin of fragmentation. Our hypothesis is that 
embryos with low GADD45A levels would not arrest even if they have some 
damage and would create fragments in those chaotic divisions. ZSCAN4 is 
telomere maintenance gene, and its low expression in high fragmentation could 
be related to the high proportion of aneuploid embryos in the high-fragmented 
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group. This finding would be in concordance with previous studies showing low 
telomere length in embryos with high fragmentation at day 3 of development 
(Keefe et al., 2005). In contrast, the two most upregulated genes in embryos 
with high fragmentation were FASLG and YBX2 (Figure 29c). FASLG is a death 
receptor, which would correlate fragmentation with apoptosis processes, and 
YBX2 is a maternal gene that has been showed to protect the maternal mRNA 
from degradation in mouse embryos (Yu et al., 2003). More interestingly, it has 
been reported that arrested embryos have lower expression of YBX2 mRNA 
(Wong et al., 2010), thus its high expression in the high-fragmented embryos of 
our study would be in concordance with the low levels of GADD45A transcripts, 
and would highlight once again fragmentation as an alternative to cell cycle 
arrest. 
In addition, we detected that all blastomeres from the embryo 6B1 had an 
expression profile more similar to those embryos with low fragmentation (Figure 
29a). We observed that the exact percentage of fragmentation was 25%, which 
is the threshold value to define the fragmentation groups. 
There was only one other embryo with 25% fragmentation, 3B1, but in this case 
its expression profile was similar to embryos in the high fragmentation group. It 
is important to note that the evaluation of fragmentation degree could be 
difficult in some cases, as the fragments are distributed in the whole embryo 
and, although we use the multiplane capture to increase the accuracy of the 
measure, some small error margin is expected. For the same reason, for future 
studies we propose to compare extreme degrees of fragmentation, such as <10% 
versus >40%, that, due to the small sample size, we were not able to perform. 
RESULTS AND DISCUSSION 
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Figure 29 | Differential gene expression between low- and high-fragmented embryos. 
Heatmap of genes showing significant differential expression (P<0.05, limma test, n = 29) 
in low- and high-fragmented embryos collected after 30 h post PNd (a). Each column 
represents a single blastomere. Blue colored squares show low expression, red color 
represents high levels of gene expression, and white squares indicate moderate 
expression (log2). Box plots from the top downregulated (b) and upregulated genes (c) in 
embryos with high fragmentation (≥25%) compared with low fragmentation (<25%) after 
30 h following PNd. A plot represents gene expression values between quartile 1 and 3, 
the black line inside the box is the median value, and the black circles are outliers. 
Relative expression was obtained by dividing by the median expression value in embryos 
with low fragmentation. 
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4.7.2 Gene expression in multinucleated embryos 
Another morphological parameter that we studied and correlated with gene 
expression was multinucleation. We collected gene expression data 
corresponding to 65 blastomeres from embryos retrieved during the first 30 
hours after PNd and 54 blastomeres from embryos retrieved later. The 
differential analysis showed no differences in any of the timing groups between 
multinucleated and non-multinucleated embryos for the studied genes. It 
remains unknown if this result was produced for the low number of 
multinucleated embryos in our sample group, as there was a total of 12 
embryos, 6 collected during the first time range and 6 embryos during the 
second one. 
 
4.7.3 Gene expression in vacuolated embryos 
According to vacuole formation, none of the 86 selected genes was previously 
correlated with this morphology feature. Nevertheless, taking advantage of the 
deepness of our study, we wanted to include this correlation study to see if 
embryos with vacuoles were expressing some genes differentially. For the group 
of embryos collected between the PNd and the next 30 hours, we found 4 
differentially expressed genes between those blastomeres that had vacuoles (n 
= 6; P<0.05, limma test) compared with those that did not (n = 59, P<0.05, 
limma test; Figure 30a). Two genes, YY1 and Cofilin 1 (CFL1), were the most 
upregulated in embryos with vacuoles in comparison to embryos without (Figure 
30b), whereas AURKA and POU Class 5 Homeobox 1 (POU5F1) were the two 
most downregulated (Figure 30c). 
In the embryos that were collected after the first 30 h post PNd we found just 
one differentially expressed gene, RB transcriptional corepressor 1 (RB1), that 
was downregulated in those blastomeres from embryos with vacuoles (n = 12) 
compared with embryos without vacuoles (n = 42; P<0.05, limma test; Figure 
31a). 
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Figure 30 | Differential gene expression between embryos with and without vacuoles 
during the first 30 h after pronuclear disappearance. 
Heatmap of genes showing significant differential expression (n = 4; P<0.05, limma test) 
in embryos without vacuoles and with vacuoles collected during the first 30 h after PNd 
(a). Each column represents a single blastomere. Blue colored squares show low 
expression, red color represents high levels of gene expression, and white squares 
indicate moderate expression (log2). Box plots from the upregulated (b) and 
downregulated (c) genes in embryos with vacuoles collected during the first 30 h of 
development after PNd. A plot represents gene expression values between quartile 1 and 
3, the black line inside the box is the median value, and the black circles are outliers. 
Relative expression was obtained by dividing by the median expression value in embryos 
without vacuoles. 
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We noted that all nine embryos with vacuoles were from the same woman, with 
only one more embryo from the same woman not containing vacuoles (6D2). 
This embryo was collected after the first 30 hours post PNd and showed low RB1 
expression (Figure 31b), similar to those embryos with vacuoles collected at 
similar time, pointing to a new dimension of individual expression differences. 
This is in accordance with a previously published case report that support that 
the vacuole existence is a patient-dependent feature with a probable genetic 
cause (Wallbutton and Kasraie, 2010).  
 
 
 
Figure 31 | Differential gene expression between embryos with and without vacuoles 
during the 30 h and 60 h after pronuclear disappearance. 
Heatmap of genes showing significant differential expression (n = 1; P<0.05, limma test) 
in embryos without vacuoles and with vacuoles collected between 30 h and 60 h post PNd 
(a). Each column represents a single blastomere. Blue colored squares show low 
expression, red color represents high levels of gene expression, and white squares 
indicate moderate expression (log2). Box plot from differential RB1 expression between 
embryos with vacuoles and without (b). A plot represents gene expression values between 
quartile 1 and 3, the black line inside the box is the median value, and the black circles 
are outliers. Relative expression was obtained by dividing by the median expression value 
in embryos without vacuoles. 
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4.8 Correlation between kinetics and aneuploidy 
4.8.1 Kinetic parameters versus aneuploidy 
We next evaluated the developmental kinetics of euploid versus aneuploid 
embryos to determine which parameter(s) may be correlated with the presence 
of aneuploidy. We found that two parameters were statistically significant 
between aneuploid and euploid embryos (Table 11). Since embryos were taken 
out for analysis at different developmental times, it is important to note that 
the sample size gradually decreased as development proceeded, making the 
analysis of statistically significant differences for later parameters difficult. 
The most significant parameter was the time between the PNd and the start of 
the first cytokinesis (P=0.025, Mann-Whitney U-test), which was longer in 
aneuploid embryos compared with euploid embryos. This finding suggests that 
chromosome missegregation may have occurred to influence the length of this 
first mitotic cycle and that further consideration should be given to the 
competency of the sperm used for fertilization since several mitotic spindle 
components for the first cell division are paternally inherited in human embryos 
(Sathananthan et al., 1991; Palermo et al., 1994). In addition, although this 
parameter has been recently found predictive of which embryos will reach the 
blastocyst stage (Desai et al., 2014), no study to our knowledge has defined this 
parameter for assessing chromosomal status in embryos. Just one recent 
publication studied a similar parameter, the time between PNd and the two-
cell stage, between euploid and aneuploid embryos (Patel et al., 2016). Their 
results did not show statistically significant differences between groups, 
although it is important to note that their parameter, unlike ours, includes the 
duration of the first cytokinesis, and that could be masking the results. We 
suspect that the time between PNd and the start of the first cytokinesis will be 
particularly useful as it may potentially help in the selection against 
chromosomal abnormalities of gametic origin, whether maternal or paternal; is 
independent of the irregular divisions, as they will not affect its duration; and 
can be measured in non-ICSI and vitrified zygotes, in contrast to other 
parameters that require the exact time of fertilization as a reference point. 
  
 
Table 11 | Kinetic parameters in euploid versus aneuploid embryos. 
  
 
All embryos 
 
Regular divisions  Irregular divisions 
  
 
N Median IQR  N Median IQR  N Median IQR 
PNd to first 
cytokinesis (h) 
Euploid  22 2.4a (2.1;2.9)  18 2.3c (2.1;2.9)  4 2.9 (0.9;3.1) 
Aneuploid  26 2.8a (2.5;3.3)  14 2.8c (2.5;3.3)  12 2.9 (2.5;7.9) 
First cytokinesis 
(min) 
Euploid  22 15.0 (13.8;26.3)  18 15.0 (10.0;21.3)  4 25.0 (16.3;60.0) 
Aneuploid  26 20.0 (13.8;31.3)  14 20.0 (10.0;31.3)  12 22.5 (15.0;37.5) 
Two to three cells 
(h) 
Euploid  14 11.3 (1.4;12.2)  10 11.7 (11.1;12.6)  4 1.3 (0.5;4.3) 
Aneuploid  23 11.4 (0.8;12.6)  11 12.5 (11.8;12.9)  12 0.8 (0.1;2.4) 
Three to four cells 
(h) 
Euploid  12 0.8b (0.2;1.3)  10 0.8 (0.4;1.3)  2 5.4 (0.1;NA) 
Aneuploid  20 2.4b (0.9;8.4)  11 1.7 (0.8;2.7)  9 4.4 (1.6;12.3) 
Four to five cells 
(h) 
Euploid  5 5.3 (1;13.8)  4 8.8 (2.9;14.6)  1 0 (0;11.2) 
Aneuploid  25 9.9 (0.8;12.3)  6 12.8 (11.7;15.7)  9 2.7 (0.3;9) 
Five to six cells 
(h) 
Euploid  5 7.2 (1.4;9.3)  4 4.9 (0.7;7.4)  1 11.2 (11.2;4.3) 
Aneuploid  12 1.6 (0.4;3.8)  6 1.6 (0.5;2.7)  6 1.6 (0.3;13.8) 
Six to seven cells 
(h) 
Euploid  4 1 (0.6;3.5)  3 0.8 (0.5;NA)  1 4.3 (4.3;0.8) 
Aneuploid  12 2 (1;8.5)  6 1.5 (0.5;3.9)  6 5.1 (1.2;13.2) 
Seven to eight cells 
(h) 
Euploid  4 0.8 (0.6;1.1)  3 0.8 (0.5;NA)  1 0.8 (0.8;0.5) 
Aneuploid  10 0.7 (0.4;3.4)  6 1.5 (0.4;3.4)  4 0.6 (0.3;4.9) 
Eight to nine cells 
(h) 
Euploid  1 0.5 (0.5;0.5)  0 NA (NA;NA)  1 0.5 (0.5;NA) 
Aneuploid  2 2.5 (1.6;NA)  0 NA (NA;NA)  2 2.5 (1.6;NA) 
IQR, interquartile range (Q1;Q3); NA, not applicable; PNd, pronuclear disappearance. 
Kinetic parameters were first calculated for every euploid and aneuploid embryo (‘All embryos’). In addition, they were classified according to the type of divisions (‘Regular divisions’ and 
‘Irregular divisions’), since one irregular division may alter all subsequent kinetic parameters, which are calculated base on the cell stage of the embryo. a,b,c P<0.05 (Mann-Whitney U-test). 
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As Table 11 demonstrates, the time between the three- and four-cell stages was 
also statistically different between aneuploid and euploid embryos (P=0.048, 
Mann-Whitney U-test), and approximately three times longer in aneuploid 
embryos. We thus used both significant parameters, PNd to first cytokinesis and 
time between the three- and four-cell stages, to visually differentiate euploid 
from aneuploid embryos (Figure 32).  
 
 
Figure 32 | Distribution of embryos according to the most differential kinetic 
parameters for aneuploidy. 
Euploid embryos (blue) are clustered in the lower left corner, compared with aneuploid 
embryos (orange), which are scattered over the chart. A zoom window has been to better 
detect possible overlapping between ploidy groups. 
 
Whereas it was clear that euploid embryos had shorter values of these two 
parameters, we could still observe some overlapping or outliers that did not 
allow the complete differentiation of euploid embryos (Figure 32). For this 
reason, although we consider that kinetic parameters can help to increase the 
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probability of selecting a euploid embryo, they should not be used as a 
replacement for genetic screening in the clinical routine since they have a low 
predictive value for ploidy (60-70%) (Chavez et al., 2012; Campbell et al., 
2013; Basile et al., 2014). Also, it is important to consider that embryo kinetic 
behaviors can be affected by several factors, such as different clinical settings, 
different time-lapse instruments or interpatient variability (Kaser and 
Racowsky, 2014; Kramer et al., 2014). In any case, even if kinetics should not 
be applied for aneuploidy prediction in a clinical program, we should take them 
into consideration, as a complementary test to predict blastocyst formation and 
implantation (Wong et al., 2010; Meseguer et al., 2011). 
 
4.8.2 Irregular divisions versus aneuploidy 
We observed that the number of embryos with irregular divisions in the 
aneuploid group was considerably higher (12/26) when compared with the 
euploid group (4/22), although not statistically significant. To determine 
whether there were differences in the aneuploidy frequency owing to this 
phenomenon, we analyzed the developmental kinetics of regular versus 
irregular embryo divisions separately (Table 11), since irregular divisions 
directly influence the parameter timing.  
When we separated the embryos solely on the basis of regular and irregular 
divisions, we did not detect a significant difference in the timing from three- to 
four-cell stages between ploidy groups to confirm that the previous detected 
difference was due to the division type (regular/irregular), instead of the 
ploidy status. Nevertheless, we still detected statistically significant 
differences in the time between PNd and the start of the first cytokinesis 
between ploidy groups in embryos with regular divisions (P = 0.049, Mann-
Whitney U-test), but not in embryos with irregular divisions. Thus, we would 
like to emphasize once again the importance of analyzing embryos with 
irregular division separately. Otherwise, significant differences between the 
study groups may be masked by this phenomenon since they have very different 
kinetic patterns creating very scattered data, or vice versa, that the finding 
differences originate from the type of division, instead of the study variable, as 
has occurred in our data with ploidy. 
RESULTS AND DISCUSSION 
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Surprisingly, 4 out of 20 embryos that underwent irregular divisions were 
euploid. Three of these embryos were analyzed immediately after the first 
mitosis—the irregular one—and only one blastomere from each embryo was 
analyzed using aCGH. The fourth embryo also exhibited an abnormal first 
division, but was removed for analysis at the nine-cell stage and the three 
blastomeres examined using aCGH were euploid male. No multinucleation was 
detected in any of the four embryos and, notably, three of the four embryos 
were from the same couple, indicating an individual dimension of embryo 
development. 
It is not new that euploid embryos can also have irregular divisions (Campbell 
et al., 2013), although it still remains unclear if these type of divisions work as 
a correction mechanism in polyploid embryos resulting in euploid embryos, or if 
they result in mosaic embryos with a mix of cells that are euploid and 
aneuploid, or both. 
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4.9 Correlation between kinetics and gene expression  
As we have kinetic information for all of the embryos analyzed we aimed to 
look for some trends in gene expression related with altered kinetic patterns. 
To avoid bias during analysis due to expression differences in embryos collected 
at different developmental times, we created two groups using a cutoff of 30 
hours. 
4.9.1 Kinetic parameters versus gene expression 
To study the effect of kinetics on gene expression, we first determined the 
median value of each parameter to create two comparison groups: embryos 
with a parameter shorter than the median and embryos with the parameter 
longer. In the analysis, we only included parameters with data for a minimum 
of ten embryos, to assure the sample size to detect statistical significant 
differences. For those embryos analyzed before 30 h post PNd, we found 
differences in gene expression for one kinetic parameter, the time between the 
PNd and the first cytokinesis (P<0.05, limma test; Table 12).  
  
RESULTS AND DISCUSSION 
 111 
Table 12 | Statistically differentially expressed genes between embryos with 
different kinetics. 
 
 N Median 
N under 
median 
N above 
median 
Differential 
genes 
Before 
30 h 
post 
PNd 
PNd to 1st cytokinesis (h) 48 2.38 25 23 5 
First cytokinesis (min) 49 15.0 26 23 0 
Two to three cells (h) 31 10.83 15 16 0 
Three to four cells (h) 23 0.92 12 11 0 
After  
30 h 
post 
PNd 
PNd to 1st cytokinesis (h) 49 2.75 27 22 13 
First cytokinesis (min) 51 0.42 25 26 0 
Two to three cells (h) 50 10.75 25 25 0 
Three to four cells (h) 50 2.42 27 23 0 
Four to five cells (h) 46 11.29 23 23 6 
Five to six cells (h) 43 2.25 22 21 0 
Six to seven cells (h) 43 1.25 23 20 0 
Seven to eight cells (h) 40 0.83 23 17 0 
PNd, pronuclear disappearance. 
Number of statistical differential genes (P<0.05, limma test) between embryos with shorter and longer kinetics 
parameters during the first 30 h and the time after 30 h post PNd. 
 
Five genes were differentially expressed (P<0.05, limma test) between the 
embryos with this parameter shorter than the median (2.38h) and embryos with 
a longer parameter. Three of the differential genes—OOEP, cryptochrome 
circadian clock 1 (CRY1) and RB1—were highly expressed in the embryos with 
shorter time between PNd and the start of the first cytokinesis, whereas two 
genes –FASLG and diaphanous related formin 1 (DIAPH1)- were highly expressed 
in embryos with longer time between PNd and the start of the first cytokinesis 
(Figure 33). 
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Figure 33 | Differential expression for embryos with shorter versus longer time 
between the PNd and first cytokinesis during the first 30 h post PNd. 
(a) Statistically significant gene expression differences between embryos with the shorter 
time between PNd and the start of the first cytokinesis and embryos with the longer time 
(n = 5; P<0.05, limma test). Each column represents a single blastomere. Blue colored 
squares show low expression, red color represents high levels of gene expression, and 
white squares indicate moderate expression (log2). Box plots from the top downregulated 
(b) and upregulated genes (c) during the first 30 h post PNd in embryos with a time 
between the PNd and 1st cytokinesis longer than the median (2.38 h) compared with 
embryos with a time between the PNd and the 1st cytokinesis shorter. A plot represents 
gene expression values between quartile 1 and 3, the black line inside the box is the 
median value, and the black circles are outliers. Relative expression was obtained by 
dividing the data between the median value from embryos with the shorter parameter 
(<2.38 h). 
RESULTS AND DISCUSSION 
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For the embryos analyzed between 30 and 60 h post PNd, there were two 
kinetic parameters that affected the transcriptomic profile: the time between 
the PNd and the start of the first cytokinesis, as in the previous group, and the 
time between the four- and the five-cell stages (Table 12). For the time 
between the PNd and the start of the first cytokinesis, a total of 13 genes were 
expressed differentially between the 27 embryos with the parameter shorter 
than the median (2.75h) and the 22 embryos with this parameter longer 
(P<0.05, limma test; Table 12). The genes that were highly expressed in the 
embryos with a parameter shorter were mutS homolog 6 (MSH6), mutS homolog 
2 (MSH2), MCL1, CFL1, and YY1; the genes period circadian clock 1 (PER1), RB1, 
nucleophosmin/nucleoplasmin 2 (NPM2), DEAD-box helicase 4 (DDX4), regulator 
of chromosome condensation 2 (RCC2), mutS homolog 3 (MSH3), DNA damage 
recognition and repair factor (XPA), and FASLG, showed a lower expression in 
these embryos (Figure 34).  
Note that FASLG and RB1 were differentially expressed also in embryos during 
the first 30 h after PNd for the same parameter, the time between PNd and the 
start of the first cytokinesis. More importantly, FASLG showed lower levels of 
expression in all embryos with a shorter time of the parameter, independent of 
the time of collection. It is known that FASLG is an apoptosis receptor that had 
been related to cell fragmentation at the two- and four-cell stages (Kawamura 
et al., 2001), which indicates that a shorter time between the PNd and the first 
cytokinesis may be related with better embryo development. This is also in 
concordance with our previous results (see sections 1.1, 5.1 and 7.1), where 
FASLG levels were upregulated in high-fragmented embryos and, at the same 
time, this group of embryos showed longer time between PNd and the first 
cytokinesis, as the first division is when most of the fragmentation takes place.  
Finally, the differential genes found in embryos with shorter versus longer time 
between the four- and the five-cell stages were discarded as we found 
statistically significant differences in the average collection time of the 
samples of each group that could bias the findings (average collection time of 
embryos with short time between four- and five-cell stages: 42.6±6.7 h and 
average collection time of embryos with long time between four- and five-cell 
stages: 38.1±4.5 h; P<0.05, t-test). 
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Figure 34 | Differential expression for embryos with shorter versus longer time 
between the pronuclear disappearance and first cytokinesis between 30 h and 60 h 
post PNd. 
Statistically differentially expressed genes between embryos with shorter time between 
PNd and the start of the first cytokinesis and embryos with longer time (n = 13; P<0.05, 
limma test). Each column represents a single blastomere. Blue colored squares show low 
expression, red color represents high levels of gene expression, and white squares 
indicate moderate expression (log2). Box plots from the top downregulated (b) and 
upregulated genes (c) between the 30 h and 60 h post PNd in embryos with a time 
between the PNd and 1st cytokinesis longer than the median (2.75 h) compared with 
embryos with a shorter time between the PNd and the 1st cytokinesis. A plot represents 
gene expression values between quartile 1 and 3, the black line inside the box is the 
median value, and the black circles are outliers. Relative expression was obtained by 
dividing between the median expression value in embryos with short parameter (<2.75 h). 
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4.9.2 Irregular divisions versus gene expression 
We analyzed the expression of all genes in embryos with regular divisions versus 
irregular divisions. For the group of embryos analyzed between the PNd time 
and the next 30 h we found one significantly differentially expressed gene, 
GADD45A (P<0.05, limma test; Figure 35) between embryos with at least one 
irregular division (n =15) and embryos with all regular divisions (n = 34). 
Whereas for the group from 30 h to 60 h post PNd, we did not find any 
differentially expressed genes between the embryos with irregular divisions (n = 
17) and embryos with regular divisions (n = 37).  
Since there is a strong link between the irregular divisions and aneuploidies, it 
remains unknown if GADD45A expression difference in the first time range 
group is due to the high proportion of aneuploid embryos in the group of 
irregular divisions (72.7%) compared with the group with embryos with regular 
divisions, in which the percentage of aneuploid embryos was as low as 22.7%. 
 
 
Figure 35 | GADD45A expression between embryos with regular or irregular divisions 
during the first 30 h post PNd. 
GADD45A was the only gene differentially expressed between embryos that showed one 
irregular division during the first 30 h after PNd (n = 15) and embryos with all regular 
divisions during the same time (n = 34; P<0.05, limma test). Relative expression was 
obtained by dividing between the median expression value in embryos with regular 
divisions. 
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4.10 Correlation between aneuploidy and gene expression 
Via a combination of single-cell gene expression and whole chromosomal data 
analysis within a single embryo, we also uncovered gene expression patterns 
indicative of ploidy status. Ploidy and gene expression information was 
obtained from a total of 53 embryos with 92 cells analyzed using RT-qPCR and 
76 cells assessed via aCGH. To compare the expression profiles between ploidy 
groups without introducing bias due to differences in developmental time, two 
different groups were created using a cutoff of 30 h post PNd. For the first 
group, we obtained 41 expression profiles from 33 embryos with an incidence of 
aneuploidy of 39.4%; in the second group, we collected 52 gene expression 
profiles from 20 embryos with a 75.0% aneuploidy incidence. We determined 
that the incidence of aneuploidy was higher in the second group because of the 
increased frequency of mitotic errors identified by aneuploid blastomere 
mosaicism compared with the first group. We then used Babelomics (Medina et 
al., 2010) to compare gene expression levels between the two. In the embryos 
collected before 30 h, 20 of 86 analyzed genes showed statistically significant 
differences between euploid versus aneuploid embryos (P<0.05, limma test; 
Figure 36a).  
More specifically, we identified a set of genes highly expressed in aneuploid 
embryos and almost undetectable in euploid embryos, such as caspase 2 
(CASP2), cyclin D1 (CCND1), CCNA1, DEAD-box helicase 20 (DDX20) and 
GADD45A, that further increases in expression as development proceeds (Figure 
36b). This distinct pattern of expression may be explained by the propagation 
of chromosomal errors that occurred early in preimplantation development 
with each subsequent mitotic division. 
In contrast, the expression of the catenin beta 1 (CTNNB1), YBX2 and tuberous 
sclerosis 2 (TSC2) were tremendously downregulated in aneuploid embryos 
compared with euploid embryos (P=0.01, limma test; Figure 36c). We 
determined that most of the transcripts with decreased expression in aneuploid 
embryos belonged to Cluster 1, which contains genes expressed at high levels in 
the zygote before embryonic activation and thus, likely of gametic origin. 
RESULTS AND DISCUSSION 
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An analysis of gene expression 30 h after PNd, however, did not show 
statistically significant differences between aneuploid and euploid embryos. 
This was possibly due to an increase in the transcriptomic variability between 
embryos from the same stage in late development. Recently, it has been shown 
that four-cell stage embryos show the highest variability compared to oocytes 
and blastocysts (Shaw et al., 2013). The main reason for this phenomenon is 
that during this stage, as at the eight-cell stage, there is a gradual degradation 
of maternal transcripts overlapping with the new synthesis by the embryonic 
genome. This highly dynamic process could take place with different rhythms 
between embryos from the same developmental stage, and even in cells from 
the same embryo, as it has been shown for individual blastomeres from eight-
cell embryos (Yan et al., 2013). Another reason for the non-detected 
differences between ploidy groups at later stages could be a hypothetical 
asymmetric distribution of the transcripts throughout development caused by 
irregular divisions. Uneven blastomere size is correlated with a high aneuploidy 
incidence (Magli et al., 2001; Hardarson et al., 2001) and, at the same time, 
uneven blastomere size has been hypothesized to be related to an irregular 
transcript distribution (Hardarson et al., 2001; Prados et al., 2012). 
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Figure 36 | Differential gene expression in euploid versus euploid embryos. 
(a) Heatmap of genes showing significant differential expression (P<0.05, limma test) in 
euploid versus aneuploid embryos during the first 30 h post PNd. Each column represents 
a single blastomere. Blue colored squares show low expression, red color represents high 
levels of gene expression, and white squares indicate moderate expression (log2). (b) Box 
plots from the most upregulated in aneuploid embryos before 30 h post PNd. (c) Box plots 
from the most downregulated genes in aneuploid embryos before 30 h post PNd. A plot 
represents gene expression values between quartile 1 and 3, the black line inside the box 
is the median value, and the black circles are outliers. Relative expression was obtained 
by dividing between the median expression value in euploid embryos. 
RESULTS AND DISCUSSION 
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We also evaluated the significant GO terms in these 20 genes, to determine 
which molecular pathways were influenced by aneuploid generation (Table 13). 
We observed that the most significant GO terms (n = 16; P<0.001, Fisher´s 
exact test) were related to cell cycle (7/16) or DNA damage (5/16).  
 
Table 13 | Significant gene ontology terms for genes differentially expressed 
between aneuploid and euploid embryos. 
GO:Term Term name C G 
Adjusted 
P value 
GO:0007049 Cell cycle 11 941 1.14E-07 
GO:0022402 Cell cycle process 9 640 1.19E-06 
GO:0000278 Mitotic cell cycle 8 470 1.98E-06 
GO:0051726 Regulation of cell cycle 7 314 2.94E-06 
GO:0051301 Cell division 6 281 4.51E-05 
GO:0051716 Cellular response to stimulus 8 865 1.05E-04 
GO:0006259 DNA metabolic process 7 640 1.56E-04 
GO:0033554 Cellular response to stress 7 623 1.56E-04 
GO:0034984 Cellular response to DNA damage 
stimulus 
6 383 1.56E-04 
GO:0006974 Response to DNA damage stimulus 6 423 2.38E-04 
GO:0051329 Interphase of mitotic cell cycle 4 109 4.29E-04 
GO:0019953 Sexual reproduction 6 484 4.29E-04 
GO:0051325 Interphase 4 115 4.52E-04 
GO:0051246 Regulation of protein metabolic process 6 508 4.52E-04 
GO:0048609 Reproductive process in a multicellular 
organism 
6 506 4.52E-04 
GO:0006281 DNA repair 5 330 9.96E-04 
GO, gene ontology; C, number of genes annotated by the given term in the test set; G, number of genes annotated 
by the given term in the reference set. 
Only GO terms with P≤0.001 (Two-tailed Fisher´s exact test) are shown.  
 
What is the possible significance of those genes differentially expressed 
between aneuploid and euploid embryos and their possible roles in aneuploidy 
generation? Indeed, the most difficult, but also the most interesting question 
for us was what is first, the aneuploidy or the transcriptomic modification? To 
address this question, we took the 20 differentially expressed genes and 
disregarded those maternally inherited and, at the same time, activated by the 
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embryonic genome, since it was not possible to know if those changes were a 
cause or an effect of aneuploidies. Thus, we focused exclusively on 7 genes. 
Four of them—AKT1, CRY1, DNA methyltransferase 3b (DNMT3B), YBX2—were 
maternally inherited and did not show any embryonic activation during the time 
of the study; and the other 3 genes—CASP2, CCND1, GADD45A—were exclusively 
activated by the embryo genome and did not show any expression levels before 
PNd. 
Starting with the maternal genes, all four were downregulated in the aneuploid 
embryos, and we considered them useful to study the possible cause of the 
aneuploidies.  
The first maternal gene, AKT1, is an initiator gene of the G2/M transition and is 
essential for promoting the first mitosis after fertilization in mouse (Wu et al., 
2011; Baran et al., 2013). AKT1 is also the main agent responsible for mediating 
the anti-apoptotic signal in the zygote (Wu et al., 2011; Baran et al., 2013). 
Based on these findings, low AKT1 levels inherited from the oocyte could lead 
to errors during the first embryo mitosis, and/or could end in an apoptotic 
process that would avoid most of these embryos to go further in development.  
Our aneuploid embryos also had low CRY1 transcript levels. CRY1 synthetizes a 
circadian regulator protein that has been described to have a function during 
female meiosis (Amano et al., 2009). More specifically, low expression of CRY1 
seems to slows meiotic progression in mouse oocytes (Amano et al., 2009). 
From our results, we could hypothesize that this effect of CRY1 in meiosis could 
lead to the generation of meiotic aneuploidies, but even if does not, altered 
transcripts levels may have an effect in the subsequent mitotic division after 
fertilization.  
DNMT3B synthetizes a protein involved in de novo methylation during 
mammalian development and has been identified in human oocytes (Kocabas et 
al., 2006). One recent study showed that DNMT3B has lower expression in 
human embryos arrested at the one- or two-cell stages (Wong et al., 2010). We 
also found low DNMT3B levels in aneuploid embryo, suggesting that a altered 
mRNA inheritance of this gene could lead to chromosomal abnormalities during 
development.  
RESULTS AND DISCUSSION 
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Finally, we found YBX2 to be a crucial gene to study in early embryo 
development. The mouse Y-box protein (MSY2) is the YBX2 homologous gene in 
mouse and it has been shown to bind maternal transcripts to avoid degradation 
during the first stages of the embryo development (Yu et al., 2003). In 
addition, MSY2 knockout mice showed a 25% mRNA reduction in their oocytes as 
well as aberrant spindle formation (Medvedev et al., 2011). Thus, low YBX2 
expression could impede the proper maternal mRNA inheritance and the 
embryo development could be adversely affected, not only in the division 
machinery producing aneuploidies, but also in any other crucial process of early 
stages. In fact, a previous study in human embryos showed that YBX2 mRNA 
levels were significantly lower in arrested embryos (Wong et al., 2010).  
After analyzing those maternal genes that we hypothesized are involved in the 
origin of aneuploidies, we moved to the analyses of those genes that were not 
expressed in the oocyte and showed differential expression levels in the 
aneuploid embryos compared to the euploid embryos. These three genes were 
highly expressed in the aneuploid embryos, meaning that they are crucial to 
understand which are the first changes that occur inside the embryo and that 
are driven by its own genome as a response to the existence of chromosomal 
abnormalities.  
Two of these three genes, CASP2 and GADD45A, are DNA damage response 
genes that activate cell cycle arrest. This finding would be in concordance with 
previous studies showing that around 90% of the arrested embryos are 
aneuploidy (Magli et al., 2007; Qi et al., 2014). 
Finally, CCND1 was also found at high levels in the aneuploid embryos. This 
gene encodes a protein involved in the G1/S transition in the mitotic cell cycle. 
The overexpression of this gene would have an effect on cell cycle progression, 
opposite to the function of the other two activated genes, but consistent with 
the still high aneuploidy incidence found in human blastocysts, which is more 
than 50% (Fragouli and Wells, 2011). 
In summary, our findings suggest that aneuploidies in the human embryo are 
mainly the consequence of the inheritance of an abnormal pool of transcripts, 
which could cause either a meiotic error during gametogenesis or a mitotic 
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error during the first cleavages of the embryo development. In any case, the 
embryo response includes the activation of genes involved in development 
arrest and those genes that contribute to cell cycle progression. The final 
balance of transcript levels will define the destiny of the aneuploid embryo. 
4.10.1 Model to predict ploidy status in early embryos 
Taking advantage of the difference in transcript expression observed between 
euploid and aneuploid embryos during the first 30 h of development, our next 
aim was to create a prediction model for embryo ploidy on the basis of a 
specific gene expression signature (Figure 37). To accomplish this, cells from 
which both ploidy and gene expression data were obtained with a collection 
time before 30 h post PNd were selected (n = 41). Although expression values 
from all 86 genes were available, we focused on the most informative genes to 
improve the functionality of the predictor. The Mann-Whitney U-test was 
performed on the aneuploid and euploid samples to obtain 31 differentially 
expressed genes (P<0.05). Before model construction, samples were randomly 
split into a training group (n = 27) and a validation group (n = 14). Only the 
samples from the training group were used for the model design. To assess 
model accuracy, a five-fold cross-validation was performed and repeated 20 
times to estimate the misclassification rate. From this, several models were 
generated depending on the number of closest neighbors evaluated for the test 
step and the number of genes selected for the training step. To obtain the most 
reliable predictor, we applied additional restrictive parameters and only 
selected genes with a P<0.005 (Mann-Whitney U-test, n = 12). Cross-validation 
showed that the model with k = 7 was the most stringent [accuracy 85.2%, 
Matthews correlation coefficient (MCC) 0.62, root mean squared error (RMSE) 
0.31, AUC 0.92]. Once selected, the predictor model was tested using the 
validation sample group. The confirmation rate was 85.7% (12/14) with two of 
the euploid samples being misclassified as aneuploid and no aneuploid samples 
inappropriately called as euploid. Finally, we tested the prediction model in a 
different group of samples collected at the same time as the training samples, 
but for which no results from aneuploidy screening were obtained (n = 25). The 
prediction model classified 11 of the samples as aneuploid and 14 as euploid 
with an incidence of aneuploidy of 44.0%, which is similar to the observed 
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aneuploidy rate in the samples with known ploidy results at the same stage 
(39.0%). We also compared the time intervals between the PNd and the start of 
the first cytokinesis in each embryo since this was the most relevant parameter 
related to chromosome status. As expected, the median time was much longer 
in the embryos classified as aneuploid versus those predicted to be euploid 
(2.58 h versus 1.09 h). 
 
Figure 37 | Embryo aneuploidy prediction model. 
A diagram of each phase of the aneuploidy prediction model. All samples with gene 
expression data were used in this process. Samples with ploidy results were selected for 
model generation and validation. Samples without ploidy information became the 
prediction group. KNN, k-nearest neighbors; MCC, Matthews correlation coefficient; AUC, 
area under the curve; RMSE, root mean squared error. 
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The predictor model identified 12 genes as applicable for the classification of 
euploid versus aneuploid samples: BUB1 mitotic checkpoint serine/threonine 
kinase (BUB1), BUB3, CASP2, CDK7, CTNNB1, E2F transcription factor 1 (E2F1), 
GADD45A, GAPDH, pituitary tumor-transforming 1 (PTTG1), TP53, TSC2, and 
YBX2. With the exception of BUB1, CASP2, GAPDH, and GADD45A, which were 
more highly expressed in aneuploid embryos, the majority of genes were 
upregulated in euploid embryos (Figure 36a).  
The vast majority of these genes were expressed at lower levels in aneuploid 
embryos compared to euploid embryos such as BUB3, CDK7, PTTG1, TSC2, and 
YBX2, and all of them appeared to be inherited from one, or possibly both 
gametes. This supports the idea that embryos that receive an abnormal pool or 
levels of certain transcripts proceed from an aneuploid oocyte or are destined 
to be aneuploid later in development. Taken together, these data identify a 
gene subset that are differentially regulated in euploid versus aneuploid 
embryos and suggests that mathematical modeling on the basis of the 
expression of this key group of genes may provide a useful tool to largely 
predict the ploidy status of embryos (Figure 38). 
 
Figure 38 | Distribution of embryos according to the aneuploidy prediction signature. 
Principal component analysis of cells (n = 41) from embryos at early stages (before 30 h 
post PNd) on the basis of expression of the 12 genes selected in the prediction model. 
Cells from euploid embryos are shown in black (n = 25), and samples from aneuploid 
embryos are designated red (n = 16). 
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While previous time-lapse studies have provided methods for the enrichment in 
the selection of euploid embryos following early cleavage divisions or blastocyst 
formation (Chavez et al., 2012; Campbell et al., 2013; Basile et al., 2014), our 
data suggest that euploid embryos may be distinguished from aneuploid 
embryos before the first mitotic division. Due to the limited number of human 
samples available for research, this should be considered as a pilot study and 
further work would be necessary to confirm the ploidy predictor model in case 
of clinical use. Although our results can be considered robust, since they have 
been obtained from a very diverse population of embryos coming from different 
clinics, with different culture conditions and different stimulation protocols, 
they would need to be replicated in fresh embryos, as the timing intervals 
and/or the expression levels may be displaced. In addition, because of data 
protection, we did not have access to possible relevant patient information, 
such as, semen quality, or infertility status that could help to find different 
patterns in future studies. 
Although we did not consider the clinical application as the aim of our study 
since other invasive techniques, such as aCGH or NGS, are currently available 
for chromosomal analysis with a very high efficiency. We would like to highlight 
that our model was designed for the first 30 h after PNd in which embryos have 
between 1 and 4 cells and should not be biopsied at these stages for clinical 
purposes. Rather, we consider our study as a keystone in the knowledge of 
human embryo development that should contribute to the establishment of 
non-invasive diagnostic tools that could reliably predict aneuploidy generation 
at the zygote stage via detection of surrogate molecules in the embryo culture 
media. 
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4.11 Descriptive atlas of human embryo development 
To integrate all descriptive analysis of this study, morphology, kinetics, 
aneuploidy screening and gene expression data, we aimed to create a unique 
atlas of the early human embryo development (Figure 39). We focused on 
grouping embryos with similar morphokinetic patterns to better understand all 
variations of the human embryo development and their effects on the 
chromosome status. Our atlas shows the high variability underlying human 
embryo development, with 18 groups being the minimal number of patterns 
that we were able to differentiate in our sample size. Euploid embryos were 
clustered into 3 groups, whereas aneuploid embryos, including those that were 
mosaic, could be classified in 11 groups. We have to note that 16 embryos could 
not be classified in any of the previous groups because to their chromosome 
status, creating 4 additional groups, called “OVERLAPPING”, with common 
patterns for euploid and aneuploid embryos. 
It is important to understand that while human euploid embryos seem to follow 
a unique way to succeed without high variability, aneuploid embryos may 
follow different pathways, overlapping and camouflaging with euploid embryos 
in some cases. The variability in the behavior of aneuploid embryos could be 
related to different types of aneuploid embryos that can be observed, starting 
with embryos with single or multiple aneuploidies and combinations of 
monosomies and trisomies for any of the 23 pairs of chromosomes. This would 
be the reason why all the attempts to purely separate the populations based on 
visual or behavior characteristics have failed. 
In the atlas, four parameters were used for the clustering of the embryos 
according to their chromosomal status, two kinetic (PNd to 1st cytokinesis and 
PNd to three-cell stage) and two morphologic parameters (fragmentation and 
multinucleation). The time between PNd and the first cytokinesis was used in 
combination with the percentage of fragmentation. When embryos started the 
first cytokinesis in less than 2.5 h after PNd and, in addition, showed less than 
10% fragmentation, they were all euploid (n = 6), even in one case showing one 
irregular division from 1 to 3 cells. In contrast, embryos that took more than 6 
hours to divide from the PNd and, in addition, showed more than 35% 
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fragmentation, were all aneuploid (n = 7). Those embryos that did not follow 
the previous patterns were classified according to the time from PNd to the 
three-cell stage. If the time until the three-cell stage was between 13 and 14 h 
from the PNd, the embryos were euploid (n = 6); when the time was between 
14.4 and 17 h the embryos were all aneuploid (n = 10) or mosaic (n = 2). We 
then analyzed those embryos that did not follow any of the previous patterns, 
and we selected those ones showing multinucleation at any stage (n = 8). All of 
them were aneuploid or, in one case, mosaic. The leftover embryos were a mix 
of euploid (n = 11) and aneuploid embryos (n = 5) that could not be 
differentiated attending to their morphokinetic behavior. 
Although the irregular divisions were not helpful in classifying behaviors from 
euploid versus aneuploid embryos, we considered them to be included in the 
atlas since they are an uncommon phenomenon whose origin has not been yet 
well described. Interestingly, there was one euploid embryo that underwent 
one irregular division during the first mitosis from the one to the four-cell 
stage. 
Finally, a gene expression descriptive was also included to complete the human 
embryo atlas. We showed which genes were upregulated and downregulated in 
aneuploid embryos at four different stages. A high number of genes were 
differentially expressed in aneuploid embryos during the three first divisions 
studied, which would represent cleavage until the four-cell stage in embryos 
with regular divisions, whereas after the 7th division only four genes were 
differentially expressed.  
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Figure 39 | Atlas of the human embryo development. 
All analyzed embryos have been represented and grouped together according to 
morphology, kinetics and chromosome patterns. Numbers on the top of each pattern 
column represent the number of embryos that were grouped. The overlapped patterns 
represent both euploid and aneuploid embryos that were indistinguishable by 
morphokinetics. Embryos at one-cell stage were not included in the morphokinetic 
pattern classification, as they did not have any division-related information (n=8). 
Nevertheless, a same embryo could be included in two groups, in case it followed the 
criteria for both. For fold-change calculation in gene expression charts, euploid embryos 
expression levels were taken as a reference. PNd, pronuclear disappearance; cyto, 
cytokinesis; Fragm, fragmentation; ∩, logical intersection.  
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5 | Conclusions 
 
C1. Morphological parameters can display a dynamic behavior during embryo 
development. Specifically, most of the cellular fragmentation appears 
during the first mitotic division, and fragments can be reabsorbed, divided 
or fused with other fragments or blastomeres.  
C2. Kinetic parameters are sensitive to the existence of irregular divisions, 
thus they should be always calculated according to the division type to 
avoid drawing misleading conclusions. 
C3. More than half of the human embryos from IVF patients are aneuploid. 
Aneuploidy incidence is correlated with multinucleation, but not with 
fragmentation or vacuole existence. 
C4. The gene expression patterns during embryo development follow different 
patterns according to the origin: maternal, embryonic or both. In addition, 
we have observed that embryonic genome activation starts as early as at 
zygote stage. 
C5. The kinetics of aneuploid embryos are altered in comparison to the 
euploid. More specifically, the time between the pronuclear 
disappearance and the start of the first cytokinesis is longer in aneuploid 
embryos. Similarly, the time between the three- and the four-cell stage is 
longer in aneuploid embryos, although this is caused by the higher 
proportion of aneuploid embryos with irregular divisions, which alter the 
kinetic behavior. 
C6. The transcriptomics of aneuploid embryos show significant differences 
during the first 30 hours of development in comparison to euploid 
embryos. Taking this into account, the ploidy status of cleavage-stage 
embryos can be predicted by a transcriptomic signature. 
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C7. The atlas generated from the embryos analyzed in this study shows the 
high variability underlying human embryo development. While the euploid 
embryos seem to follow a uniform development without high variability 
for morphokinetics, aneuploid embryos may follow different pathways, 
overlapping with and mimicking euploid embryos in some cases, making 
them hard to differentiate. 
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Supplementary Figure 1 | Gene expression charts with quadratic regressions.  
All genes placed in alphabetic order showing expression values (28-Ct value) of single cells 
throughout the developmental time. PNd was established as zero and samples taken 
before were represented at -10 h. Quadratic regressions are with red lines.  
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7.2 Supplementary tables 
Supplementary Table 1| Primers for gene expression analysis by RT-qPCR. 
 
Target 
Gene 
Gene 
ID 
Forward primer Reverse primer 
Product 
Length 
 
AHR 196 AGCCGGTGCAGAAAACAGTA GGTCTCTATGCCGCTTGGAA 75 
AKT1 207 CCATCACACCACCTGACCAA CGAGTAGGAGAACTGGGGGA 83 
ALKBH2 121642 CTGTTTGGCAAAGCTGAGGC GGGGCCAGTTCTCTTTCATCA 127 
APC 324 GGGCTTACTAATGACCACTACA TGCAGCCTTTCATAGAGCATA 118 
ATM 472 TGCTTGCTGTTGTGGACTA ATCCAGCCAGAAAGCATCA 80 
AURKA 6790 GGTGGTCAGTACATGCTCCA GCATCCGACCTTCAATCATTTCA 90 
AURKB 9212 ATGGAGAATAGCAGTGGGACAC CAGAGGACGCCCAATCTCAA 78 
BAD 572 CTCCGGAGGATGAGTGACGA CACCAGGACTGGAAGACTCG 125 
BCL2 596 AGGGTACGATAACCGGGAGAT CATCCCACTCGTAGCCCCTC 74 
BRCA1 672 AAGACTGCTCAGGGCTATCC CCATTTCCTGCTGGAGCTTTA 96 
BRCA2 675 ATGCAGCAGACCCAGCTTA TCCTTTTGTTCAGCAGATTCCA 148 
BUB1 699 ACAAGCTTCCAGTGGAGTCA AATCCAAAGTCGCCTGGGTA 84 
BUB3 9184 CTGCATACGAGCGTTTCCAAA GGCTTGGGTCCAAATACTCAAC 86 
CASP2 835 AACTGCCCAAGCCTACAGAA TTGGTCAACCCCACGATCA 84 
CCNA1 8900 GCTCGTAGGAACAGCAGCTA CAAACTCGTCTACTTCAGGAGGATA 74 
CCND1 595 ATCTACACCGACAACTCCATCC GGTTCCACTTGAGCTTGTTCAC 79 
CCNE1 898 ATACTTGCTGCTTCGGCCTT TCAGTTTTGAGCTCCCCGTC 148 
CCT3 7203 CCCGATGTGGTCATCACTGAA CTCTGCGGATGGCTGTGATA 85 
CDH1 999 CGTCACCACAAATCCAGTGAAC TACTGCTGCTTGGCCTCAAA 78 
CDK1 983 CCTAGTACTGCAATTCGGGAAA CCTGCATAAGCACATCCTGAA 85 
CDK2 1017 TGGGCCCGGCAAGATTTTAG TGTTAGGGTCGTAGTGCAGC 91 
CDK7 1022 GGGAGCCCCAATAGAGCTTATA CTACACCATACATCCTAGCTCCA 91 
CETN2 1069 GGAGTTGGGTGAGAACCTGAC TCTTGCTCACTGACCTCTCC 90 
CFL1 1072 GCTCCAAGGACGCCATCA TCCTTGACCTCCTCGTAGCA 79 
CHEK1 1111 TGGTACAACAAACCCCTCAA CACTGGGAGACTCTGACAC 76 
CHEK2 11200 GCCCTTCAGGATGGATTTGC ACAGCTTTTGTCCCTCCCAAA 72 
CLOCK 9575 CCTGAGACAGCTGCTGACAA ACGGCCGTGTGAGATGATTT 149 
CRY1 1407 AACCAGCAGATGTGTTTCCC CCTTTCCAAAGGGCTCAGAA 87 
CTCF 10664 GCGGCTTTTGTCTGTTCTAA CTGGGCCAGCACAATTATCA 85 
DDX20 11218 ATGCATCGGATTGGGAGAGC TTTTCTTCCTCTCCCCGGCA 80 
DIAPH1 1729 TCCCTTCGTGTGTCTCTCAA TAAGGAGGCCAAGCCTTCA 75 
DNMT1 1786 GCCATTGGCTTGGAGATCA AGCAGCTTCCTCCTCCTTTA 84 
DNMT3A 1788 AGCCTCAATGTTACCCTGGAAC TACGCACACTCCAGAAAGCA 83 
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DNMT3B 1789 GTGAAGCACGAGGGGAATATCA TTCCGCCAATCACCAAGTCA 100 
DPPA3 359787 AAGACCAACAAACAAGGAGCC TCCCATCCATTAGACACGCAG 90 
E2F1 1869 AGCTCATTGCCAAGAAGTCCAA TCCTGGGTCAACCCCTCAA 94 
ECT2 1894 GCTGTGTCGACATGTAGCTAA CAAAGGATTCTGGATCAGCAGTA 80 
FASLG 356 CTTGGTAGGATTGGGCCTGG TGTGTGCATCTGGCTGGTAG 91 
GADD45A 1647 GCGACCTGCAGTTTGCAATA CTTTCGGTCTTCTGCTCTCCA 63 
INCENP 3619 AGCAGAAGGCTTGCCAAGAA ATTCAGGAGCCTCTCCAGGTAA 87 
MAD2L1 4085 AGATCACAGCTACGGTGACA TGTGGTCCCGACTCTTCC 118 
MBD4 8930 TGGAAGCTTCTCATCGCTAC GCTGAAGGATACTTCTCCAGAAAC 95 
MCL1 4170 TGGGTTTGTGGAGTTCTTCCA CTCCAGCAACACCTGCAAAA 83 
MRE11A 4361 AGCCAGAGAAGCCTCTTGTA TCTGGCTAAAGCGAAGAACAC 81 
MSH2 4436 GCCCAGGATGCCATTGTTAA TTGAGTGTCTGCATTGGTTCTAC 71 
MSH3 4437 TGCCATTGCCTATGCTACAC GGCGGATAATGGGTGACAAA 78 
MSH6 2956 CCAAGGCGAAGAACCTCAAC TTGGCCCAAACCAAATCTCC 97 
NPM2 10361 AAGAAGATGCAGCCGGTCAC GGGAGAAAGCTGCACTCCTAC 84 
OOEP 441161 GTGCCTGGCATGGTTTCAC TCTGATGCATGGGCCTTCAA 87 
PADI6 353238 GTACGCCACAGTGAAGATGACA ATCCTCGTTGGGCCCATAGTA 85 
PCNT 5116 TCTCTGGAAGGTTTCAGCCG CGCACCATCTGCAGTAAAGC 88 
PDCD5 9141 GGCCCAACAGGAAGCAAA ACTGATCCAGAACTTGGGCTA 71 
PER1 5187 TCTGCCGTATCAGAGGAGGT GGTCACATACGGGGTTAGGC 77 
PLK1 5347 GCAGCGTGCAGATCAACTTC CTCGTCGATGTAGGTCACGG 83 
POT1 25913 CGAGGTAGAAAGATGTCAACAGCTA CACATAGTGGTGTCCTCTCCAAA 77 
POU5F1 5460 GCTTGGGCTCGAGAAGGATG CATAGTCGCTGCTTGATCGC 80 
PRMT1 3276 AGTTCACACGCTGCCACAA GTCTGCTTCCAGTGCGTGTA 73 
PTTG1 9232 GCCTCAGATGATGCCTATCCA TCAGGCAGGTCAAAACTCTCA 80 
RAD51 5888 GGGAAGACCCAGATCTGTCA ATGTACATGGCCTTTCCTTCAC 86 
RAD52 5893 GGATCTTGGGACCTCCAAACTTA TCTTCATGTCCTGGCTCTTCC 85 
RB1 5925 CTCACCTCCCATGTTGCTCA GGGTGTTCGAGGTGAACCAT 73 
RCC2 55920 TGCCTGTACCAAACGTGGTT GGAGAAGACTCGCTTCTGGG 86 
RPL10L 140801 CGAGGTGCCTTTGGAAAACC TTCTGAAGCTTGGTGCGGAT 86 
RPS24 6229 CGAATCGTGGTTCTCTTTTCCTC TAGTGCGGATAGTTACGGTGTC 79 
SMARCA4 6597 TCCGTGGTGAAGGTGTCTTA AGCAAGACGTTGAACTTCCC 89 
TERF1 7013 CAGCTTGCCAGTTGAGAACG GGGCTGATTCCAAGGGTGTA 117 
TERF2 7014 CCACCGTTCTCAACCAACC AACCCCATTAGAGCTGTTCCA 80 
TERT 7015 CGCCTGAGCTGTACTTTGTCA TGATGATGCTGGCGATGACC 93 
TP53 7157 GTGTGGTGGTGCCCTATGAG CGCCCATGCAGGAACTGTTA 90 
TSC2 7249 GCTGAACATCATCGAACGGC CGTGGAACTCGTTCTGGTCA 122 
TUBG1 7283 GGCTCATGATGGCCAACC CGCTTACGCAGCTTGTCATA 79 
 162 
XPA 7507 ACATCATTCACAATGGGGTGATA ACCCCAAACTTCAAGAGACC 76 
YBX2 51087 GTCCTGGGCACTGTCAAA AAAGACATCTTCCTTGGTGTCA 81 
YY1 7528 CCAAGAACAATAGCTTGCCCTCA TGTTTTCTCATGGCCGAGTTATCC 71 
ZAR1 326340 TGTGTGGTGTGTACAGGGAAC TCCTCCACTCGGTAAGGGTT 90 
ZSCAN4 201516 CCCGGGATTACCCAGTCAA AGTCTCTTGCCTTGTGTCTCTA 91 
ACTB 60 NA NA NA 
CTNNB1 1499 NA NA NA 
DDX4 54514 NA NA NA 
GAPDH 2597 NA NA NA 
GATA4 2626 NA NA NA 
KHDC3L 154288 NA NA NA 
MLH1 4292 NA NA NA 
NLRP5 126206 NA NA NA 
RPLP0 6175 NA NA NA 
SOX2 6657 NA NA NA 
NA, DNA sequence not available. 
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Supplementary Table 2 | Aneuploidy screening results using single-cell aCGH. 
Embryo Cell type aCGH result 
1A1 Blast 46 XY 
1A3 Blast 46 XY 
1A3 PB 23 X 
1B3 Blast -1 -3 +4 -9 +10 +14 +16 +17 -18 +19 -21 -22 XY 
1B3 PB +1 +3 -4 +9 -10 -14 -16 -17 -19 +22 +X 
2A3 PB 23 X 
2B1 Blast +2 +5 +6 +7 +8 +15 +17 +19 +21 XXX 
2B3 Blast 46 XX 
2B3 Blast 46 XX 
3A1 Blast 46 X0 
3B1 Blast -1 +2 +3 -4 -5 -6 -7 +9 +11 -13 -19 +22 XY 
3B2 Blast 46 XX 
3C1 Blast 2p+ 2q- XY 
3D1 Blast -4 +5 +6 -7 +11 -12 -13 +14 -15 +16 -17 -18 +19 -20 -21 +22 XXY 
4A1 Blast +10 +12 +14 -16 +20 -22 XX 
4A2 Blast -1 +2 +3 +5 -9 -10 +11 +13 -15 -16 +17 XY 
4B1 Blast 46 XY 
4C1 Blast 46 XX 
4D3 Blast -13 XY 
5A2 Blast -1 -3 +4 +5 +6 +7 -9 +10 +11 +12 +13 -14 -15 -17 -18 -19 +20 XX 
5B2 Blast 46 XX 
5C1 PB 23 X 
5C2 Blast -2 +5 -9 +12 +18 +20 +21 +22 XX 
5C2 Blast -9 -15 XX 
5C3 Blast -7q -8 XXY 
5D1 Blast 46 XX 
5D2 Blast -2 -5 -6 +7 +10 +13 -14 +15 +16 +17 +18 +20 +21 XX 
5D3 Blast -2 -7 -16 -19 Y0 
5D3 Blast +1 +2 +7 -9q +16 +19 XXY 
6A1 Blast 46 XX 
6A2 Blast +17 XX 
6A2 Blast +17 XX 
6B1 Blast +14 XY 
6B1 Blast 46 XY 
6B2 Blast -8p -13q +16 XX 
6B3 PB 23 X 
6C1 Blast -16 XY 
6C2 Blast +18 XY 
6C2 Blast -10 -21 Y0 
6C2 Blast 46 XY 
6C2 Blast 46 XY 
6D1 Blast 46 XY 
6D2 Blast 46 XY 
6D2 Blast 46 XY 
6D2 Blast 46 XY 
7A1 PB 23 X 
7B1 Blast 46 XY 
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7B1 PB -22 X 
7B3 PB 23 X 
7C1 Blast 46 XY 
8A1 Blast 46 XY 
8A1 Blast 46 XY 
8A1 Blast 46 XY 
8A1 Blast +1 +5 -8 -9 -11 +12 +14 -15 +17 +18 -19 -20 -21 XXXYY 
8A1 PB 23 X 
8A2 Blast 46 XY 
8A2 Blast 46 XY 
8A3 Blast 46 XY 
8A3 Blast 46 XY 
8B1 Blast +13 Y0 
8B1 Blast +13 Y0 
8B1 Blast +13 Y0 
8B1 Blast +13 Y0 
8B2 Blast 46 XX 
8B2 Blast 46 XX 
8B3 Blast 46 XY 
8B3 PB 23 X 
8C2 Blast -2 -4 -5 -6 -9 -13 +16 -20 XX 
8C2 PB 23 X 
8C3 PB -3 -10 +12 -14 X 
8D2 Blast -6 XX 
8D2 PB +1 +12 +22 X 
8D3 Blast 46 XX 
8D3 Blast 46 XX 
9A1 Blast 46 XY 
9A4 PB 46 XX 
9A4 PB 23 X 
9B1 Blast +20 XX 
9B3 PB +1 +3 +4 +5 +10 +12 +13 +19 +20 X 
9B4 PB +22 X 
9C2 Blast +2 -7 -9 -10 -11 -13 -14 +16 -17 +19 -20 -22 XY 
9C2 Blast -2 -5 +9 +10 +11 +13 +15 -16 +18 +20 -21 X0 
9C3 Blast 46 XX 
9C3 Blast 46 XX 
9C3 Blast 46 XX 
9C3 Blast 46 XX 
9D1 PB 23 X 
9D3 Blast +1 +2 -3 -6 -7 -11 +15 -16 +17 -18 +19 -21 XX 
9E3 Blast 46 XX 
aCGH, array-comparative genomic hybridization; Blast, blastomere; PB, polar body. 
Individual aCGH results from all conclusive samples have been annotated. Aneuploidies are represented by the 
number of the chromosome affected preceded by a minus symbol when there is a loss (Ex. -9), and a plus symbol 
when there is a gain (Ex. +9). The result was reported as chaotic when no individual gains or losses could be 
identified. The exact endowment was written for the sex chromosomes (Ex. XXXY), reporting a zero when one of 
the two sex chromosomes was missing (Ex. Y0). 
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Supplementary Table 3 | Quadratic regression analysis of individual gene 
expression profiles. 
Gene 
Equation coefficients 
P value 
Predicted 
Expression values 
a b(x) c(x2) 
 At  
start time 
 At  
final time  
ACTB 5.91 -0.01 6.48E-04 3.2E-04 5.91 7.60 
AKT1 1.32 -0.05 8.01E-04 2.6E-02 1.32 1.05 
AURKA 13.30 0.01 -1.37E-03 <1.0E-06 13.30 9.81 
AURKB 9.71 -1.2E-03 -3.86E-04 4.8E-03 9.71 8.43 
BCL2 0.87 0.02 8.54E-04 1.1E-04 0.87 4.50 
BRCA1 1.56 0.02 -5.83E-04 4.6E-02 1.56 0.92 
BUB3 10.63 -0.03 -1.69E-04 2.6E-03 10.63 8.42 
CASP2 0.98 0.05 -6.55E-04 8.3E-04 0.98 2.00 
CCNA1 3.92 0.24 -2.06E-03 <1.0E-06 3.92 10.93 
CCND1 0.64 0.03 7.00E-04 2.0E-06 0.64 4.36 
CDH1 10.17 0.03 -1.68E-03 <1.0E-06 10.17 6.50 
CDK1 6.95 -0.10 2.63E-03 1.0E-02 6.95 9.60 
CDK2 1.74 -0.01 6.24E-04 5.8E-03 1.74 3.07 
CDK7 12.05 -0.02 -8.09E-04 <1.0E-06 12.05 8.51 
CHEK2 6.95 -0.01 -6.11E-04 1.2E-05 6.95 4.28 
CRY1 2.85 -0.10 9.54E-04 <1.0E-06 2.85 0.09 
CTCF 3.83 -0.03 1.34E-03 4.3E-04 3.83 6.24 
CTNNB1 9.19 -0.02 -2.33E-04 4.7E-04 9.19 7.28 
DDX20 2.99 -0.01 9.04E-04 2.8E-02 2.99 5.02 
DDX4 4.46 -0.02 -1.54E-04 8.0E-06 4.46 2.66 
DNMT1 7.22 -0.03 -8.63E-04 <1.0E-06 7.22 3.03 
DNMT3A 7.49 0.03 -1.17E-03 8.2E-05 7.49 5.54 
DNMT3B 4.23 -1.6E-03 -8.87E-04 1.2E-05 4.23 1.36 
DPPA3 11.85 -0.05 1.67E-03 1.7E-02 11.85 14.02 
E2F1 1.25 -0.05 5.09E-04 <1.0E-06 1.25 0.23 
FASLG 1.03 0.09 -3.23E-04 <1.0E-06 1.03 4.82 
GADD45A 1.87 0.17 -1.42E-03 <1.0E-06 1.87 6.94 
GAPDH 9.59 0.04 -4.36E-04 3.6E-02 9.59 10.19 
GATA4 3.03 0.01 -9.43E-04 8.0E-06 3.03 0.36 
INCENP 5.59 -0.01 -3.15E-04 3.6E-04 5.59 4.06 
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MCL1 4.32 -0.07 2.89E-03 <1.0E-06 4.32 9.55 
MSH3 4.26 0.02 -1.16E-03 2.0E-06 4.26 1.65 
MSH6 0.07 -0.01 1.01E-03 <1.0E-06 0.07 2.72 
NLRP5 1.32 -0.04 5.22E-04 7.5E-05 1.32 0.51 
NPM2 7.27 0.04 -1.65E-03 6.0E-06 7.27 4.54 
OOEP 11.01 -0.03 -2.27E-04 2.4E-05 11.01 8.45 
PADI6 11.83 0.04 -2.02E-03 <1.0E-06 11.83 7.89 
PDCD5 9.41 -0.03 -7.92E-04 <1.0E-06 9.41 5.18 
POT1 8.52 -0.02 -1.57E-04 1.8E-02 8.52 6.84 
POU5F1 8.10 -0.02 9.06E-04 8.8E-03 8.10 9.70 
RAD52 0.23 -0.01 1.09E-03 2.0E-06 0.23 2.85 
RB1 6.20 -0.02 -6.55E-04 5.2E-03 6.20 2.99 
RCC2 8.81 -0.01 -3.12E-04 4.6E-05 8.81 7.34 
RPLP0 6.76 -0.03 1.49E-03 7.0E-06 6.76 9.96 
RPS24 5.95 -0.02 1.09E-03 9.9E-03 5.95 8.08 
SOX2 0.28 -0.02 1.88E-03 <1.0E-06 0.28 4.82 
TERF2 7.16 -0.01 -2.11E-04 2.7E-05 7.16 5.81 
TP53 5.64 0.01 -1.11E-03 1.0E-06 5.64 2.48 
TSC2 1.33 -0.01 -1.60E-04 2.9E-02 1.33 0.17 
TUBG1 6.11 -0.03 7.91E-05 1.2E-04 6.11 4.79 
XPA 2.89 -0.06 2.92E-04 <1.0E-06 2.89 0.18 
YBX2 3.38 -0.05 1.56E-05 <1.0E-06 3.38 0.59 
YY1 7.43 -0.03 1.85E-03 2.0E-06 7.43 11.41 
ZAR1 4.88 0.13 -1.08E-03 <1.0E-06 4.88 8.66 
ZSCAN4 1.61 0.15 -1.37E-04 <1.0E-06 1.61 9.33 
Only genes with P<0.05 (ANOVA test) are shown (n = 55).  
Predicted log2 values (y) were obtained by using the quadratic equation (y=a+bx+cx2) for the start time (x = 0) and 
the final time (x = 56h). 
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7.3 Supplementary movies 
(as separate files) 
 
Supplementary Movie 1 | Main kinetic frames for parameter calculation. 
Time-lapse imaging with the identification of the annotated frames until the eight-cell 
stage for later parameter calculation. Multicapture images from the last frame have been 
included at the end of the movie. 
 
Supplementary Movie 2 | Fragmentation appearance during zygote stage. 
Embryo at the zygote stage with two visible polar bodies generating fragmentation in the 
top side (frames 10-28). 
 
Supplementary Movie 3 | Fragmentation appearance during the first mitotic division. 
Time-lapse imaging showing a human embryo at zygote stage with two pronuclei and two 
polar bodies (frames 71-86), after pronuclear disappearance (frame 87), the first mitosis 
starts (frame 121) and afterwards some irregularities can be detected in the membranes 
(frame 123) giving origin to fragments before the first mitosis is completed (frame 127). 
 
Supplementary Movie 4 | Fragmentation appearance after the first mitotic division. 
Time-lapse imaging showing a human embryo completing the first mitotic division (frame 
78) and the generation of fragments in this stage (frame 93) 
 
Supplementary Movie 5 | Fragmentation dynamics during embryo development. 
A highly fragmented embryo imaging in which fusion of fragments (frames 306-316), 
fragment resortion for a blastomere (frames 324-332, frames 374-389), and fragment 
division (frames 447-458) were detected. 
 
Supplementary Movie 6 | Multinucleation in the human embryo. 
An embryo at zygote stage with 5 nuclei detected (frame 134) after a failed division 
attempt that generated high fragmentation. 
 
Supplementary Movie 7 | Vacuole fusion during embryo development. 
Human embryo at the zygote stage with three big vacuoles (frame 27) that are fused 
producing one larger one (frame 124). 
 
Supplementary Movie 8 | Abnormal first division from 1 to 3 cells. 
On the left, an embryo with normal mitotic divisions. On the right, an embryo with an 
abnormal first division from 1 to 3 cells. Multicapture images from the last frame have 
been included at the end of the movie.  
 
Supplementary Movie 9 | Abnormal first division from 1 to 4 cells. 
On the left, an embryo with normal mitotic divisions. On the right, an embryo with an 
abnormal first division from 1 to 4 cells. Multicapture images from the last frame have 
been included at the end of the movie.  
 
Supplementary Movie 10 | Abnormal third division from 1 to 3 cells. 
On the left, an embryo with normal mitotic divisions. On the right, an embryo with an 
abnormal third division from 1 to 3 cells. Multicapture images from the last frame have 
been included at the end of the movie.  
 
